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1 Introduction 
1.1 Summary 
 
This thesis study was designed to investigate the impact of the neuromodulator acetylcholine (ACh) 
on γ-aminobutyric acid (GABA)-ergic inhibition in neocortex. GABAergic inhibition counterbalances 
excitatory transmission by glutamatergic pyramidal cells (PY), the dominating neuronal cell type in 
cortex. Inhibition is provided by a diversity of interneuron (IN) classes which differ in terms of 
morphology, electrophysiological properties and sensitivity to ACh. Importantly, IN classes establish 
postsynaptic connections characterized by specific subtype composition of the GABAA receptors 
(GABAAR). Thus, the principal hypothesis investigated here is that ACh should modulate the quality 
and possibly the magnitude of GABAergic inhibition in neocortex by altering the relative inhibitory 
impact of different GABAAR subtypes. This hypothesis was investigated on the basis of subtype-
specific GABAAR pharmacology and targeted recordings of somatostatin-positive (SOM
+) INs in mostly 
spontaneously active in vitro preparations of neocortex. Congruent with expectations, ACh excited 
SOM+ INs and increased inhibition in the network, as evident in a higher frequency of inhibitory 
postsynaptic potentials (IPSCs) recorded in voltage-clamp experiments and shorter and smaller 
spontaneous network bursts in extracellular recordings in organotypic cultures of neocortex. To 
investigate the involvement of specific GABAAR subunits, GABAAR modulators with differing subunit 
preferences were tested in the presence and absence of ACh. Results revealed that the actions of 
GABAAR modulators on burst parameters and correlation of activity were specifically altered by the 
presence of ACh. Overall, inhibition and decorrelation increased most when the α1, 2, 3 modulator 
zolpidem was applied in the presence of ACh, while the additional modulation of GABAARs containing 
the α5 subunit with diazepam suspended the differences between the two ACh conditions. The 
functional antagonism of α5 subunit-containing GABAAR by L-655,708 evoked a difference between 
the two ACh conditions opposite to the differences seen with zolpidem. Thus, the α5 subunit is 
proposed to play an important role in ACh-induced inhibition. 
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1.2 The role of acetylcholine for cortical processing 
 
Cerebral cortex, the outer shell of the mammalian brain, functions as the main processing and 
storage center for afferent signals (e.g. sensory input) and relays processed information back to deep 
brain regions. It is organized into columns and layers, which take on specific functions. Neocortex, 
the largest part of cerebral cortex, is composed of five to six histologically distinct layers, depending 
on the area. According to the classic hierarchical model, sensory input from thalamus to sensory 
neocortex terminates in layers IV and VI, is transmitted to superficial layers II and III and outputted 
via subcortically projecting neurons in layers V and VI (Schüz and Miller, 2002; Xu and Callaway, 
2009). Additionally, layer V pyramidal neurons (PYs) are directly activated by thalamus 
(Constantinople and Bruno, 2013; Krause et al., 2014). PYs are glutamatergic projection neurons. 
They are the dominating cell type in cortex, which form excitatory intracortical subnetworks (Otsuka 
and Kawaguchi, 2008), and transmit the computational outcome to both, other cortical areas and 
extracortical brain regions .  
It has long been recognized that neuromodulators alter and shape cortical activity. Neocortex is the 
target of a number of neurotransmitter and –modulator systems, e.g. acetylcholine (ACh), 5-
hydroxytryptamine (serotonin), dopamine and noradrenaline, which help to fine-tune cortical output 
by modulating neuronal excitability (Bacci et al., 2005). The neocortex receives cholinergic input 
mostly from projection neurons located in the nucleus basalis of Meynert within the basal forebrain 
(Selden et al., 1998; Woolf, 1991). Although the entire depth of neocortex is innervated by 
cholinergic fibers, layers II-III, V and VI receive the most pronounced innervations, with region-
dependent specificities (Eckenstein et al., 1988; Tian et al., 2014; Zaborszky et al., 2013). A question 
still discussed in the literature is whether ACh fibers form classical synapses onto target neurons 
(synaptic transmission) or whether they release ACh nonspecifically into the extracellular space,  
providing a tonic-modulating concentration (volume transmission). In line with the classification of 
ACh as a neuromodulator (as opposed to a neurotransmitter) in the central nervous system (CNS), 
the volume transmission hypothesis has long been favored (Descarries, 1998; Kimura, 2000; Sarter et 
al., 2009; Yamamoto et al., 2010). Only recently, more evidence was provided for the co-existence of 
direct synaptic ACh transmission, which may be essential for specific attention tasks like cue 
detection (Parikh et al., 2007, 2008; Sarter et al., 2014; Turrini et al., 2001).  
On the behavioral level, ACh is involved in – grossly speaking – attention, wakefulness, learning and 
memory (Broussard et al., 2009; Hasselmo and McGaughy, 2004; Hasselmo and Sarter, 2011; 
Jiménez-Capdeville and Dykes, 1996). For example, in microdialysis studies it was shown that ACh 
concentrations were higher during wakefulness in comparison to sleep, especially during periods of 
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activity (Jiménez-Capdeville and Dykes, 1996; Marrosu et al., 1995). While concentrations of ACh 
changed state-dependently in somatosensory and visual cortical areas, no changes were measured in 
motor cortical areas (Jiménez-Capdeville and Dykes, 1996). These findings not only showed that the 
ACh status seems to play a role for the sleep-wake cycle but also suggested that ACh is necessary for 
stimulus processing. Another study by Parikh et al. (2007) supported the importance of ACh for 
attention by demonstrating that cue detection coincided with an increase in ACh concentration, that 
more cues were missed when cholinergic input to the medial prefrontal cortex (but not to motor 
cortex) were abolished and that the pre-cue cholinergic concentration was a predictor of cue 
detection. In line with these observations, cognitive impairment as seen for example in schizophrenic 
patients is likely related to a dysfunctional cholinergic system (Carruthers et al., 2015; Gould et al., 
2015). Patients suffering from different types of dementia are commonly treated with 
acetylcholinesterase inhibitors increasing the cholinergic level in the brain to improve cognitive 
performance (Engelhardt et al., 2007).  
Focused attention and cue detection involve an enhancement of the signal-to-noise ratio of afferent 
sensory information in neocortex (Wester and Contreras, 2013). Research has provided evidence that 
gating attention towards a specific stimulus is achieved by an ACh-induced reduction of ongoing 
cortico-cortical excitatory signal transmission amongst PYs. At the same time, thalamic afferent input 
to cortex, which carries information about the newly detected stimulus, remains unaffected, as 
recently confirmed by a calcium imaging study (Runfeldt et al., 2014). Thus, thalamic signaling is 
allowed to pass through to cortex, where it can be processed with less intracortical interference 
before it is relayed back to deeper brain regions (Castro-Alamancos and Gulati, 2014; Gigout et al., 
2012; Hasselmo and McGaughy, 2004; Oldford and Castro-Alamancos, 2003; Picciotto et al., 2012). 
This switch from intracortical communication to afferent input processing has been correlated with 
network activity in different frequency bands. During resting states (inactivity) and sleep when 
intracortical communication dominates, detected EEG frequencies mostly fall in the delta frequency 
band and below (≤ 5Hz), while states of activity, when new stimuli are processed, are associated with 
higher frequencies in the theta (~ 6-12 Hz) to gamma (~ 30-80 Hz) range (Cape et al., 2000; Manns et 
al., 2000). It has been shown that the presence of ACh leads to a decrease of the delta power and 
below, while power in the theta and gamma frequency bands increases, again supporting the role of 
ACh for attention (Buhl et al., 1998; Kalmbach and Waters, 2014; Tateno et al., 2005). The shift from 
low to high frequencies in the power spectrum caused by an increase in ACh concentrations has been 
termed desynchronization (Metherate et al., 1992). Another characteristic of the presence of ACh is 
reduced firing synchrony between cortical neurons termed decorrelation and thought to improve 
stimulus coding and perception (Goard and Dan, 2009).   
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Subnetwork- and cell type-specific modulation of excitation and inhibition seem to underlie the 
switch from inactivity or sleep to a state of attentiveness. Undoubtedly, ACh changes the state of 
excitability of neuronal groups in preparation for subsequent stimulus processing (Picciotto et al., 
2012). While tonic ACh concentrations can elicit depolarization in neocortical PYs of layer V via 
muscarinic and nicotinic receptors (Hedrick and Waters, 2015; Pafundo et al., 2013; Vidal and 
Changeux, 1993), ACh also has a strong inhibitory component mediated by multiple mechanisms 
(Arroyo et al., 2012; Gulledge and Stuart, 2005; Gulledge et al., 2007, 2009). Not only does phasically 
applied ACh inhibit layer V PYs directly via M1 muscarinic receptors located on these neurons 
(Gulledge and Stuart, 2005) and decreases glutamatergic excitatory postsynaptic potentials (EPSPs) 
via muscarinic M4 receptors (Gigout et al., 2012), but additionally some types of inhibitory γ-
aminobutyric acid (GABA) interneurons (INs) are excited by ACh and thus, inhibition mediated via 
these INs is strengthened by ACh (Amar et al., 2010; Blatow et al., 2003; Gulledge et al., 2007; 
Kawaguchi, 1997; Lucas-Meunier et al., 2009; Porter et al., 1999). Generally, different cortical IN 
classes respond in quite distinct ways to ACh application. Therefore, the effect of ACh on cortical 
GABAergic INs presumably plays a central role for the transition of the neocortical modus operandi 
from spontaneous intracortical activity towards thalamic input enhancement. Before effects of ACh 
on specific IN types are described in more detail, the GABAergic IN system will be introduced next. 
1.3 GABAergic INs in neocortex 
 
If neocortex were designed as a purely excitatory network, its computational capacity would be 
limited greatly and information transmission would eventually become unstable (Kepecs and Fishell, 
2014). Thus, modulation of PY activity by INs, which release the inhibitory neurotransmitter GABA, is 
indispensable. Even though INs only make up about 10 – 20% of the total neuronal population in 
neocortex, they powerfully counteract runaway excitation and allow for the execution of specific 
computational goals, promoting a dynamically adjustable network (Fino et al., 2013; Kepecs and 
Fishell, 2014; Rudy et al., 2011; Schüz and Miller, 2002). The proper balance between excitation and 
inhibition in the brain, which can be understood as the constant adjustment of inhibitory power in 
relation to excitation present in the network, is essential for normal functioning (Isaacson and 
Scanziani, 2011; Okun and Lampl, 2008). An insufficient amount of GABAergic inhibition – in 
combination with environmental factors – increases the susceptibility to numerous neurological 
disorders, e.g. epilepsy, schizophrenia, anxiety disorder and autisms (Gonzalez-Burgos and Lewis, 
2008; Jiang et al., 2012; Levitt et al., 2004; Rudolph and Möhler, 2014; Tai et al., 2014). By contrast, a 
controlled pharmacological increase in inhibition is a major molecular mechanism of anesthesia 
(Rudolph and Antkowiak, 2004).   
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The IN population is heterogeneous and the classification of IN types is in the center of an ongoing 
debate in the scientific literature (DeFelipe et al., 2013). INs can be grouped in terms of 
morphological, molecular and physiological features (Ascoli et al., 2008; Hu et al., 2014). On the basis 
of the coexpression of molecular markers, three main IN groups were identified by Rudy et al. (2011): 
Ca2+-binding protein parvalbumin-positive neurons (PV+), neuropeptide somatostatin-positive 
neurons (SOM+), and ionotropic serotonin receptor 5-HT3a-expressing neurons. These groups can be 
further subdivided by morphological and electrophysiological features. Briefly, the PV+ IN group has 
been split up into fast-spiking and multipolar bursting cells. Named after their morphological 
appearance, basket and chandelier cells both belong to the fast-spiking class (Figure 1). The SOM+ 
group is made up of Martinotti cells located in layers II/III to VI, some of which coexpress the Ca2+-
binding proteins calretinin (CR), calbindin (CB), the neuropeptide Y (NPY) or cholecystokinin (CCK). 
They can be fast-spiking, regular-spiking, or irregular-spiking with classic or bursting onset responses 
(Wang et al., 2004). Furthermore, a transgenic mouse line termed X94 revealed at least one further 
group of SOM+ cells located in layer IV and V and innervating layer IV, unlike Martinotti cells (Ma et 
al., 2006). The main group expressing the 5-HT3a receptor contains INs coexpressing the neuropeptide 
vasoactive intestinal polypeptide (VIP). Basket cells expressing CCK and innervating the soma of PYs 
belong to the VIP+ group. The rest of 5-HT3a INs are VIP-negative, but mostly reelin
+. In this thesis, PV+ 
basket cells and SOM+ Martinotti cells will be in focus, although other IN groups will also be 
discussed. 
FIGURE 1: CLASSIFICATION OF GABAERGIC CORTICAL INS BY MORPHOLOGICAL, MOLECULAR AND 
PHYSIOLOGICAL FEATURES (modified from Rudy et al. (2011)). 
 
1.3.1 PV+ basket cells 
 
About 50% of INs are PV+ multipolar basket cells; they make up the largest IN population and are 
likely the central building block of neocortical inhibition and essential for the excitation/inhibition 
PV+ 
FS 
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cells 
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MB 
5-HT3a 
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balance (Beierlein et al., 2003; Hu et al., 2014; Markram et al., 2004; Rudy et al., 2011; Xue et al., 
2014). Electrophysiologically, PV+ basket cells belong to the fast-spiking group, which is characterized 
by short action potential duration, a particularly low input resistance, a fast membrane time 
constant, and non-adapting firing patterns upon constant current injection. These characteristics 
endow the cells with the ability to discharge brief, high-frequency bursts of action potentials in 
response to synaptic excitation (Ascoli et al., 2008; Hu et al., 2014; Kawaguchi, 1995; Kawaguchi and 
Kubota, 1998; Klostermann and Wahle, 1999; McCormick et al., 1985). Additionally, molecular 
features including a high density of dendritic voltage-gated K+ channels and axonic Na+ channels, and 
the prevalence of fast P/Q-type Ca2+ channels and synaptotagmin 2 in presynaptic terminals set PV+ 
basket cells apart from other IN types (Hu et al., 2014; Kruglikov and Rudy, 2008; Rossignol et al., 
2013; Zaitsev et al., 2007). Their morphology is characterized by dense axonal arborizations near or 
just above their soma with horizontal branching (Kawaguchi, 1993, 1995). These basket-like 
structures are draped around somata, axon initial segments and proximal dendrites of PYs, where 
they establish synapses with GABAA receptors (GABAAR)  in which the α1 subunit dominates (Hu et al., 
2014; Kawaguchi and Kubota, 1998; Thomson et al., 2000; Wafford et al., 1993). Further description 
of GABAARs will follow later on.  
Taken together, PV+ basket cells are equipped to promote fast temporal signal integration and 
precise action potential propagation. They are involved in feedback and feedforward inhibition, but 
due to their non-adapting action potential firing and fast kinetics, they are especially suited for the 
latter type. Feedforward inhibition occurs if INs and their postsynaptically connected PYs 
simultaneously receive excitatory input. Briefly after the arrival of the excitatory pulse in both IN and 
PY, inhibition in the PY sets in and restrains or even prevents further PY output (Figure 2). In fact, 
multiple studies have provided evidence for strong excitatory input to PV+ basket cells from 
thalamocortical projection neurons and cortical PYs, which exceeds that observed in other IN groups 
and even PY neurons (Armstrong and Soltesz, 2012; Cruikshank et al., 2007; Kim et al., 2014; Rotaru 
et al., 2005; Xu and Callaway, 2009). As quickly as PV+ basket cells are engaged in activity, as 
promptly can they be shut off due to inhibition by other PV+ basket cells, by other interneuron types 
and autapses, and a sudden drop of excitation by the PYs with which they are reciprocally connected 
(Bacci and Huguenard, 2006; Bacci et al., 2003; Hu et al., 2014; Otsuka and Kawaguchi, 2009; Pfeffer 
et al., 2013). Thus, PV+ cells are embedded in multiple negative feedback loops. Moreover, the 
excitatory inputs PV+ cells receive are of a depressing nature, which are defined by an initial large-
amplitude EPSP but subsequently steadily declining EPSPs (Beierlein et al., 2003; Reyes et al., 1998). 
Hence, these INs are precisely tuned to the onset of PY activity. As they are tightly time-locked to 
excitatory input to PYs, they control the probability and timing of action potentials of PYs (Haider and 
McCormick, 2009; Hu et al., 2014; Rudy et al., 2011; Xue et al., 2014). 
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FIGURE 2: TWO DIFFERENT INHIBITORY PATHWAYS. 
 
1.3.2 SOM+ Martinotti cells 
 
SOM+ Martinotti INs are the counterpart to PV+ basket INs in multiple respects and seem to take on a 
complementing functional role within the inhibitory network as will be outlined below. 
Martinotti cells can be identified by their ascending axonal arbors and collaterals, which mostly 
terminate in layer I. They spread laterally and innervate tuft, apical and basal dendrites of PY cells 
across multiple columns (Fino et al., 2013; Gupta et al., 2000; Kawaguchi and Kubota, 1996, 1997; de 
Lima and Morrison, 1989; Ma et al., 2006; Wang et al., 2004). In contrast to PV+ basket cells, which 
form local subnetworks with neighboring PYs, the excessive branching and connectivity allow one 
Martinotti cell to innervate a multitude of PY targets even at great distance.  
Silberberg and Markram (2007) argued that most of the inhibition to PYs provided by Martinotti cells 
is restricted to the dendrites due to the long electrotonic distance of the synapse to the soma. In 
contrast to the powerful perisomatic inhibition by PV+ basket INs, dendritic inhibition is inadequate to 
control pyramidal somatic membrane potential and action potential output. However, it is well 
suited to prevent action potential-induced calcium spike generation in dendrites. This hypothesis was 
supported by in vivo and in vitro research, which showed that calcium signals are strong during 
phases of Martinotti cell inactivity (Gentet et al., 2012; Murayama et al., 2009), but considerably 
diminished especially by inhibition of apical dendrites provided by these INs (Marlin and Carter, 
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2014). Thus, Martinotti cells are presumably responsible for adjusting distal excitatory input in PYs 
through the control of dendritic integration (Silberberg and Markram, 2007).  
Not only morphological aspects clearly distinguish Martinotti cells from basket cells, but also their 
electrophysiological finger print and their firing pattern. In general, they have action potentials of 
much longer duration, a higher input resistance and a more depolarized resting membrane potential 
than PV+ basket cells (Kawaguchi and Kubota, 1996; Wang et al., 2004). The latter two of these 
characteristics make Martinotti cells more excitable and sensitive to electrical stimuli (Fanselow et 
al., 2008). Unlike PV+ basket cells, Martinotti cells cannot be clearly identified on the basis of their 
firing pattern. Some show a fast-spiking firing pattern similar to that of PV+ basket cells and fewer 
display a so-called stuttering or irregular-spiking firing pattern, but most are regular-spiking, which is 
characterized by an increase of the inter-spike interval over the duration of a depolarizing current 
step. Most regular-spiking cells fire a single spike at the onset of a depolarization step (classic onset); 
only few start with a spike doublet or an outright burst of spikes (Wang et al., 2004). Martinotti cells’ 
accommodating firing patterns allow for fundamentally different functionality in comparison to PV+ 
basket cells. Whereas basket cells supply local feedforward or feedback inhibition which is instant 
and strong, but also depressing, inhibition provided by Martinotti cells increases gradually and in 
proportion to the rate and duration of presynaptic discharges (Fino et al., 2013; Silberberg and 
Markram, 2007). This is partly the result of facilitating synapses connecting presynaptic PYs to 
postsynaptic Martinotti cells, but also a result of the wide dynamic firing range of Martinotti cells. 
Even though they settle to 3-10 Hz when excited, they are capable of transiently firing with up to 50 
Hz, which makes them more flexible than PV+ basket cells and adaptable to different network 
conditions (Fanselow et al., 2008).   
In terms of the network architecture, Martinotti cells are involved in a so-called disynaptic pathway, 
where they receive excitatory input from presynaptic PYs and mediate inhibitory output to 
neighboring postsynaptic PYs (Figure 2) (Silberberg and Markram, 2007). Unlike PV+ basket cells, they 
rely on local cortical information and are not or only sparsely innervated by thalamic afferents, 
depending on the cortical layer. Thus, disynaptic inhibition may serve as an intracortical mechanism 
to contain spontaneous PY activity and to mediate synchronization of PY action potential firing 
(Berger et al., 2010).  
1.4 Spontaneous network activity in vitro is regulated by INs 
 
The comparison of two types of INs in the preceding chapter illustrates exemplarily the diversity of 
GABAergic inhibition in neocortex. Firing modes of INs, their dendritic and axonal morphology, and 
the spatial distribution, postsynaptic targets and short-term plasticity of the synapses they establish, 
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are key factors determining their potential impact on cortical activity. The electrophysiological 
characteristics of INs have mostly been determined via intracellular stimulation or with the cortical 
network driven into action by sensory or artificial stimuli. In acute brain slices in vitro, such 
experiments were usually carried out on a background of nearly complete neuronal silence. 
However, it has increasingly been recognized that a neurophysiologically realistic picture of cortical 
function must incorporate spontaneous network activity, that is, neuronal activity which is not 
caused by external stimuli but is an emergent property of the neuronal networks. Spontaneous 
network activity is innate to the mammalian central nervous system including neocortex. Numerous 
studies have shown that the constant synaptic input into neurons caused by spontaneous activity has 
a profound impact on the integration properties of neurons (Destexhe et al., 2003), a feature which is 
routinely built into models of cortical networks. Spontaneous activity is thus both a factor influencing 
neuronal information processing and a naturally emerging, homeostatically regulated characteristic 
of cortical networks (Desai et al., 1999).   
In cortical networks in vitro, spontaneous activity originates in layer 5 and takes the form of 'bursts' 
('UP' states), which are phases of recurrent network activity, alternating with 'silent periods' ('DOWN' 
states), which are characterized by relative neuronal silence (Sanchez-Vives and McCormick, 2000). 
There are some differences in the properties of UP states between different in vitro preparations, 
especially between acute brain slices and organotypic slice cultures. In slice cultures, the rate of UP 
states is about an order of magnitude higher than in acute slices, most likely due to their high degree 
of synaptic connectivity (Drexler et al., 2010; Gähwiler et al., 1997; Johnson and Buonomano, 2007; 
Klostermann and Wahle, 1999). Regardless of the type of preparation, spontaneous UP/DOWN state-
like activity requires glutamatergic excitation and is shaped by GABAergic inhibition. Specifically, the 
diverse classes of INs are believed to govern UP states in diverse ways. Especially PV+ INs have the 
highest action potential firing rate during UP states in comparison to other INs (Neske et al., 2015), 
where they seem to be especially active in the beginning and at the end of an UP state (Puig et al., 
2008). While their role as restrainers of PY firing activity might suggest that the absence of PV+ 
activity during UP states would lead to even longer activity phases, the opposite was found. Multiple 
studies showed that the blockade of GABAAR and especially the prevention of PV
+ IN activity 
shortened UP states and led to more intense, high-frequency firing in the initial phase of the bursts 
(Kawaguchi, 1997; Kuki et al., 2015; Mann et al., 2009; Sanchez-Vives et al., 2010). Pharmacological 
enhancement of GABAergic currents either shortens or prolongs UP states, depending on the 
molecular mechanism (Antkowiak, 1999; Drexler et al., 2009; Razik et al., 2013). These findings 
collectively suggest that finely tuned IN activity is an important, but also incompletely understood, 
factor in shaping UP states. 
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Within UP states, cortical networks engage in high-frequency oscillatory activity over a wide 
frequency range (Steriade et al., 1996). Oscillations in the gamma band (40-80 Hz) arise from an 
interplay between excitatory and inhibitory neurons. Particularly PV+ INs have been suggested to be 
the initiator of gamma rhythms (Hasenstaub et al., 2005; Kuki et al., 2015). Due to electrical and 
chemical coupling of PV+ cells amongst each other, synchronized output is possible leading to gamma 
oscillations (Fries et al., 2007; Gibson et al., 1999). 
In contrast to PV+ INs, which play an important role within UP states, SOM+ INs have been reported 
to fire during both UP and DOWN states (Fanselow and Connors, 2010; Neske et al., 2015). Their role 
in UP state modulation is not clear. Although they have been proposed in the past to be responsible 
for the termination of UP states (Fanselow and Connors, 2010; Krishnamurthy et al., 2012), recent 
work could not support this hypothesis (Neske et al., 2015). Kuki et al. (2015) showed the 
involvement of SOM+ INs in the generation of delta oscillations embedded within UP states, which is 
the first time that low frequency bands have been associated with this IN type. 
ACh has been shown to modulate the neocortical interneuronal system via nicotinic and muscarinic 
ACh receptors (Alkondon et al., 2000; Aracri et al., 2010; Lucas-Meunier et al., 2009; Xiao et al., 2009; 
Yi et al., 2014). In the following, evidence is presented for the hypothesis that GABAergic 
interneurons are crucially involved in bringing about the change of cortical activity patterns seen 
upon cholinergic stimulation.   
1.5 ACh and GABA INs 
 
PV+ basket cells are the largest group of INs in cortex and thus one of the main study objects when 
the effect of ACh on inhibition is investigated. Intriguingly, the intrinsic properties of PV+ basket cells 
remain unchanged in the presence of ACh and thus it has been concluded that they are not directly 
or only marginally activated by bath or focal ACh application (Gulledge et al., 2007; Kawaguchi, 1997; 
Yi et al., 2014). Alitto and Dan (2013) stimulated basal forebrain cholinergic neurons and analyzed 
calcium imaging signals from PV+ basket cells in mouse layer 1 and 2/3 of visual cortex. About half of 
the cells responded with excitation, while the other half showed less activity. Additional application 
of CNQX, a competitive AMPA/kinate receptor antagonist, blocked the positive responses and thus 
confirmed the glutamate-dependence of ACh-induced excitation in PV+ cells. Conclusively, PV+ basket 
cells do not respond to ACh directly; however, ACh increases the glutamatergic excitatory input to 
PV+ cells, which can be detected as an increase of EPSP frequency in PV+ cells. As a result, their firing 
probability increases (Pafundo et al., 2013). It is likely that ACh-activated cortical PYs and 
thalamocortical input are the source of PV+ cell depolarization. Usually, this excitation would initiate 
the inhibitory feedback-loop where PV+ cell firing dampens prospective PY output. Surprisingly, 
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paired recordings from PV+ basket cells and PY cells revealed a cholinergic suppression of inhibitory 
postsynaptic currents (IPSCs) in PYs (Kruglikov and Rudy, 2008; Yamamoto et al., 2010). Thus, GABA 
release from presynaptic PV+ basket cell terminals was extenuated by ACh as a result of the 
activation of inhibitory presynaptic muscarinic M2/M4 receptors. Their presence on PV+ basket cells 
has been confirmed by immunohistochemistry for hippocampus and visual cortex (Disney and Aoki, 
2008; Hájos et al., 1997). Consequently, the inhibition of GABA release from these INs decreases 
feedback inhibition of PY cells in cortex. Due to this mechanism, the time window of signal 
transduction from thalamus to cortex is broadened and hence thalamocortical communication is 
improved.  
Not as much detail is known about the interaction of ACh with SOM+ INs. In general, these INs have 
been shown to react with strong depolarization when ACh was applied (Chen et al., 2015; Kawaguchi, 
1997), which seems to be mediated via muscarinic but not nicotinic ACh receptors (Fanselow et al., 
2008; Porter et al., 1999). Chen et al. (2015) recently provided evidence for a connection between 
SOM+ and PV+ INs, suggesting that SOM+ activation directly inhibits PV+ activity, which in turn would 
reduce somatic inhibition to PY cells. Thus, the activation of SOM+ INs through the cholinergic system 
and the ensuing inhibition of pyramidal dendrites but disinhibition of pyramidal somata very likely 
contributes to above-mentioned switch of neocortex' modus operandi.        
The observation that different IN types are differentially sensitive to ACh argues strongly in favor of 
an ACh-mediated qualitative switch of GABAergic inhibition. An important, but thus far largely 
uninvestigated ramification of such a switch is implied in the coupling of IN classes to specific 
postsynaptic GABAAR subtypes (Figure 3). For example, as briefly mentioned above, fast-spiking PV
+ 
basket cells establish synapses with mostly α1 subunit-containing GABAAR which possess fast decay 
kinetics. Therefore, a cholinergically mediated shift of the activation of IN types should also result in 
a differential activation of GABAAR subtypes. This raises the intriguing possibility of investigating the 
effect of ACh on GABAergic inhibition by GABAAR subtype-specific pharmacology. Before this central 
idea of the present study can be further developed, the composition, properties and pharmacology 
of GABAAR need to be explained. 
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FIGURE 3: SCHEMATIC OF PY-IN COUPLING IN NEOCORTEX. 
 
1.6 Coupling of GABAAR subunits to presynaptic IN types 
 
GABAARs are ligand-gated chloride channels. Activation of the receptor by GABA leads to an opening 
of the channel and, if the membrane potential is above the equilibrium potential of chloride, an 
inflow of chloride ions into the cell, which causes a hyperpolarization of the membrane potential. 
Independent of an effect on the membrane potential, opening of the receptor increases the 
membrane conductance, leading to a 'shunt' of excitatory input. GABAARs assemble as 
heteropentamers. Thus far, 19 subunits have been identified: α1-6, β1-3, γ1-3, δ, ε, θ, π, and 3 ρ 
subunits (Olsen and Sieghart, 2009).  The most common stoichiometry is 2 α : 2 β : 1 γ. Due to the 
diversity of subunits, a very large number of combinations would be possible. However, the number 
of observed and physiologically relevant receptor subtypes is limited. 60% of GABAARs consist of α1 
β2γ2 (Rudolph and Antkowiak, 2004), the most prevalent GABAAR subtype. The ultrastructural 
distribution of GABAAR is subunit-specific. Receptors containing α1-3, β1-2 and γ2 subunits can mostly 
be found in the synaptic cleft, where they mediate phasic inhibition. α4 and α6 βxδ subtypes are 
typical extrasynaptic receptors which are sensitive to low ambient concentrations of GABA; these 
receptor subtypes mediate tonic inhibition (Fritschy and Panzanelli, 2014; Korpi and Sinkkonen, 2006; 
Winsky-Sommerer, 2009). Receptors containing α5 (with β3γ2) subunits mediate both slow phasic and 
tonic currents and are located extracellularly and in pyramidal dendritic regions (Ali and Thomson, 
2008; Fritschy and Panzanelli, 2014; Serwanski et al., 2006; Yamada et al., 2007). 
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Benzodiazepines, a group of psychoactive drugs which mediate sedative, anxiolytic and 
anticonvulsant effects, are highly affine, positive allosteric modulators of GABAAR. They prolong the 
open times of the receptors. As a consequence, tonic and/or phasic inhibitory postsynaptic currents 
(IPSCs) and/or above-mentioned shunting effect are enhanced, leading to stronger inhibition of the 
postsynaptic cell (Rudolph and Antkowiak, 2004). The classical benzodiazepine binding site lies 
between the α and γ subunit of the GABAAR. Specifically, these substances have high affinities for 
GABAAR containing α1-3,5 and γ2 subunits, lower affinities for receptors with γ1 and γ3 subunits, and no 
affinity for receptors with α4 and α6 subunits (Olsen and Sieghart, 2009). Although most 
benzodiazepines like diazepam are characterized by a broad pharmacological bandwidth and are thus 
not subunit-selective, some benzodiazepines and related drugs do show preferences for receptors 
with certain subunits. One prominent example is zolpidem, a non-benzodiazepine, which is more 
likely to bind to receptors containing the α1 subunit (and temperature- and concentration-
dependently, α2/ α3) than to those containing α5 (Munakata et al., 1998; Olsen and Sieghart, 2009; 
Puia et al., 1991; Sanna et al., 2002; Sigel and Buhr, 1997). This characteristic in combination with 
specific receptor subunit knock-in mice makes these substances a valuable tool to investigate 
functional differences between GABAAR subtypes.   
To illustrate this last point, a study by Ali and Thomson (2008) will be described in more detail, in 
which zolpidem and diazepam were employed to study the association of cortical INs with 
postsynaptic GABAAR subtypes. Research in hippocampal slices had already suggested a specific IN 
type - GABAAR coupling (Freund, 2003; Nyíri et al., 2001). For example, PV
+ INs preferentially form 
synapses with GABAARs containing the α1 subunit, whereas PV-negative IN synapses have a low 
density of α1 (Klausberger et al., 2002; Thomson and Jovanovic, 2010; Thomson et al., 2000). For 
cortex, much less is known about IN-receptor subunit coupling. Ali and Thomson (2008) showed that 
neocortical GABAAR subunit insertion is also presynaptic neuron-specific. In this study, dual whole-
cell recordings were performed from IN-PY cell pairs and IPSPs were recorded from PYs in the 
presence of different GABAAR modulators. When zolpidem at a concentration of 0.4 µM was applied, 
IPSPs generated by PV+ INs were enhanced while SOM+ IPSPs remained stable. Keeping in mind 
zolpidem's preference for GABAARs containing the α1 subunit at the chosen concentration, the idea 
was supported that PV+ INs form synapses with this specific type of receptor. Diazepam, on the other 
hand, enhanced SOM+ IN-mediated IPSPs. This effect was attenuated by an α5-specific antagonist. 
Since the α5 subunit has been identified in dendritic synapses (Serwanski et al., 2006) and SOM
+ INs 
target PY dendrites, this subunit is the suggested postsynaptic partner for SOM+ neurons mediating 
the increase in inhibition seen with diazepam (Figure 3). Nonetheless, it needs to be stressed that IN-
PY GABAAR coupling in neocortex is almost exclusively based on above-mentioned study or inferred 
from data derived from hippocampus.  
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1.7 Project motivation 
 
In summary, INs play a crucial role in restraining and shaping excitation, and the neuromodulator 
ACh is believed to alter the contribution of the various IN types to inhibition. Although knowledge on 
the cholinergic excitability of the various IN classes and their interconnectivity is growing, a complete 
picture of cholinergic modulation of GABAergic inhibition is still far off. The impacts of activating pre- 
and postsynaptic nicotinic and muscarinic receptors on INs, and the mutual GABAergic inhibitory 
connections between INs are only two of numerous factors defining the complexity of cholinergic-
GABAergic interactions.  
The main hypothesis of the current project was that the population of GABAAR subtypes contributing 
to GABAergic inhibition should differ depending on the cholinergic status of neocortex. The approach 
to study these interactions was pursued based on GABAAR pharmacology.  It was hypothesized that a 
GABAAR subtype-preferring pharmacological enhancement or depression of GABAergic inhibition 
should have quite different impacts in different cholinergic states. GABAAR modulators with different 
receptor subtype preferences were tested in the presence and absence of ACh to investigate this 
general hypothesis. Because ACh activates some classes of INs, it was hypothesized that ACh might 
be able to enhance the effect of these modulators, as seen by an overall increase in inhibition.  
The first part of the project was dedicated to the effects of ACh alone. In this context, organotypic co-
cultures of the cholinergic cell-containing basal forebrain (BF) and the somatosensory neocortex 
were established. Ideally, in such preparations cholinergic neurons would fire spontaneously and 
provide neocortex with a close to physiological mode of delivery and level of ACh. Although the 
anatomy of this system has been described in the past, there are no electrophysiological results until 
the present day (Baratta et al., 1996; Distler and Robertson, 1992; Ha et al., 1999). Co-cultures were 
made from a mouse mutant expressing GFP in ACh neurons. Thus, it was possible to specifically 
target them in basal forebrain and monitor their activity with current clamp recordings during 
spontaneous network activity. However, as a success of this approach could not be predicted, 
conventional application of ACh via the bath solution was applied in all further experiments.  
Since Martinotti cells have been shown to depolarize in the presence of ACh but their overall 
contribution to network activity is still incompletely known, one experimental series was designed to 
understand their activity level in the presence and absence of ACh. A mouse mutant with GFP-
labelled Martinotti cells was used to reliably identify this cell type and specifically record from these 
cells during different ACh states in organotypic cultures and acute slices.  
For the main part of the project, different GABAAR modulators were bath-applied to somatosensory 
cortical organotypic cell cultures while ACh (ACh+ condition) or cholinergic receptor antagonists 
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atropine and mecamylamine (ACh- condition) were co-applied. The preferences of GABAAR 
modulators for specific receptor subtypes were used as a pharmacological tool to enhance inhibition 
at certain synapses but not at others. The main substances used were zolpidem and diazepam. While 
zolpidem (depending on its concentration) preferentially binds to GABAAR containing the α1 subunit 
(and α2/3 in higher concentrations), diazepam binds to GABAARs containing the α1,2,3,5 subunits and is 
thus a less specific GABAAR modulator than zolpidem.  
Due to the sensitivity of SOM+ INs to ACh and their association with α5 subunit-containing receptors, 
a notable difference between the ACh+ and ACh- condition was hypothesized for GABAAR modulators 
acting via these receptors (diazepam and L-655,708). Specifically, it was hypothesized that in the 
ACh+ condition positive allosteric modulation of these receptors would be enhanced compared to the 
ACh- condition because SOM+ IN activation by ACh would lead to an increase in GABA release. Since 
SOM+ IN activity was recently linked to decreased delta power and ACh has also been shown to shift 
spectral power from delta to higher frequencies, it was expected that the combined application of 
ACh and GABAAR modulators acting via α5 would lead to reduced power in the lower frequency 
spectrum (Kalmbach and Waters, 2014; Kuki et al., 2015). Moreover, the increase of SOM+ cell 
activity in the presence of ACh seems to be a fundamental cause of ACh’s desynchronizing and 
decorrelating effects (Chen et al., 2015). Hence, diazepam in combined application with ACh was 
expected to have especially strong decorrelating effects.  
The outcome of the combination of mostly α1-preferring substances like zolpidem at low 
concentrations with ACh was harder to predict. As previously described, ACh does not directly 
activate PV+ basket cells presynaptic to the α1 subunit-containing GABAARs. Presynaptic M2 receptors 
might even inhibit GABA release from PV+ INs. Additionally, Chen et al. (2015) provided evidence for 
direct inhibition of PV+ cells by activated SOM+ cells. Hence, it was believed that the GABAAR 
modulator in combination with ACh might result in less network inhibition than in the absence of 
ACh. According to Kuki et al. (2015), the reduced activity of PV+ cells might manifest itself as 
shortened activity phases and a decrease in higher frequencies.   
In order to characterize the IN-GABAAR coupling and the effects of ACh further, inhibitory 
postsynaptic potentials were recorded from cells in neocortex with the same GABAAR modulators 
under ACh+ and ACh-. This specific project was designed to focus specifically on the change of 
inhibition in the network and resolve the results received from the extracellular experiments 
described above in more detail. 
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2 Methods 
2.1 Animals 
 
For most of the experiments, organotypic cultures and acute slices were prepared from C57Bl/6 mice 
(Charles River, Sulzbach, Germany). Additionally, some experiments were carried out with strains 
Tg(Gad1-EGFP)98Agmo/J, henceforward called X98 for convenience, and B6.Cg-Tg(RP23-268L19-
EGFP)2Mik/J, furtheron called Mik (both by The Jackson Laboratory, Bar Harbor, Maine, USA). X98 
and Mik animals were housed in groups of three in an animal housing facility with food and water 
available ad libitum. A 12/12-hour light/ dark cycle was used with lights on at 07.00 A.M.  
2.2 Preparation system 
2.2.1 Organotypic cultures of somatosensory neocortex 
 
All procedures were approved by the local animal care committee (Eberhard-Karls-University, 
Tübingen, Germany) and were in accordance with German law on animal experimentation. 
Organotypic cultures of mouse neocortex mostly comprised of the somatosensory part were 
prepared and maintained in vitro using the roller-tube technique (Gähwiler, 1981; Antkowiak & 
Helfrich-Förster, 1998). Mice of postnatal age three to five days (P3-5) were deeply anesthetized with 
isoflurane and killed by decapitation. Once the brain was removed, it was cooled down in ice-cold 
dissection medium composed of Gey’s balanced salt solution (GBSS, Sigma-Aldrich, Taufkirchen, 
Germany) with 60 mM glucose (50%, Sigma-Aldrich) and 11 mM MgCl2 (Applichem, Darmstadt, 
Germany). With the cerebellum removed, the cerebrum was glued to the stage of a vibratome 
(NVSLMI Motorized Advance Vibroslice, World Precision Instruments, Berlin, Germany) and 300 μm 
thick slices were cut in the solution specified above. Pieces of neocortex were dissected, placed on 
glass cover slips and fixed with a coagulate of chicken plasma and thrombin (both Sigma-Aldrich), 
transferred into plastic tubes containing 750 μl of culture medium and incubated in a roller drum 
(Heracell 240, Thermo Scientific (Heraeus), Waltham, MA USA) at 10 rev/h at 37°C. The culture 
medium consisted of 50 % Basal medium Eagle, 25 % Hank's balanced salt solution and 25 % horse 
serum and had a final concentration of 1 mM l-glutamine and 61 mM glucose (Table 1). One day after 
preparation, the medium was changed and anti-mitotics were added to reduce glial proliferation. 
Thereafter, the culture medium was changed twice a week. After preparation and after each medium 
renewal, the cultures were incubated 1-2 h in an atmosphere of 5% carbon dioxide in room air, 
attaining a pH of 7.2-7.4. Cultures were used between two to six weeks of incubation.  
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TABLE 1: ORGANOTYPIC CULTURE MEDIA. The alternative culture medium was developed to potentially unify 
firing patterns. 
 
2.2.2 Co-cultures of basal forebrain and neocortex 
 
In the majority of experiments presented in this study ACh was applied externally via the bath 
solution, mimicking ambient ACh (e.g. Descarries (1998)). However, as there is also a phasic/synaptic 
component of ACh signaling (Sarter et al., 2009, 2014), an experimental series was dedicated to the 
investigation of this mode of cholinergic release. Co-cultures of basal forebrain (origin of cholinergic 
projection neurons) and neocortex were prepared. Organotypic cultures were prepared as stated 
above, except that a piece of neocortex was placed next to a piece of basal forebrain on a glass cover 
slip, both prepared from Mik mice of postnatal age three days. To provide a more physiological pH 
environment for the slices during the dissection process, GBSS-based dissection medium (pH = 8.20 
at room temperature) was substituted by Dulbecco’s phosphate buffered saline (DPBS; pH = 7.24 at 
room temperature; Sigma-Aldrich).  
It has been shown that neuronal growth factor (NGF) enhances cholinergic cell development, 
especially in the presence of urea (Mobley et al., 1986; Zassler et al., 2005). Thus, 10 µM urea (Sigma-
Aldrich) were added to the culture medium while 0.005µg/ml NGF (Sigma-Aldrich) were pipetted 
directly into the culture tubes upon culture medium change for the first two weeks. Additionally, 
pyruvate (2.5 mM; Sigma-Aldrich) was added to the culture medium as an energy source (Hodgkins 
and Schwarcz, 1998; Holmgren et al., 2010).  
One of the problems observed when recording from organotypic cultures was a drift in neuronal 
activity from initially long phases of activity to shorter but more frequent bursts within minutes (data 
not shown). It was hypothesized that the sudden change in ionic concentrations between the culture 
medium and the artificial cerebral spinal fluid (aCSF) in the bath chamber, particularly the decline of 
Substances Supplier Traditional culture 
medium 
Alternative 
culture medium 
Horse serum Life Technologies  25% 25% 
Basal medium Eagle with phenol 
red, without glutamine (BME) 
Sigma-Aldrich 50% 50% 
Hank’s balanced salt solution with 
phenol red (HBSS) 
Sigma-Aldrich 25% -- 
HBSS substitute self-made -- 25% 
Glucose Sigma-Aldrich 61 mM 30 mM 
L-glutamine Sigma-Aldrich 1 mM 1mM 
Sodium Pyruvate (for cholinergic 
neurons) 
Sigma-Aldrich 2.5 mM -- 
Urea (for cholinergic neurons) Sigma-Aldrich 10 µM -- 
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the potassium concentration, caused this phenomenon. The traditional nutrition medium cultures 
received for at least two weeks contained > 5 mM K+, a concentration chosen to promote neuronal 
activity and health during early development. On the other hand, the K+ concentration of the 
recording aCSF corresponded to rodent CSF with 3.5 mM K+. It appeared conceivable that cortical 
and basal forebrain neurons could be differentially susceptible to such sudden changes in the ionic 
environment. In order to exclude this factor as a confound, an alternative medium was created for 
this experimental series which had the same concentration of major ions (Na+, K+, Ca2+, Mg2+, Cl-) as 
the aCSF. Basal medium Eagle (BME) and horse serum were considered indispensable constituents of 
the medium as they contain numerous amino acids and other substances vital for long-term neuronal 
survival. The third component of the classical nutritional medium, Hank's balanced salt solution 
(HBSS), was substituted by a tailor-made medium (Table 2). The resulting ionic concentrations of the 
alternate medium were identical to those of the aCSF. Finally, the glucose concentration was halved 
from 60 mM to 30 mM (Table 1). Cultures received the traditional medium with high K+ from the day 
of preparation until day nine in vitro for optimal early cell development, and the alternative medium 
with low K+ and low glucose from day ten on until the recording day.   
 
TABLE 2: HBSS VS HBSS SUBSTITUTE 
 
2.2.3 Acute slices of neocortex 
 
For acute slice preparations, animals were deeply anesthetized with isoflurane and killed by 
decapitation. The brain was removed quickly and placed into ice-cold modified aCSF containing (in 
mM): NaCl 110.0, KCl 2.5, NaH2PO4 1.13, NaHCO3 26, MgCl2 10.0, CaCl2 0.5, D-glucose 10, buffered to 
pH 7.4 and saturated with 95% O2 and 5% CO2 (Table 3). After the brain was cooled down for about 
one minute, it was blocked at the cerebellum and the cerebrum was then glued to the stage of a 
Substances HBSS concentration 
(mmol/l) 
HBSS substitute concentration 
(mmol/l) 
KCl 5,366 -- 
NaCl 137,931 133.61 
CaCl2 2H2O 1,258 0.00 
D-glucose 5,551 65.13 
KH2PO4 0,439 -- 
MgCl2 6H2O 0,000 1.32 
MgSO4 0,812 -- 
NaHCO3 4,166 16.66 
NaH2PO4 0,399 2.36 
Phenolred*Na 0,029 -- 
KCl -- 1.10 
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microslicer (DTK-1000, Dosaka, Kyoto, Japan) with the dorsal side leaning against an agar block for 
enhanced mechanical stability during cutting. The stage was filled with ice-cold modified aCSF, which 
was continuously oxygenated. Using the microslicer, 300 μm thick slices were cut. Slices were 
immediately transferred into a holding chamber containing aCSF of the following composition (in 
mM): NaCl 120.0, KCl 3.5, NaH2PO4 1.13, NaHCO3 26, MgCl2 1.0, CaCl2 1.2, D-glucose 11.0, buffered to 
pH 7.4 and oxygenated (Table 3). Slices were incubated in the holding chamber for one hour at 34°C 
and then maintained at room temperature until recording.  
 
Substances Prep aCSF acute slices (in mM) Recording aCSF acute slices/ 
Organotypic cultures 
NaCl 110.0 120.0 
KCl 2.5 3.5 
NaH2PO4 1.13 1.13 
MgCl2  10.0 1.0 
CaCl2 0.5 1.2 
D-glucose 10.0 11.0 
NaHCO3 26.0 26.0 
TABLE 3: ACSF COMPOSITION 
 
2.3 Electrophysiological recordings 
2.3.1 In vitro extracellular recordings 
 
In vitro extracellular recordings were performed at 33-34°C under continuous superfusion with aCSF 
(flow rate 1 ml/min for cultures and 2 ml/min for acute slices). The aCSF was gassed with a mixture of 
95 % O2/5 % CO2. In experiments with drug application, organotypic cultures were placed into the 
recording chamber for 30 minutes prior to baseline recordings. Thus, cultures had time to adapt to 
the ionic differences between the culture medium and the aCSF. Extracellular recordings were 
carried out with aCSF-filled glass electrodes with resistances of 3-5 MΩ. For each recording, one 
electrode was placed in the supragranular layers II/III and a second electrode in the infragranular 
layer V of neocortex. Signals were amplified with a MultiClamp 700A amplifier (Axon Instruments, 
Union City, CA, USA) or a Microelectrode AC Amplifier 1800 (A-M Systems, Sequim, WA, USA) and 
digitized by a Digidata 1440A digitizer (Molecular Devices, Union City, CA, USA). Data were collected 
with a sampling rate of 10-20 kHz. Signal acquisition was performed using pCLAMP 10 software 
(Molecular Devices, Sunnyvale, CA, USA).  
One known confounding factor in the analysis of recordings from organotypic cultures is the 
systematic difference of activity patterns between different culture batches. To control for this 
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variability, at least three different culture batches were used per experimental block. Furthermore, 
one batch was usually used (if possible) for more than one experimental block so that between-
batches variability was apportioned roughly equally across experimental groups.  
2.3.2 Whole-cell voltage clamp recordings 
 
Whole-cell voltage clamp recordings were obtained from neurons in layer V of organotypic neocortex 
cultures. Glass pipettes (1.3-2.7 MΩ tip resistance with recording solution) were pulled from 
borosilicate glass (World Precision Instruments, Sarasota, FL, USA) with a laser puller (P-2000, Sutter 
Instrument Company, Novato, CA, USA) and filled with an intracellular solution containing (in mM): 
CsCl 145.0, MgCl2 1.0, EGTA  5.0, HEPES 10.0, ATP 4.0, QX 314 5.0, Alexa 555 0.05, pH 7.2. The 
theoretical liquid junction potential of this solution, determined with Clampex software (Molecular 
Devices), was -6.6 mV and was corrected for during the experiment. Cells were held at -70 mV in 
order to record inhibitory postsynaptic currents (IPSCs). Recordings were performed only when the 
initial access resistance did not exceed 9 MΩ and did not change by more than 40% during the course 
of the experiment. The NMDA and AMPA receptor antagonists, AP5 (50µM) and CNQX (10µM) (both 
Sigma-Aldrich), respectively, were added to the extracellular bath solution to block glutamatergic 
currents.  Signals were amplified with a MultiClamp 700A amplifier and sampled and digitized at a 
frequency of 20 kHz with a Digidata 1440A digitizer and pCLAMP 10 software. Neurons filled with 
Alexa 555 (Invitrogen/ Life Technologies, Darmstadt, Germany) were visualized by epifluorescence 
with a mercury arc lamp mounted on an Axioskop 2 FS plus microscope (Zeiss, Jena, Germany). PY 
cells were distinguished from interneurons by their large pyramidal-like shaped cell body, and apical 
dendrite and spines.  
2.3.3 Whole-cell current clamp recordings 
 
Whole-cell current clamp recordings were performed on Bl6 organotypic cultures, X98 organotypic 
neocortex cultures/ acute slices and MIK basal forebrain-neocortex co-cultures with simultaneous 
network activity recording by an extracellular electrode (applicable for cultures only). Patch glass 
pipettes (3-4 MΩ tip resistance with recording solution) were pulled from borosilicate glass (World 
Precision Instruments, Sarasota, FL, USA) and filled with an intracellular solution containing (in mM): 
K-gluconate 138.0, EGTA 10.0, CaCl2 0.5, HEPES 10.0, MgCl2 2.0, Na2ATP 3.0, GTP-Na 0.3, Na2-
phosphocreatine 10.0, pH 7.2. For visualization, either neurobiotin (5%, Linaris, Dossenheim, 
Germany) or Alexa 555 (0.05 mM) were added to the pipette solution. Signals were amplified with a 
MultiClamp 700A amplifier in current clamp mode. Series resistance was compensated for and 
generally between 10 – 20 MΩ. The calculated liquid junction potential of -17 mV was corrected for 
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offline. Temperature was kept at 33-34°C. After the initial break-through and sufficient time for cell 
stabilization, baseline activity was recorded.  
Depolarizing current pulses of increasing amplitude (duration, 400 ms) were used to stimulate action 
potentials, from which numerous cell characteristics were evaluated, including spike waveform, spike 
width at half-maximal amplitude, and stimulus-response curves for the spike rate including the 
maximal firing rate. However, the reaction of the neurons to current injection depended on 
spontaneous activity (Razik et al 2013): while during network bursts the responses were distorted 
and either amplified or depressed, they were as a rule depressed by the hyperpolarized membrane 
potential in immediate post-burst phases. Thus, obtaining undistorted responses would have 
required many repetitions of current injections, triggered to spontaneous bursts, which would have 
left less recording time for stimulation protocols which were deemed more important. Therefore, 
usually the sequence of depolarizing current injections was applied twice or thrice and the maximal 
firing rate determined from the least distorted response; this parameter is termed “approximate 
maximal firing rate” to indicate this fact.   
Small negative current pulses (140-300 ms, current adjusted to result in hyperpolarizing responses of 
5-10 mV amplitude) were repetitively injected into the cells; fitting single exponentials to the 
resulting hyperpolarizing membrane potential responses allowed the extraction of membrane 
resistance and time constant (see also paragraph 'current clamp analysis'). Together, these 
parameters were used in addition to morphological characteristics to classify cells.  
Cultures containing neurobiotin-loaded cells were fixed by immersion in 4% paraformaldehyde at 4°C 
overnight before they were washed three times for ten minutes each in 0.01 M phosphate-buffered 
saline (PBS). Then they were incubated in fresh 1.5% H2O2 in 0.01 M PBS and again washed three 
times for ten minutes each in 0.01 M PBS and three times for ten minutes each in Triton 4% in 0.01 M 
PBS. Cultures were incubated in the avidin-biotin complex (Vectastain Elite ABC kit, Vector Labs, 
Burlingame, CA, USA) for at least 60 minutes followed by washing them with 0.1 M phosphate buffer 
(PB) three times for ten minutes each and incubating them with DAB (Vector) for two to four 
minutes. Cultures were rinsed with 0.1 M PB twice for 20 minutes each, dehydrated in graded 
ethanol, washed with Xylol and covered with DePex. Not all cells could be stained sufficiently. 
Stained cells were visualized under a Leitz Orthoplan microscope with an oil immersion objective 25x 
and photographed with a Pentax K20D camera. 
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2.3.4 Applied substances 
 
All drugs were administered via O2/CO2-saturated aCSF. The drug-containing aCSF was delivered to 
the perfusion chamber via a system of gas-tight syringes (Hamilton, Reno, NV, USA) driven by syringe 
pumps (Harvard Apparatus, Holliston, MA., USA) and connected to teflon tubing.  
For the central part of the thesis, GABAAR modulators with different GABAAR subunit affinities were 
compared in two conditions marked by the presence and absence of tonic cholinergic activity, 
henceforth called ACh+ and ACh-, respectively. For the ACh+ condition, a constant cholinergic tone 
was created by bath-applying ACh (1 or 10 µM) together with the ACh esterase inhibitor neostigmine 
(1 µM). For ACh-, the cholinergic system was completely blocked by the application of muscarinic 
receptor antagonist atropine (1 µM) and the nicotinic receptor antagonist mecamylamine (3 µM). An 
overview over all application schemes is provided in table 4.  
 
Experiment Control Drug 1 Drug 2 Wash 
CC ACh+ aCSF ACh & Neo / aCSF 
VC ACh+ aCSF ACh & Neo Atr & Mec aCSF 
VC TTX & ACh+ aCSF TTX ACh & Neo / 
Extra ACh+ & ACh- aCSF ACh (1/ 10 µM)  
& Neo 
Atr & Mec aCSF 
CC & Extra Co-
culture Mik 
aCSF Neo Atr & Mec aCSF 
CC & Extra X98 aCSF ACh & Neo / aCSF 
VC ACh+ sham ACh & Neo ACh & Neo Atr & Mec ACh & Neo 
VC ACh & Ana ACh & Neo Zolpi (1/ 0.2 µM)/  
Dia 
Atr & Mec ACh & Neo 
Extra ACh+ & Ana aCSF ACh & Neo Zolpi (1/ 0.2 µM)/ 
Dia/ Dia in α1 mutant/ 
L655,708 
aCSF 
Extra ACh- & Ana aCSF Atr & Mec Zolpi (1/ 0.2 µM)/ 
Dia/ Dia in α1 mutant/ 
L655,708 
aCSF 
TABLE 4: DRUG APPLICATION DESIGN. Experiments are ordered according to order of appearance in results 
section.  
 
The common drug application scheme started with a six-minute recording of the baseline condition, 
during which the cultures or acute slices received aCSF alone. After a twelve-minute wash-in period 
of the substance(s), a second six-minute recording followed. In a subset of experiments, a second 
drug was applied for another twelve minutes, followed by a further six-minute recording. The 
experiment ended with a twelve-minute wash-out period of all drugs followed by a final recording in 
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order to assess the reversibility of the drug effects. Specific drug applications are explained in the 
results section.  
Five different GABAAR modulator conditions were tested in the current work. Concentrations of 
substances were chosen in a way to modulate specific single GABAAR subunits or combinations of 
subunits in the most effective way. Zolpidem was used in two different concentrations distinguished 
by differential GABAAR subunit preferences. While a concentration of 0.2 µM preferentially binds to 
receptors with the α1 subunit as reported in the literature, 1.0 µM additionally modulates receptors 
containing the α2 and α3 subunit (Munakata et al., 1998). To indicate preference (instead of 
selectivity), zolpidem (0.2 µM) is later on marked in figures as α1 (2, 3), while zolpidem (1.0 µM) is 
marked as α1, 2, 3.  
Diazepam was used to target GABAAR containing α1, α2, α3 and α5 subunits. The concentration used 
here was chosen based on Drexler et al. (2010b), who showed a concentration-dependent biphasic 
action of diazepam. Between 50 nM to 6.25 μM, diazepam had a plateau effect in decreasing the 
firing rate by about 20%. Starting at 12.5 μM, firing rate decreased constantly in a concentration-
dependent manner. The GABAAR antagonist bicuculline only partially antagonized these effects, 
suggesting unspecific binding of diazepam in high concentrations. Additionally, Puia et al. (1991) 
showed that the affinity for the α3 subunit-containing receptors increases disproportionately to 
receptors with the other three subunits diazepam binds to with increasing concentrations. Thus, the 
concentration used in the current project (1 μM) was chosen from the plateau concentration range, 
since a clear, GABAAR-specific effect was expected at this concentration with a relatively balanced 
activation of all four receptor classes. Nonetheless, the exact weighting of the different receptor 
classes for this concentration is not known. Diazepam was also applied in the α1-knock-in mouse 
strain, in which GABAARs containing the α1 subunit cannot be modulated by benzodiazepines. This 
paradigm was used to investigate the modulation of receptors with the α2, α3 and α5 subunits.  
Lastly, L-655,708 was employed, which is a highly specific, negative allosteric modulator of GABAAR 
containing the α5 subunit. In the case of L-655,708, concentrations were not as critical since a 50-fold 
selectivity of this drug for GABAAR containing the α5 subunit over GABAAR with α1, α2, α3, and α6 has 
been shown, and concentrations differing by a factor of 10 had nearly the same effect on tonic 
inhibitory currents in hippocampus (Caraiscos et al., 2004; Quirk et al., 1996). L-655,708 was applied 
at 5 µM in the current project for effective blockage of α5 subunit-containing receptors. All drugs, 
their supplier and concentrations used for specific experiments are listed in table 5. 
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Substance Abbreviation Concentration  Target site and action Supplier Experiments 
Acetylcholine  ACh 1 µM 
 
 
 
1 µM & 10 µM 
Agonist of muscarinic and nicotinic 
cholinergic receptors 
Sigma-Aldrich CC Bl6 cultures 
CC/extra Mik co-culture 
CC X98 acute/ culture 
VC Bl6 
Extracellular Bl6 cultures 
(2R)-amino-5-
phosphonovaleric acid 
AP5 50 µM Antagonists on NMDA receptor Tocris VC Bl6 
Atropine  1 µM Antagonists on muscarinic cholinergic 
receptors 
Sigma-Aldrich Extracellular culture Bl6 
CC/extra Mik co-culture 
VC Bl6 
6-cyano-7-
nitroquinoxaline-2,3-dione 
CNQX 10 µM Antagonists on AMPA/kianate receptors Sigma-Aldrich VC Bl6 
Diazepam-Lipuro Dia 1 µM Positive allosteric modulator on GABAAR 
containing α1, 2, 3, 5 subunits 
Uni-pharmacy Extracellular Bl6/ α1 
mutant 
VC Bl6 
L-655,708  5 µM Negative allosteric modulator on GABAAR 
containing α5 subunit 
Tocris/Biotrend  Extracellular Bl6 
Mecamylamine Mec 3 µM Antagonist on nicotinic cholinergic receptors Sigma-Aldrich Extracellular culture Bl6 
CC/extra Mik co-culture 
VC Bl6 
Neostigmine Neo 1 µM Inhibitor of acetylcholinesterase  Sigma-Aldrich  CC Bl6 cultures 
Extracellular Bl6 cultures 
CC/extra Mik co-culture 
CC X98 acute/ culture 
VC Bl6 
Tetrodotoxin TTX 1 µM Na2+ channel blocker Tocris VC Bl6 
Zolpidem Zolp 0.2 µM 
 
1 µM 
Positive allosteric modulator of GABAAR 
containing α1 subunit 
Positive allosteric modulator of GABAAR 
containing α1, 2, 3 subunit  
Sigma-Aldrich Extracellular Bl6 
VC Bl6 
TABLE 5: SUBSTANCE LIST. All drugs used were listed for each experiment; VC: voltage clamp; CC: current clamp; Bl6: black 6 mouse strain; X98: X98 mouse mutant strain
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2.4 Data analysis 
2.4.1 Extracellular data from spontaneously active organotypic cultures 
 
All data analyses described below were performed in custom-written programs in Matlab (R2008a-
R2014a). 
Most data collected for this thesis project were obtained from experiments on cortical organotypic 
slice cultures (Figure 4A). A distinguishing feature of these cultures in comparison to cortical acute 
slice preparations is their spontaneous network activity. The typical activity pattern is marked by 
alternating phases of high network activity (bursts) and low collective neuronal activity (silent 
periods) as displayed in figure 4B. Hence, the first step of analysis consisted of quantifying and 
describing the degree and pattern of this activity by parameterizing bursts and action potential 
activity. To this end, the raw extracellular signal was split up via digital Butterworth bandpass filters 
into local field potential (LFP; passband 1-100 Hz) and action potential (AP; passband 300-5000 Hz) 
signals (Figure 4B). Filtering was performed in both forward and reverse direction (via Matlab routine 
'filtfilt'), resulting in zero phase shifts. The LFP signal was used for the detection of network bursts 
(Figure 4C). Network bursts were variable in shape, often composed of a large initial transient and 
smaller, oscillatory signal excursions, here collectively termed 'burstlets'. In order to capture both 
positive and negative burstlet components the LFP was rectified.  
A threshold was set, and sub- to suprathreshold transitions of the LFP were defined as the beginning 
of a burstlet. The end of a burstlet was defined as the point in time when the LFP signal made a 
supra- to subthreshold transition across a second threshold, which was set to 20-100% of the first 
threshold (Figure 4C). A series of burstlets separated by less than 400-700 ms was defined as a burst. 
Single burstlets of less than 20 ms duration usually represented artifacts and were rejected. Multi-
unit action potentials were detected in the high frequency-containing signal (300-5000 Hz) by setting 
a threshold to about four times the standard deviation of the base line noise, and registering the 
times of sub- to suprathreshold transitions of the signal. 
Once the detection of bursts and action potentials was concluded, a wide range of parameters 
describing activity (e.g. burst length, action potential rate) was computed. Of these, a subset of six 
parameters was chosen for analysis and statistical comparisons between drug conditions, based on 
the following considerations: 
a) As LFP and AP signals reflect different aspects of neuronal activity (mostly synaptic input versus 
suprathreshold excitation), parameters based on both signals were picked. 
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FIGURE 4: SCHEMA OF EXTRACELLULAR RECORDING AND DATA ANALYSIS. A. Scheme of cortical organotypic 
culture and electrode placement during extracellular recordings. B. Raw data (upper trace) was filtered to 
extract the local field potential (LFP; middle trace) and action potential activity (AP; bottom trace). C. For burst 
detection, the absolute value (second trace) of the LFP (first trace) was used. Then, two thresholds were used 
to define the beginning and the end of the burst phases, respectively (third trace). Burst length is measured 
from the beginning to the end of a burst (time in ms), while silent periods were measured from burst end to 
beginning of the next burst. The burst amplitude is determined from the burst envelope (fourth trace). D. 
Construction of peri-event time histograms (PETH) of APs. APs were collected in bins covering pre-and post-
burst time as determined on the basis of the LFP. Time point zero of the PETH is the burst beginning. 
  
 
b) As specific manipulations of GABAergic inhibition result in specific, fingerprint-like alterations of 
burst structure, burst shape and the overall degree of activity (Razik et al., 2013; Sanchez-Vives et al., 
2010), parameters describing these aspects of spontaneous activity were chosen. 
Thus, the following parameters were chosen: action potential rate, fraction of time bins containing 
action potentials, relative time spent in burst, burst rate, burst length (Figure 4C) and burst peak 
amplitude (Figure 4C last trace). A summary explaining the derivation of all parameters can be found 
in table 6.    
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Parameter  Unit Description 
Action 
potential rate 
Hz Time-averaged multiunit action potential frequency (number of 
action potentials divided by recording length) 
Burst rate Hz Field-potential based burst frequency (number of field potential 
bursts divided by recording length) 
Fraction of 
active bins  
Dimensionless 
(range 0 – 1) 
Recording is subdivided into time bins (100 ms). The number of bins 
containing action potentials is divided by the total bin count.  
Relative time 
in burst 
Dimensionless 
(range 0 – 1) 
Time occupied by bursts divided by total recording time. It is the 
fraction of time the networks spend in a neuronally active state. 
Equivalent to “fraction of active bins”, but based on local field 
potential. 
Burst length ms Median length of bursts as detected in the field potential  
Burst 
amplitude 
mV Mean peak amplitude of envelope of field potential within first 500 
ms of bursts 
TABLE 6: DESCRIPTION OF EXTRACELLULAR ACTION POTENTIAL AND BURST PARAMETERS.  
 
Beyond this 'classical' burst and action potential analysis, spectral analysis was performed. Each 
recording was divided into segments with a length of 16.384 seconds and an overlap of 8.192 
seconds. Each segment was windowed with the Blackman-Harris window function; a Fast Fourier 
Transform was applied and the power spectral density (PSD) was computed for the frequency range 
0.5 to 200 Hz. The resulting PSDs were averaged across segments. 
Furthermore, the synchrony and similarity of the LFP signals between recording sites (supragranular 
vs. infragranular layer) were quantified via cross-correlations. Cross-correlation analysis was 
performed for broadband LFP signals ([1-200] Hz, here termed 'wide band') as well as for bandpass 
filtered signals in five different frequency bands: δ [2-5] Hz, θ [6-12] Hz, β [15-30] Hz, γ [30-50] Hz, 
high γ [50-80] Hz. Filtered LFP traces were divided up into 30 second long segments. Pairs of 
segments were cross-correlated and for all signals the largest positive peak of the cross-correlation in 
an interval of [-0.25 0.25] seconds was determined.  
In order to describe the relation between action potential and LFP signals at each recording site, a 
spike density function was computed from the spikes detected at the site. This was done by 
representing each detected spike by a triangular window (half-width 6 ms) and adding the resulting 
triangular waveforms (Nawrot et al., 1999; Szűcs, 1998). This resulted in a discrete time series here 
termed 'instantaneous firing rate' (ifr) which was cross-correlated with the LFP signals from the same 
recording electrode (segment length was 30 s as above). Specifically, ifr were correlated with the LFP 
filtered in the δ, θ, and β band, and with the envelope of γ and high γ band. The analysis was meant 
to assess the correlation between the magnitude of action potential firing and the magnitude of the 
oscillations; the timing of action potentials within the oscillation cycle was not of interest. Therefore, 
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the envelope of the cross correlations were computed, and the peak of the envelope was 
determined in an interval of [-0.25 0.25] seconds. 
Lastly, the temporal profile of action potential activity during network bursts (as defined via the local 
field potential) was quantified via peri-event time histograms (PETHs) (Figure 4D). Peri-burst time 
was divided into bins of 10 ms length; the number of APs falling into each bin was counted for each 
individual burst and the values converted to Hz by dividing the counts, averaged across bursts, by the 
bin width (Figure 4D). 
2.4.2 Whole-cell current clamp analysis 
 
In organotypic cultures, intracellular signals recorded in current clamp mode reflect spontaneous 
network activity as well as extracellularly recorded signals (Czarnecki et al., 2012; Razik et al., 2013). 
Therefore, spontaneous bursts and action potentials in current clamp data traces were detected by 
threshold analysis in a manner similar to that employed for extracellular signals. Prior to analyses of 
the average pre-, post and within-burst membrane potential explained below, action potentials in 
the voltage traces were pruned by replacing the spike waveforms by a linear fit through the 
membrane potential values flanking the spike waveforms (2 ms on either side).  
Spontaneous activity strongly influences cellular parameters like membrane resistance and time 
constants (Destexhe and Paré, 1999). In some neurons in organotypic cultures, the low membrane 
resistance as observed during bursts recovers only very slowly (on the order of seconds) to high, 
'resting' values (Razik et al., 2013). In order to obtain values of these parameters during a most stable 
and precisely defined state of the network, they were determined from responses to hyperpolarizing 
current injections only in silent periods up to 1 s before each burst. In similar vein, the resting 
membrane potential (Emrest) was analyzed in fixed intervals of [-1500 -200] ms before bursts. The 
membrane potential within bursts (Emburst) was analyzed in an interval of [15 80] ms after burst 
beginning. Last, the difference between the Em before and after each burst (Embefore and Emafter, 
respectively) was analyzed. The median Em was determined in a 0.40 s time interval before each 
burst and 2.00 to 10.00 s after each burst with interval length from 0.20 s up to 5.00 s (depending on 
the burst frequency in each recording). Then, the difference between Embefore and Emafter was 
calculated per burst and the median of this difference was calculated for each recording under 
control, ACh and wash condition. In this manner, changes in Em in relation to bursts were evaluated 
for different drug conditions.   
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2.4.3 Whole-cell voltage clamp analysis 
 
'Classical' analysis of data traces containing spontaneous inhibitory postsynaptic currents (IPSCs) 
consists of isolating individual events and quantifying their frequency, amplitude and decay and rise 
times. Due to the high degree of synaptic connectivity in the cultures the frequency of inhibitory 
postsynaptic currents was quite high, leading to a substantial overlap between IPSCs. This posed a 
challenge insofar as single events with an uninterrupted decay phase were rare and an analysis based 
solely on a very small subset of events can be expected to be biased in several ways. The analysis of 
IPSC data was therefore two-pronged, consisting of i) a classical routine adapted to a frequent 
overlap of IPSCs and ii) an approach pioneered by Glykys and Mody (2007) which did not rely on the 
detection of IPSCs (Figure 5 presents details of the analysis). 
 
 
FIGURE 5: ANALYSIS OF IPSCS. A. Exemplary current trace from a cortical cell under drug-free condition 
featuring numerous overlapping IPSCs. B. Pseudo-differentiated current trace representing the rising phase of 
IPSCs as negative 'spikes'. Blue dotted line is the threshold used for detecting IPSCs (marked by magenta dots). 
C. Same current trace as in A, but inverted and with Ipredict overlaid in ochre (see main text). Minimal fit quality 
was R
2
=0.3. Note that about half of the detected IPSCs were not incorporated in Ipredict as they either did not 
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conform to the minimal fit quality criterion or were spaced too closely to each other. IPSC marked by a star did 
satisfy the quality criteria for both inclusion in Ipredict and the final selection and is illustrated in D. D. Left, IPSCs 
marked by star in C. Overlaid trace is Ipredict prior to fitting of this IPSC. Right, same IPSC as left, but with Ipredict 
subtracted. Blue overlaid trace is the double exponential fit to this IPSC. E. Same current trace as in A, shown to 
illustrate the quantification of inhibitory current independent of the detection of IPSCs. Gray area is the integral 
of the current trace, assuming a base line (thin black line) as described in the main text, corresponding to a 
'total phasic current' of -43.2 pA in the excerpt shown.  
 
2.4.3.1 Adapted classical analysis 
Inhibitory postsynaptic current traces were first passed through a 'pseudodifferentiation' routine, 
which consisted of running a boxcar filter of 0.5-1.0 ms length through the data and subtracting the 
resulting signal by a copy of itself shifted by 0.5-1.0 ms to the left (Banks et al., 2000). The 
pseudodifferentiation isolated the rapid rising edge of the IPSCs and eliminated both the much 
slower decay of the IPSCs and fluctuations of the base line, similar to a highpass filter. A time point at 
which this signal crossed a manually set threshold was defined as the time of occurrence of an IPSC. 
IPSCs thus detected were cut out and passed through a Savitzky-Golay filter (polynomial order 5, 
frame size 1.0-1.2 ms), which efficiently eliminated noise but preserved the steep rise phase of the 
IPSCs. From each of the cutouts, the base line was computed and subtracted from the waveform, 
followed by a computation of the peak amplitude and 10-90% rise time. Thus, up to this stage the 
routine yielded values of IPSC frequency, rise time and amplitude independent of any fitting 
procedure. For the computation of all other parameters, which were based on fitting the decay 
components of individual IPSCs to a double exponential function, unfiltered current traces were 
used. The fitting algorithm accommodated overlaps between IPSCs to some degree by subtracting 
from each IPSC the extrapolated current decays of preceding IPSCs (Figure 5). This was done in a 
sequential way as follows: starting with the first IPSC, each IPSC was investigated for the length of its 
decay phase uninterrupted by subsequent (detected) IPSCs. A double exponential fit was performed 
if the uninterrupted decay phase was at least 8-12 ms long, otherwise the IPSC was discarded. The 
length of the actual decay fitted was limited by the lesser of [time of occurrence of a subsequent 
IPSC, end of maximal fit interval of 35-40 ms]. If the fit quality parameter R2 (discussed below) 
exceeded a threshold of 0.3-0.6 the IPSC's decay was extrapolated up to ten times its weighted decay 
time constant. The resulting extrapolated current trace was added to a template array (initialized 
with zeros) which matched the length of the whole recording and is here termed 'Ipredict' for 
convenience. From each of all subsequent IPSCs matching excerpts of this extrapolated current were 
subtracted prior to fitting, and the process described above repeated. The algorithm was not able to 
trace bursts of IPSCs separated by less than the minimal time interval required for fitting, but it did 
resolve a proportion of IPSC doublets and occasionally triplets with an inter-event separation which 
was above said limit but still so short as to compromise the following IPSCs (Figure 5C, D). 
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R2, the coefficient of determination (range 0 to 1), indicated which proportion of the variance in the 
data (decay phase of IPSC) was explained by a decay over time as quantified by a double exponential 
fit. Its value depended strongly on the ratio of IPSC amplitude to current noise amplitude, being low 
for low ratios. Hence, a threshold value of 0.3-0.6 can be regarded as conservative, preferring large, 
well-fit IPSCs. Note that at this stage the chosen value of R2 determined only the inclusion of IPSCs 
into Ipredict; the final selection of IPSCs for analysis followed an additional criterion designed to reflect 
the quality of the fit in a manner less dependent on IPSC amplitude:  
𝑚𝑠𝑒𝑛𝑐 =
𝑚𝑠𝑒𝑓𝑖𝑡 −𝑚𝑠𝑒𝑛𝑜𝑖𝑠𝑒
𝑎𝑚𝑝𝐼𝑃𝑆𝐶
 
where  
msefit is the mean squared error of the fit to the data 
msenoise is the mean squared error of the noise, obtained from a highpass-filtered 
version of the IPSC (-3dB frequency of 500 Hz) 
ampIPSC is the amplitude of the IPSC.  
msenc (nc = noise-corrected) is a measure of the fit error, expressed as the deviation of the data from 
the fit, corrected for the deviation expected given the current noise level, and scaled by IPSC 
amplitude. The cutoff value ranged between 0.8 and 1.0.  
Finally, from the IPSCs/fits fulfilling the quality criteria, the following parameters were computed: 
weighted decay time, weighted amplitude, and charge per IPSC (Table 7).  
 
Parameter full name Unit Description 
Weighted decay time 
τ 
ms Time from peak until IPSC decays to 36.8 % (100/e) of its peak 
amplitude  
IPSC frequency Hz Number of IPSCs divided by recording length 
IPSC amplitude pA Mean amplitude of peak IPSCs 
Phasic current pA Integral of inhibitory currents divided by recording time 
TABLE 7: DESCRIPTION OF IPSC PARAMETERS. 
 
As the analysis of IPSCs in the aforementioned way involved many subjective choices of analysis 
parameters, the results may be biased. Furthermore, particularly in recordings with a substantial 
overlap of IPSCs only a minority of IPSCs could be retained for analysis on the basis of above-
mentioned criteria. The sequential selection of IPSCs based on fit quality explained above usually 
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resulted in a 50-95% loss of events relative to the initial detection stage. The implication of this 
strong pruning of IPSCs would have been a severe underestimation of the total charge transferred by 
all IPSCs. This parameter was of interest here because it quantifies the sum of all inhibitory inputs 
experienced by the cell recorded from. Therefore, a method independent of the detection of 
individual IPSCs based on the approach by Glykys and Mody (2007) was used and is described in the 
next paragraph. 
2.4.3.2 Current analysis independent of IPSC detection  
The whole recording was passed through a Savitzky-Golay filter as described above and divided into 
segments of 4 s, and from each of these segments an all-points histogram (bin width 2 pA) was 
computed. Due to the presence of IPSCs, the histograms were skewed toward negative values. A 
Gaussian was ﬁtted to the unskewed part of the histogram up to the bin representing the first peak. 
The abscissa value of the Gaussian’s maximum was taken as the baseline of the data segment, and 
subtracted. The integral of the trace thus obtained, divided by its duration, yielded the total charge 
transferred per time, here termed 'total phasic current' (Figure 5F). In a final step, values from all 
segments were averaged. 
2.5 Statistical analysis 
2.5.1 Normality and homoscedasticity of analyzed data 
 
A characteristic of spontaneous activity in cortical cultures is the large variability of burst- and silent 
period duration and frequency in different preparations and culture batches as described in more 
detail by Johnson and Buonomano (2007) and Razik et al. (2013). Even in one culture and under 
constant conditions, short and long bursts can appear. The baseline variability has to be taken into 
account in the choice of statistical analyses of such data.  
First, values for all extracted parameters were plotted as histograms and boxplots to visually 
characterize the distributions in terms of normality and homoscedasticity (homogeneity of variance), 
respectively. A number of tests are available to statistically predict if a sample originated from a 
normally distributed population. However, simulation data has shown that normality tests are 
especially susceptible to small sample sizes because power is too small and thus, normality test 
results are heavily biased (Öztuna et al., 2006; Razali and Wah, 2011). Because sample sizes within 
this thesis project can all be considered “small”, no adequate test-based prediction about the 
underlying distributions could be made. Therefore, non-parametric statistical tests, which do not 
depend on normality, were used for the analysis. For independent data sets, the Kruskal-Wallis 
omnibus test was used followed by the Wilcoxon ranksum test for specific group comparisons. 
Dependent data were analyzed with Friedman’s test to compare more than three groups and 
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Wilcoxon signed rank test for post-hoc analysis. Although non-parametric statistics do not rely on the 
assumption of normality, they very well assume approximately equal variances (Erceg-Hurn and 
Mirosevich, 2008). Therefore, all data sets were tested for homoscedasticity with the non-parametric 
Brown-Forsythe test (data not shown). For the Brown-Forsythe test, the median was subtracted from 
each individual value of a sample data set. The resulting absolute differences from the median were 
compared between samples to evaluate the equality of variances. Almost all compared data sets 
passed the test for homoscedasticity. However, in some rare cases where variances were unequal, p-
values were marked with a ‘†’ since test assumptions were violated. In some cases, results of 
variance analyses were reported as test result since large differences of variances can be interpreted 
as treatment drug effect.   
Even though p values were reported for reader reference, an evaluation of the statistical significance 
of a result was based on a robust measure of effect size, area under the receiver operating 
characteristics  curve (AUROC) and corresponding confidence intervals  (see paragraph below).  
2.5.2 Effect size and confidence intervals: Auroc 
 
The Measures of Effect Size toolbox for Matlab by Hentschke and Stüttgen (2011) was used for 
statistical analysis to determine differences between experimental treatment conditions. For all 
analyses between two groups, effect sizes with 95% confidence intervals (CI) were reported in 
addition to traditional Chi2 (Χ2) and p-values. For the comparison of two groups, the p-value alone 
only gives the probability of obtaining a difference between the groups as large or larger than the 
one observed, given the Null Hypothesis of no difference (which is usually rejected if p < 0.05). A 
measure of effect size was provided to quantify the actual size of the difference between two 
samples. Thus, it could be explicitly stated how large the treatment effect actually was in comparison 
to a control condition. A number of measures are available to quantify the size of an effect. A non-
parametric and robust effect size – one which does not depend on normality and homoscedasticity – 
is AUROC (Grissom and Kim, 2012) and was used for all data sets analyzed. A detailed and 
enlightening description of the calculation and interpretation of AUROC is given in an article by 
Brown and Davis (2006).  
For the purpose of this study, AUROC can be interpreted as the probability of superiority. It means 
that the probability (Pr) that a randomly sampled score of sample X (Xi) exceeds (is superior to) a 
randomly sampled score from sample Y (Yi) as in Pr (Xi > Yi) (Grissom and Kim, 2012). AUROC can 
range from 0 to 1, where 0 refers to the case when none of the values in X exceed Y (Pr (X i > Yi) = 0 
(floor effect: all scores of sample X are smaller than scores of sample Y)), and 1 means that all values 
in X exceed those in Y (Pr (Xi > Yi) = 1 (ceiling effect: all scores of sample X are larger than scores of 
sample Y)). In both of these extreme examples, there is no overlap between the two sample 
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distributions. For 0.5, values in X and Y exceed each other equally often, hence there is no difference 
between the two samples.  
As an example, consider the following values for group X and group Y: 
 
Group X Group Y Result 
5 7 5 < 7; 5 > 3; 5 > 4  
6 3 6 < 7; 6 > 3; 6 > 4 
8 4 8 > 7; 8 > 3; 8 > 4 
  
Now, all values in group X will be compared to all values in group Y. Out of nine possible comparisons 
(3 x 3), values in group X exceed values of group Y seven times and two values in X are smaller than in 
Y. Here, Pr (Xi > Yi) = 7/9 = 0.78. When interpreting the thesis results later in the results section, it is 
important to keep in mind that the superiority of X over Y is calculated and thus, the input order of 
variables into the equation matters. In all cases, the order of input variables into the statistical 
equation reflected the drug application order during the experiment. Thus, a decrease of a 
parameter relative to control would present as an AUROC value above the null effect value of 0.5.  
In order to decide if an effect is small or large, the following index was provided by Grissom (1994): 
AUROC of 0.56 can be considered as a small effect, 0.64 is a medium effect, and 0.71 is a large effect. 
To evaluate the precision of the effect, 95% confidence intervals (CIs) were calculated by 
bootstrapping. CIs can be interpreted in different ways depending on their usage. Here, the CI is 
meant as a range covering the true population mean with a confidence of 95% (Cumming et al., 
2007).  
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3 Results 
 
3.1 Effects of tonic acetylcholine (ACh+) on spontaneous activity in 
organotypic cortical cultures 
 
Data for this thesis project were gained from electrophysiological recordings in vitro with the main 
focus on spontaneous activity of organotypic cultures of somatosensory neocortex. Some of the 
experimental series were also performed on co-cultures of basal forebrain and cortex and cortical 
acute slices. Spontaneous network activity in cultures was examined during the combined application 
of GABAAR modulators with ACh and neostigmine or cholinergic receptor antagonists. These 
substance combinations were studied to investigate how cholinergic modulation alters GABAergic 
inhibition in neocortex. Before this main question was tackled, the sole role of ACh on the cortical 
network was extensively tested with extracellular, current clamp, and voltage clamp experiments.  
3.1.1 Lack of substantial cholinergic tone in neocortical cultures 
 
In the first experimental block, three independent series (I-III) of paired extracellular recordings from 
supra- and infragranular somatosensory cortical layers were conducted. The goal was to assess if the 
neuronal network state differed with externally supplied ACh and without (presumably a state of 
cholinergic inactivity). Each of the three series began with a control recording in the absence of any 
drug. Following control, no external ACh was supplied in the sham condition (series I), or ACh (1 µM) 
and the acetylcholine esterase-inhibitor neostigmine (1 µM) were applied together (series II) or ACh 
(10 µM) and neostigmine (1 µM) were applied (series III) (Table 8). Each of these three conditions 
was followed by and contrasted with the ACh- condition defined by the application of the muscarinic 
receptor antagonist atropine (1 µM) and the nicotinic receptor antagonist mecamylamine (3 µM). 
The rationale for applying cholinergic blockers and thus ensuring the absence of any cholinergic 
action in the ACh- condition was an assessment not only of the effects of externally supplied ACh, but 
also of the intrinsic cholinergic tone in the cortical networks: Even though the main source of ACh in 
cortex is provided by cholinergic projection neurons from basal forebrain, cortex also contains 
cholinergic INs (Consonni et al., 2009; Engelhardt et al., 2007). Reversibility of the drug effects was 
screened in a wash-out condition terminating each experiment. 
For statistical comparison of the three experimental series with each other, the modulatory effects of 
putative intrinsic ACh (sham – series I) and externally supplied ACh (series II and III) were expressed 
as changes in activity in the ACh- condition. Specifically, within each experiment, data from the ACh- 
condition were normalized to the preceding conditions (Table 8); these normalized data sets were 
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compared with each other via a Kruskal-Wallis test, followed by specific pairwise comparisons in the 
case of a significant omnibus effect (supplementary material Table S1).  
 
Codition  Drug application order 
 
I 
Sham 
  
Control  
(drug-free) 
 
ACh-  
(Atropine (1 μM) & 
Mecamylamine (3 μM)) 
 
Wash-out 
(drug-free) 
 
II 
ACh (1 μM)  
 
Control  
(drug-free) 
 
ACh+  
(ACh (1 μM) &  
Neostigmine (1 μM)) 
 
ACh-  
(Atropine (1 μM) & 
Mecamylamine (3 μM)) 
 
Wash-out 
(drug-free) 
 
III 
ACh (10 μM) 
 
Control  
(drug-free) 
 
ACh+  
(ACh (10 μM) &  
Neostigmine (1 μM)) 
 
ACh-  
(Atropine (1 μM) & 
Mecamylamine (3 μM)) 
 
Wash-out 
(drug-free) 
TABLE 8: DRUG APPLICATION SCHEME. Data in the three ACh- conditions (in bold) were each normalized to the 
preceding condition (ACh+ or control) and then statistically compared to each other.  
 
Six parameters of neuronal activity were investigated, which were: action potential rate, fraction of 
active bins, burst rate, relative time in burst, burst length and burst amplitude. Action potential rate, 
fraction of active bins and relative time in burst were chosen to allow statements about the degree 
of activity; burst rate and burst length revealed firing pattern changes, and burst amplitude was used 
to evaluate the shape of activity (see Methods section for a detailed description).  
Since the antagonism of cholinergic receptors should reverse ACh+-induced effects, it was 
hypothesized that changes of neuronal activity from ACh+ to ACh- should be noticeable. Contrasting 
these effects with those of ACh- without previous ACh application would reveal the strength of the 
intrinsic cholinergic tone. Judged by visual inspection of exemplary raw data (Figure 6), cholinergic 
blockade altered spontaneous activity notably if it was preceded by either of the two ACh+ conditions 
(Figure 6B, C), but less so if it was preceded by the drug-free control condition (sham) (Figure 6A). 
Boxplots in Figure 6 indicate that ACh- following drug-free control increased the median burst rate 
while having no effect on burst amplitude (Figure 6A, n = 13). By contrast, ACh- decreased burst rate 
and increased burst amplitude when applied subsequent to the ACh+ conditions (Figure 6B, n = 21 
and C, n = 14). In accordance with these observations, differences between the three groups were 
detected for burst rate, burst length and burst amplitude.   
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FIGURE 6: CHOLINERGIC MODULATION OF EXTRACELLULARLY RECORDED SPONTANEOUS NETWORK 
ACTIVITY. A. Effects of cholinergic receptor blockade (ACh
-
) following a drug-free control. Top row, exemplary 
raw data. Boxplot (left) shows burst rate (Hz) for supra- and infragranular layers during control and ACh
-
. 
Boxplot (right) shows burst amplitude for the same recording sites and drug conditions. In all box plots, data 
points considered outliers in each group were collectively marked by a single '+' symbol placed at the threshold 
(dotted horizontal line) and their values were given as text. Bonferroni correction: p < 0.025; CI 0.975. B. Similar 
depiction of data as in A for effects of cholinergic receptor blockade (ACh
-
) following cholinergic stimulation (1 
μM ACh + 1 μM neostigmine, termed ACh
+
). C. Similar depiction of data as in B for effects of cholinergic 
receptor blockade (ACh
-
) following cholinergic stimulation with 10 μM ACh + 1 μM neostigmine.  
 
For example, differences for burst rate between ACh- normalized to control (I), ACh- normalized to 
ACh+ (1 µM) and ACh- normalized to ACh+ (10 µM) were detected with an omnibus test 
(supragranular layers: Χ2 (2) = 9.47, p = 0.009) (Figure 7A). Directly contrasting the burst rate for ACh- 
normalized to control (I) to ACh- normalized to either of the two ACh+ conditions (II & III) revealed 
differences (I & II supra:  p = 0.01, auroc [95% confidence intervals (CIs)] = 0.77 [0.56 0.94]; I & III 
supra:  p = 0.005, auroc 0.82 [0.60 0.97]) (Figure 7B).  Auroc values and corresponding CIs for burst 
rate, burst length and burst amplitude are displayed in Figure 7B. An auroc value of 0.5 can be 
interpreted as no difference between conditions; 0 and 1 describe maximal effects (calculations and 
interpretation of auroc are described in great detail in the Methods section). For the three other 
parameters, no differences were detected (supplementary material Table S1). 
 
 
FIGURE 7: COMPARISON AND STATISTICAL ANALYSIS OF THE EFFECTS OF CHOLINERGIC RECEPTOR BLOCKADE 
(ACH
-
) FOLLOWING CONTROL (DRUG-FREE) OR ACH
+ 
(1 OR 10 ΜM) CONDITIONS. A. Effects of ACh
-
 on burst 
rate in the supragranular layer. Data from the ACh- condition were normalized to either the preceding control 
(drug-free; left data set), ACh
+
 (1 μM; middle data set) or ACh
+
 (10 μM; right data set) conditions. Pairs of data 
sets thus normalized were compared statistically and the results plotted in B. B. Effect size (auroc) values with 
95% confidence intervals (CI) from pairwise comparisons of normalized effects of ACh- for three burst 
parameters. Dotted horizontal line depicts the auroc 'null' value. 
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Lastly, differences between the ACh+ and ACh- condition were analyzed based on PETHs (Figure 8). 
First, comparing the effect of ACh- following the control condition revealed no difference between 
the two conditions (Figure 8A, left panel) as PETHs were almost congruent. This observation was 
verified by the auroc effect size values for each bin, which were close to 0.5. When ACh- was 
compared to wash-out (Figure 8, right panel), firing rates for each bin stayed approximately the same 
with corresponding auroc values of about 0.5 indicating no change. Thus, in agreement with previous 
analyses, the ACh- condition did not have an effect on firing patterns. Figure 8B and C display PETHs 
for control and ACh+ (1 µM) and ACh+ (10 µM) (left panel), respectively. For both concentrations, but 
more so for the higher ACh concentrations, firing rates were higher prior to burst beginning (before 
time point 0) in the presence of ACh (auroc value above 0.5) and lower during the initial phase of the 
burst (~ first 50 ms) in comparison to the control conditions (auroc value below 0.5). When 
cholinergic blocker were applied and compared with the two ACh+ conditions (Figure 8B & C, right 
panel), firing in bins prior to burst beginning decreased (auroc below 0.5), but increased during the 
initial burst phase. Thus, cholinergic effects were reversed by blocker. 
In summary, antagonizing effects of cholinergic blockers were shown following the ACh+ condition for 
two different concentrations of ACh but not for the sham condition. The main conclusion drawn from 
this experimental set is the absence of significant endogenous release of ACh in organotypic cultures 
of cortex. Since the two conditions ACh+ and ACh- differed substantially, they were used for 
subsequent experiments studying the effects of ACh alone and as baseline conditions during 
experiments with GABAAR modulators. The lower ACh concentration (1 µM) was sufficient for a 
notable contrast between ACh+ and ACh- and was further on the standard ACh concentration. 
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FIGURE 8: PETHS AND EFFECT SIZES FOR ACH-, ACH+ (1 µM) AND ACH+ (10 µM). All results shown in this 
figure were recorded in infragranular layers. A, left. PETHs are shown for control (grey) and ACh- (black) (n = 
13). A, right. PETHs are shown for ACh- (black) and wash (n = 12). Below, auroc effect sizes are presented to 
show effects of ACh- in comparison to control and wash, respectively. B, left. PETHs are shown for control 
(grey) and ACh+ (1 µM) (rosé) (n = 20). B, right. PETHs for ACh+ (1 µM) (rosé) and ACh- (n = 20). Below, auroc 
effect sizes are presented to show effects of ACh+ in comparison to control and ACh-, respectively. C. Same as 
B, except that ACh+ was applied in higher concentration (10 µM), n= 14.       
 
3.1.2 ACh altered the activity pattern and reduced membrane potential excursions in 
current clamp experiments 
 
To gain a more detailed understanding of the effects of tonic ACh on spontaneous neuronal activity 
in organotypic cortical cultures, first, a variety of neuron types across cortical layers were recorded in 
whole-cell current clamp mode (n = 13). Recordings of spontaneous activity were performed under 
three successive conditions (in order of application): (I) drug-free control, (II) ACh+ (as defined 
above), and (III) wash-out. The first block of analyses dealt with characterizing changes in activity by 
means of the same parameters as employed for the extracellular data analysis. Thus, comparisons 
between the present current clamp data set and extracellularly recorded data described in chapter 
3.1.1 were possible. For all parameters, the ACh+ condition (II) was compared with both drug-free 
control (I) and wash-out (III) conditions. The change of activity from the control condition (I) to the 
ACh+ condition (II) was termed ACh+ effect, whereas the transition from ACh+ (II) to wash-out (III) was 
termed wash effect. To illustrate the effects visually, auroc effect sizes and 95 % confidence intervals 
(CIs) for ACh+ and wash effects for each parameter were plotted (Figure 9). Results showed that ACh 
changed the activity in comparison to the control recording in a reversible manner (Figure 9, 
supplementary material Table S2). Action potential rate, fraction of active bins, burst rate and 
relative time in burst increased during the ACh+ condition (auroc < 0.5); burst length was shortened 
(auroc > 0.5). The largest effect was observed for burst rate, which almost doubled (median [25th & 
75th quantile]: Ctrl = 0.08 [0.04 0.11] Hz; ACh+ = 0.14 [0.09 0.20] Hz; p = 0.003; auroc [95 % confidence 
intervals] = 0.30 [0.13 0.41]). Overall, these findings were in good agreement with the results from 
the extracellular recordings described above. For each parameter, the effect induced during the ACh+ 
condition was reversible as seen by the mirror-symmetry of ACh+ effect and wash effect values. 
Summing up, the overall intracellular activity level increased and network patterns changed notably 
during the ACh+ condition. 
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FIGURE 9: EFFECT SIZE ANALYSIS OF ACH TREATMENT ON AP AND BURST PARAMETERS AS ASSESSED IN 
CURRENT CLAMP RECORDINGS. The plot shows auroc values (filled symbols) and 95 % confidence intervals 
(vertical bars) for two sets of pairwise comparisons: "ACh effect" is the effect of ACh+ in relation to the 
preceding control (drug-free) condition. "Wash effect" is the effect of wash in relation to the preceding ACh+ 
condition. Note the mirror-symmetry of the auroc values around the null effect value of 0.5, illustrating 
reversibility of the modulatory effects of ACh+. 
 
Next, intracellular parameters were analyzed to gain a more detailed understanding of cholinergic 
modulatory effects. Two raw data examples are displayed in Figure 10. In Figure 10A, recordings 
from a neuron from supragranular layers are shown. The cell was identified by its high input 
resistance (155.28 MΩ), spike width at half amplitude of 1.05 ms and approximate maximal firing 
frequency of about 26 Hz - electrophysiological characteristics typical for regular-spiking INs in 
culture (Czarnecki et al., 2012) (It cannot be ruled out that the cell was possibly a PY neuron. 
However, measured parameters fit better with the description of regular-spiking INs in culture by 
Czarnecki et al. (2012) than the characterization of PYs in culture by Klostermann and Wahle (1999)). 
Under control conditions, the neuron displayed activity typical of neurons in spontaneously active 
neocortical organotypic cultures (Antkowiak and Helfrich-Forster, 1998; Czarnecki et al., 2012; 
Johnson and Buonomano, 2007): regularly recurring, strong depolarizations accompanied by action 
potential activity, an activity pattern termed network 'bursts', separated by periods of relative 
neuronal quiescence ('silent periods'). In the ACh+ condition, the resting membrane potential (Emrest) 
was slightly depolarized, bursts were shortened and their rate of occurrence increased. The second 
neuron (Figure 10B) was a fast-spiking cell from infragranular layers (input resistance: 39.45 MΩ; 
spike width at half amplitude: 0.48 ms; approximate maximal firing frequency: 119 Hz).    
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FIGURE 10: CURRENT CLAMP RECORDINGS IN THE PRESENCE OF ACH. A. Raw data traces from current clamp 
recordings of a regular-spiking cell. Data was recorded during control (drug-free), ACh
+
 and wash-out. Drug-
application or wash-out time was 12 minutes. Note the strong depolarization of the membrane potential 
followed by a dip in spike amplitude at burst begin (control condition, arrow) and a notable burst 
afterhyperpolarization (control condition, arrowhead), all of which are much less prominent in the ACh
+
 
condition. Rightmost panels show adapting spiking pattern elicited by current step injection (approximate 
maximal firing rate was 26 Hz) and microscopic image of the biocytin-filled cell. B. Raw data traces recorded 
from a fast-spiking cell (approximate maximal AP rate 119 Hz, see rightmost panel). 
 
Similar to the neuron described above, spontaneous activity occurred in clearly separable bursts, but 
during ACh+ Emrest hyperpolarized. Possibly as a consequence of this hyperpolarization, the cell fired 
less during bursts. For all recorded cells, ACh+ had no effect on cell resistance R (median [25th & 75th 
quantile]): Rcontrol = 106.01 [61.57 173.04] MΩ; RACh = 109.84 [85.73 130.87] MΩ; Rwash-out = 98.55 
[81.72 126.98] MΩ; Χ2 = 0.67, p = 0.72. However, as mentioned above, visual inspection of the raw 
data traces suggested that ACh exerted strong effects on Em. Hence, changes in Em were analyzed by 
selecting three time windows around bursts (Figure 11A): (a) directly before the bursts (Emrest), (b) 
during burst beginnings (Emburst), and (c) after the bursts terminated. Due to spontaneous activity in 
organotypic cultures, the baseline mean Emrest was determined in a pre-burst time window of [-1500 
-200] ms. Results were averaged for each cell under control, ACh+ and wash condition and 
summarized in Figure 11D. No consistent effect of ACh+ was observed: some cells were slightly 
depolarized while others were hyperpolarized (one cell was excluded because of a missing wash 
recording, n = 12; median [25th & 75th quantile]): Emrest-control = -77.20 [-78.97 -74.27] mV; Emrest-ACh = -
74.56 [-79.43 -71.35] mV; Emrest-wash-out = -72.69 [-75.88 -70.62] mV; Χ
2 = 4.67, p = 0.10.    
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FIGURE 11: RESULTS OF CURRENT CLAMP RECORDINGS IN THE PRESENCE OF ACH. A. Example of a 
spontaneous network burst illustrating peri-burst time windows and differences between time windows used 
for membrane potential analysis. Aa. Emrest [-1500 -200] ms prior to burst beginning. Ab. Emburst [15 80] ms 
after burst beginning. Ac. Δ Em = Empre [-400 0] ms before burst beginning - Empost [burst end +2.000] to [burst 
end +10.000] ms. B. Exemplary excerpts of bursts illustrating the difference in initial depolarization and spiking 
ability between control and ACh+. C. Example of difference between Em in control (grey) and ACh+ (rosé) after 
burst end (Empost) and before burst beginning (Empre). Thick traces and shaded areas are averaged traces and 
standard deviations, respectively, from one recording. D. Plot of Emrest for the three different drug conditions. 
Grey points and lines are from individual experiments, black lines and vertical bars represent medians with 
25th and 75th quantile. E. Plot of Emburst for three different drug conditions. Grey points and lines are from 
individual experiments, black lines and vertical bars represent medians with 25th and 75th quantile. F. Plot of 
ΔEm. Grey points/ lines from individual experiments; black lines/ vertical bars are medians with 25th and 75th 
quantile. Note that median value of ΔEm is close to zero during the ACh+ condition.  
 
This finding confirmed the diversity of effects of ACh on different cortical cell types as reported by 
other groups (Gulledge et al., 2007; Kawaguchi, 1997). 
Even though the action of ACh+ on Emrest was very cell-specific, some coherent effects were observed. 
Under control condition, most cells went into a depolarization block in the first phase of a burst. 
During this time, Em was briefly depolarized to a degree that cells were unable to fire action 
potentials until Em reached a more negative level again. When ACh+ was applied, the depolarization 
block was greatly reduced or even removed completely in some cases, resulting in a more regular 
firing pattern throughout bursts as seen in figure 11B. For analysis, action potentials were removed 
(see Methods) and Em was averaged in a time window [15 80] ms after burst beginning and 
compared between control, ACh+ and wash condition (Figure 11E), median [25th & 75th quantile]): 
Emburst control = -49.21 [-61.14 -42.01] mV; Emburst ACh
+ = -60.10 [-61.71 -49.35] mV; Emburst wash-out 
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= -51.12 [-67.78 -47.35] mV; Χ2 = 6.00, p = 0.05. Posthoc analysis with a Wilcoxon signed rank test and 
auroc between Emburst control and Emburst ACh
+ revealed that the Em during the first phase of a burst 
was on average less depolarized during the ACh+ condition, p = 0.03, auroc [95% CI] = 0.65 [0.51 
0.82]. This result is consistent with the finding that ACh diminished peak amplitudes of the bursts as 
recorded extracellularly (Figure 6, 7B). Although the general trend towards a less depolarized Em 
within the burst is supported by the statistical results, it should be noted that three cells reacted with 
stronger depolarization to ACh+ application, which again highlights the heterogeneous effects of 
ACh+. 
During the control condition, a burst was usually followed by a long-lasting afterhyperpolarization, 
resulting in a slowly rising Em before the next burst. Visual inspection of the recorded traces 
suggested that ACh abolished this rhythmic change of the Em. Therefore, Em around bursts was 
examined (Figure 11C). Em directly before burst beginning (Empre) was averaged in a [-400 0] ms time 
window and after burst end (Empost) in a window of variable size ranging from [burst end +2.000] to 
[burst end +10.000] ms depending on the kinetics of the afterhyperpolarization and the silent period 
length between bursts. The difference of membrane potentials (Δ Em) between both time windows 
was calculated for each burst (Δ Em = Empre – Empost) and averaged per recording for control, ACh
+ 
and wash-out condition. Statistical analysis revealed a difference between the three groups (median 
[25th & 75th quantile]): Δ Em control = 1.29 [0.41 2.60] mV; Δ Em ACh+ = -0.22 [-0.35 -1.40] mV; Δ Em 
wash-out = 1.02 [-0.01 2.58] mV; Χ2 = 9.5, p = 0.01). Post-hoc analysis between Δ Em control and Δ 
Em ACh+ showed that the difference between Empre and Empost decreased, p = 0.01, auroc [95% CI] = 
0.76 [0.63 0.92] (Figure 11F). Thus, the analysis confirmed the impression of a more constant resting 
membrane potential during the ACh+ condition.  
In summary, the results supported the notion of ACh modulating excitation as well as inhibition. On 
the one hand, cell and network activity notably increased, as indicated by an increase in action 
potential and burst frequency during the ACh+ condition – indication of increased excitation. On the 
other hand, inhibitory components of the effect of ACh on the networks were manifest in the form of 
dampened in-burst peak depolarizations and shortened bursts. This increase in inhibition could be 
due to heightened GABAergic IN activity (Mann et al., 2009; Razik et al., 2013). Since ACh is known to 
excite specific GABAergic INs, the next experimental series investigated the hypothesis of an ACh-
mediated increase of GABAergic inhibition in the cortical network. 
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3.1.3 ACh increased the total inhibitory current in IPSC recordings 
 
Whole-cell voltage clamp recordings were obtained from visually identified cortical PYs in culture (n = 
8). In order to record GABAergic inhibitory postsynaptic currents (IPSCs), blockers of glutamatergic 
receptors (CNQX and AP5) were added throughout the experiments and the neurons were filled with 
a chloride-based solution and held at -70 mV. Neurons were recorded under control, the ACh+, and 
the ACh- condition equivalent to the extracellular recording procedure described in chapter 3.1.1 (see 
an exemplary recording in Figure 12A).  
The decay time of IPSCs, their frequency, amplitude and the 'total phasic current' (the time-averaged 
current carried by IPSCs) were analyzed for all three tested drug conditions (for detailed description 
of parameters see Methods Table 7). In the control condition, IPSCs had a median decay time of 7.78 
[6.52 10.37] ms, an amplitude of 23.73 [19.57 30.51] pA, and occurred with a frequency of 6.51 [4.47 
9.97] Hz. In the ACh+ condition the decay time remained unaffected, but IPSCs became more 
frequent and had larger amplitudes (Figure 12, supplementary material Table S3). Thus, the overall 
inhibitory current in the ACh+ condition increased almost five times in comparison to the control and 
ACh- conditions (median [25th & 75th quantile]): control = -2.09 [-3.67 -1.10] pA; ACh+ = -9.68 [-11.38 -
6.19] pA; ACh- = -2.12 [-4.01 -1.64] pA; Χ2 =12.25, p = 0.002 (Figure 12A & B, supplementary material 
Table S3).  
Parameter values of the control condition and the ACh- condition were clearly similar, indicating that 
the blockade of cholinergic receptors solely reversed the effects of externally supplied ACh and 
neostigmine. If intrinsic cholinergic neurons had been active and released ACh in physiologically 
relevant amounts, blockade of cholinergic receptors should have reduced IPSC frequency and/or 
amplitude below control levels. In agreement with the extracellular data set described previously, no 
evidence was found to suggest significant intrinsic release of ACh in cortex.     
The magnitude of the cholinergic effect on IPSCs suggested that ACh fostered action potential activity 
of GABAergic INs. To confirm that the observed changes were action potential-dependent, a 
subseries of experiments was performed in which tetrodotoxin (TTX), a blocker of voltage-gated 
sodium channels, was applied prior to the ACh+ condition (Table 9, Figure 13A). To compare effects of 
ACh+ and [TTX & ACh+] treatments, data were normalized to their preceding control condition, which 
was either drug-free aCSF for the ACh+ condition or TTX-containing aCSF for [TTX & ACh+]. Normalized 
data sets were directly compared with a Wilcoxon ranksum test which showed major differences 
between ACh+ and [TTX & ACh+] for all parameters, particularly IPSC frequency and amplitude (Figure 
13B, supplementary material Table S4).  
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FIGURE 12: IPSC RECORDINGS IN THE PRESENCE OF ACH. A. Example recording of IPSCs in control (ctrl, drug-
free), ACh
+
 and ACh
- 
in the presence of AP5/CNQX. IPSC frequency increased and high-amplitude IPSCs 
appeared during ACh administration. B. Summary results (n = 8 cells) for decay time, frequency, amplitude and 
phasic current (gray, individual cells; black, median and 25
th
 and 75
th
 quantile). 
 
 
 
 
 
 
 
 
 
 
Results 
 
53 
 
Condition Drug application order 
I 
ACh+ 
 
Control  
(drug-free) 
 
ACh+  
(ACh (1 μM) &  
Neostigmine (1 μM)) 
 
ACh-  
(Atropine (1 μM) & 
Mecamylamine (3 μM)) 
 
II 
[TTX & ACh+]  
 
Control  
(drug-free) 
 
TTX  
(TTX (1 μM)) 
 
TTX & ACh+ 
(TTX (1 μM) & ACh (1 μM) 
& Neostigmine (1 μM)   
TABLE 9: DRUG APPLICATION SCHEME AND NORMALIZATION FOR ACH
+
 AND [TTX & ACH
+
].  
 
 
FIGURE 13: A. EXAMPLE RECORDING OF IPSCS IN CONTROL, AFTER THE ADDITION OF TTX AND [TTX & ACH]. 
Note the absence of any notable effect of ACh+ in the presence of TTX. B. Summary comparison of cholinergic 
effects on IPSCs. IPSC parameters were compared between ACh
+
 normalized to preceding control (drug-free)] 
and [TTX & ACh
+
] normalized to preceding TTX condition].  
  
To sum up, voltage-clamp experiments suggested that ACh excites GABAergic INs directly, and that 
the resulting enhancement of inhibition can be profound. Indirect activation of INs via glutamatergic 
transmission could be excluded since CNQX and AP5 were co-applied in these experiments. Finally, 
the similarity of IPSC parameter values in control and ACh- conditions (Figure 12B) suggested that 
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either intrinsic cholinergic neurons in the networks were not active or that the amount of ACh they 
released was not sufficient to drive GABAergic IN activity appreciably.  
3.1.4 ACh release in basal forebrain-neocortex co-culture system 
 
For all previously described experiments, ACh was applied via the bath perfusion system and hence, 
measured ACh effects were attributed to a constant ACh concentration. One part of the project was 
devoted to the question if an in vitro model could be developed which would provide neocortex with 
physiologically released ACh instead. As stated before, neocortex in vivo receives prominent 
cholinergic innervations from basal forebrain. To date, no acute slice preparation has been described 
which preserves these projections. However, in co-cultures of both brain regions, cholinergic axons 
from basal forebrain grow into cortex (Distler and Robertson, 1993). Therefore, these preparations 
were tested for their suitability of providing cortex with ACh. Co-cultures were prepared from the 
'Mik' mouse mutant, which expressed GFP in cholinergic cells so that these could be specifically 
targeted (for detailed specification see Methods section). To test the connectivity between the two 
brain regions, paired recordings were performed. One electrode was placed extracellularly in layer V 
of neocortex to record spontaneous network activity, while the second electrode was used for 
current clamp recordings from cholinergic neurons in basal forebrain (n = 8; Figure 14A). Cell 
parameters of cholinergic neurons were determined via hyper- and depolarizing current injection 
(median [25th and 75th quantile]): R = 106.58 [71.61 170.21] MΩ; τ = 8.39 [6.99 16.67] ms; spike width 
at half amplitude = 1.33 [1.19 1.71] ms; approximate maximal firing rate = 24.85 [19.95 27.63] Hz; 
Emrest = -74.88 [-76.67 -66.74] mV. An example is shown in figure 14B. Electrophysiological properties 
of cholinergic cells described here greatly differ from those of cholinergic cells in acute slices (Unal et 
al., 2012). Both cell populations described by Unal et al. (2012) showed a membrane resistance about 
six times greater, a six to seven times greater time constant τ, and slightly wider spikes. Moreover, 
cells in acute slices were more depolarized than cholinergic cells in cultures described here, which 
will be elaborated on in the discussion.        
Visual inspection of the firing pattern under control condition revealed that most cholinergic cells 
were spontaneously active in culture, albeit at low rates (median firing rate [25th and 75th quantile]: 
0.66 [0.11 1.79] Hz). In most cases, they depolarized and fired synchronously with neocortex; 
however, some neurons fired action potentials independent of cortical bursts, and two neurons 
showed weak hyperpolarization and inhibited firing time-locked to cortical bursts. To investigate if 
ACh released by neurons in the basal forebrain had any effect on the network activity recorded in 
neocortex, first neostigmine (1 µM) was washed in, followed by the application of atropine (1 µM) 
and mecamylamine (3 µM). An example is shown in Figure 14C. Local field potentials and action  
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FIGURE 14: PAIRED CURRENT CLAMP AND EXTRACELLULAR RECORDINGS FROM BASAL FOREBRAIN-CORTEX 
CO-CULTURE MODEL. A. Schematic illustration of co-culture model between basal forebrain and neocortex. 
Extracellular recordings were made from infragranular layers in cortex, current clamp recordings were made 
from basal forebrain cholinergic cells. Ba. Mixed fluorescent/bright field microscopic image of GFP-expressing, 
cholinergic neurons in basal forebrain in vitro derived from Mik mouse line. Bb. Fluorescent image of the same 
neuron as shown in Ba, center, after current clamp recording and filling of the cell with the fluorescent dye 
Alexa 555. Bc. Typical firing pattern of a cholinergic neuron upon injection of a current step. Note decreasing 
AP amplitude. Bd. Overlay plot of APs of a single cholinergic neuron, obtained from injection of a high-
amplitude current step. First four spikes within train are marked in red; APs widened with increasing time. For 
best comparison with acute slice data, only the narrowest APs were used for characterization of spike width at 
half-maximal amplitude (red traces). C. Example of a paired recording from a co-culture of basal forebrain and 
cortex. Intracellular activity in basal forebrain (green trace) and extracellular activity in neocortex (black trace) 
were recorded during control (drug-free), neostigmine, ACh
-
, and wash-out conditions.  
 
potentials were analyzed and compared between conditions. In some experiments, drug treatment 
had notable effects, but the effects diverged widely between experiments. On average, no consistent 
drug effect was found for any LFP- or action potential-based parameter intra- or extracellularly, 
except for a small effect between control and neostigmine conditions on cortical relative time in 
burst (supplementary material Table S5). However, the effect was not reversible with cholinergic 
blockers and was thus not regarded as result of the presence of ACh.  
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In order to illuminate possible causes of the absence of cholinergic effects, more detailed analyses of 
firing patterns were undertaken. First, the timing of basal forebrain action potentials relative to 
cortical bursts was investigated. Figure 15A shows examples of peri-event time histograms (PETHs) of 
single-neuron action potentials in basal forebrain and multi-unit action potentials in neocortex, 
aligned to the beginning of extracellular bursts in neocortex as determined on the basis of the LFP. In 
this example, characterized by vigorous activity levels in both neuronal tissues, action potential firing 
in cortex preceded firing in basal forebrain by about 15 ms, suggesting that activity in neocortex 
drove activity in basal forebrain. As basal forebrain firing rates in most cultures were quite low, this 
spike-based analysis was suitable only for a minority of experiments. Therefore, in a second analysis, 
values of the average membrane potential of cholinergic neurons were compared for three peri-
event time intervals (because only the control condition was used for this analysis, two more cells 
could be added for a total n = 10): (1) Embase [-300 -200] ms before extracellular burst start; (2) Empre-
burst [-25 0] ms before; (3) Emin-burst [20 100] ms after burst start (figure 15B). If cholinergic neurons 
were de- or hyperpolarized ahead of neocortical activity, Embase and Empre-burst should differ. By 
contrast, if cholinergic neurons were de- or hyperpolarized concomitant with or after neocortex, a 
difference between the intervals Empre-burst and Emin-burst should be detectable. Results were plotted in 
figure 15C. There was no difference between Embase and Empre-burst but between Empre-burst and Emin-
burst (median [25
th & 75th quantile]): Embase = -74.88 [-76.67 -66.74] mV; Empre-burst = -73.55 [-77.33 -
66.11] mV; Emin-burst = -66.85 [-72.16 -64.15] mV; Χ
2 = 6.2, p = 0.05; Embase & Empre-burst: p = 0.43, auroc 
[95% CI] = 0.49 [0.36 0.59]; Empre-burst & Emin-burst: p = 0.03, auroc [95% CI] = 0.32 [0.14 0.48]). The 
specific comparisons between groups indicate that Em of basal forebrain cholinergic neurons 
changes substantially after neocortical bursts begin but not before.   
 In conclusion, neurons of basal forebrain in the co-culture system showed weak action potential 
activity predominantly initiated by neocortex. Likely, this dependence on cortical drive, and/or the 
low level of activity were causal for a lack of a consistent modulation of neocortical activity (although 
other or additional causes are plausible, see discussion). In view of these results, co-cultures of basal 
forebrain and cortex were not used as a complement to bath application of ACh in subsequent 
experiments. However, this model system might be suitable for optogenetic experiments, which 
would allow specific activation of basal forebrain cholinergic fibers by light stimuli independent of 
cortical activity. 
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FIGURE 15: ANALYSIS OF ACTIVITY PATTERNS IN COCULTURES OF BASAL FOREBRAIN AND NEOCORTEX. A. 
Example of peri-event time histograms (PETHs) of multi-unit action potentials in neocortex (left) and single-
neuron action potentials in BF (right), aligned to extracellular burst beginning in neocortex on LFP basis (see Ab 
below). B. Peri-burst cutouts of cortical LFP (left) and corresponding Em of cholinergic neuron (right) for one 
experiment. Cutouts were aligned according to cortical burst begin (time zero). Individual cutouts are in grey, 
averages in black and green, respectively. Blue rectangles in right plot illustrate peri-burst time intervals used 
for analysis of Em of cholinergic neurons: (1) Embase [-300 -200] ms; (2) Empre-burst [-25 0] ms; (3) Emin-burst [20 
100] ms. C. Summary data for peri-burst Em analysis of cholinergic neurons (grey lines and symbols, individual 
cells; black, median and 25
th
 and 75
th
 quantile).  
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3.1.5 The response of X98 Martinotti cells to ACh application 
 
One main aspect of cholinergic modulation may be the influence of ACh on SOM+ GABAergic INs, as 
illustrated in the introduction. The next part of the thesis project was therefore assigned to study the 
effects of ACh on Martinotti cells in the 'X98' mouse line (Ma et al., 2006). In these mice, a subset of 
SOM+ cells identified as Martinotti cells are GFP-labeled and can thus be specifically targeted for 
electrophysiological recordings. So far, very few studies exist with this mouse line beyond the paper 
in which they were first introduced, and none of them in neocortex (Ma et al., 2006; Nassar et al., 
2015). Whole-cell current clamp recordings were performed from Martinotti cells in layer V of 
organotypic cultures and acute slices from X98 mice. Results from recordings in culture will be 
described first. Figure 16A (left) shows a typical SOM+ cell in culture with cell resistance R = 52.60 
MΩ, time constant τ = 10.35 ms, approximate maximal firing frequency = 65.15 Hz and spike width at 
half-maximal amplitude = 0.96 ms. Parameter averages for all cells (n = 10) are listed in table 10. In 
comparison to electrophysiological characteristics of X98 SOM+ cells in acute slices reported here 
later on and by (Ma et al., 2006), cells in culture had a ten times smaller cell resistance, six times 
faster membrane time constant τ, slightly narrower spikes, and were more hyperpolarized. 
 
 
Parameter 
Culture 
(n = 10) 
 Acute 
(n = 12) 
Resistance (MΩ) 52.92 [43.40 58.62] < 299.10 [222.91 390.18] 
Time constant τ (ms)  5.69 [4.39 6.06] < 36.05 [27.49 38.32] 
Approximate firing frequency (Hz) 95.59 [81.63 105.26] > 67.60 [55.58 83.16] 
Spike width at half amplitude (ms) 0.68 [0.59 0.73] > 0.60 [0.52 0.71] 
Resting Em (mV) -76.49 [-80.28 -72.72] < -81.64 [-82.69 -79.83] 
TABLE 10: CHARACTERISTICS OF X98 SOM+ CELLS FOR CULTURES AND ACUTE SLICES. All values are medians 
[25
th
 & 75
th
 quantile]. 
 
Recordings were obtained from one electrode in current clamp mode attached to a SOM+ IN in 
infragranular layers and concurrently from a second extracellular electrode placed in the same 
column in supragranular layers (Figure 16B). As in previous experiments, recordings were made from 
organotypic cultures during a drug-free control condition, an ACh+ drug condition, and a wash-out 
(Figure 16B). The cell resistance was mostly unaffected by ACh application (supplementary material 
Table S6). In contrast to whole-cell recordings from undefined cortical cell types (section 3.1.2), ACh 
had a consistent, large effect on Emrest but not on Em during bursts (Emburst) of X98 SOM+ cells. 
During the ACh+ condition, Emrest was more depolarized in the majority of cells and synaptic input to 
the cells increased as measured in fluctuations of Emrest, but there was no uniform effect on Emburst 
(supplementary material Table S6, Figure 16Ca).  
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FIGURE 16: CURRENT CLAMP RECORDINGS FROM GFP-EXPRESSING, PUTATIVE MARTINOTTI CELLS IN THE 
PRESENCE OF ACH (X98 MOUSE STRAIN). A left. Firing pattern of a typical Martinotti cell in culture induced by 
injection of a current step. AP cutouts are depicted in the inset (first APs in train marked in red). Note decrease 
of amplitude concomitant with an increase of AP width. The neuron recorded from was filled with the 
fluorescent dye Alexa 555 and is depicted in the microscopic image. A right. Firing pattern, AP cutouts and 
fluorescent microscopic image of a typical Martinotti cell in an acute slice. B left. Schematic illustration of 
paired extra- and intracellular recordings in neocortical slice cultures derived from X98 mice. Current clamp 
recordings were performed from Martinotti cells in infragranular layers; an extracellular recording electrode 
was placed in the supragranular layers of the same column. In acute slices, only intracellular recordings were 
performed (not illustrated) B right. Example raw signals from cultures and acute slices during control, ACh+ and 
washout conditions. C. Comparison of modulatory effects of ACh on Martinotti cells in cultures and acute slices. 
Ca & c. Summary data for Em (main plots) and fluctuation of the Em ('noise', insets). Grey, individual cells; 
black, median and 25
th
 and 75
th
 quantiles (due to the low number of cells recorded in acute slices no averages 
are given in these figures).  Cb & d. Summary data for AP rates (main plots). Inset in Cb depicts the fraction of 
AP in occurring outside bursts in culture, demonstrating activation of Martinotti cells by ACh.   
 
To test cell excitability, a sinusoidal ramp current was injected into the cell and thereby stimulated 
action potentials were counted (Figure 17A). Under control, cells reached a median [25th & 75th 
quantile] of 4.00 [3.19 5.09] spikes, while the spike count almost doubled under the ACh+ condition 
(7.50 [6.08 8.58]) (supplementary material Table S6, Figure 17B), likely due to the ACh-induced 
depolarization of the resting membrane potential. Thus, SOM+ neurons were more excitable in the 
presence of ACh+.  
Although cell excitability increased, median action potential firing rates did not change with ACh 
application (median [25th & 75th quantile]): Ctrl = 2.57 [0.79 6.51]; ACh+ = 2.88 [1.24 3.52]; wash = 
1.34 [0.52 2.77]; Χ2 = 2.21, p = 0.33) (Figure 16Cb, supplementary material Table S6). However, firing 
patterns were affected by the ACh+ condition (Figure 16Cb inset). During the control condition, all 
cells fired action potentials within bursts, whereas during the ACh+ condition two thirds of them also 
fired during silent periods (one third remained unaffected). The dichotomy of cell activity during 
silent periods evoked by ACh was expressed by significantly different variances between control, 
ACh+ and wash-out (median [25th & 75th quantile]): Ctrl = 0.00 [0.00 0.02]; ACh+ = 0.14 [0.01 0.40]; 
wash = 0.00 [0.00 0.02]; Brown-Forsythe test F (2, 24) = 15.55, p = 0.00005; auroc [95% CI] Ctrl-ACh+ = 
0.15 [0.00 0.29] (Figure 16Cb inset). In other words, ACh caused SOM+ INs to fire more 
independently of cortical bursts. 
For the examination of the relation between extracellular multiunit action potential activity and the 
firing of SOM+ cells with and without ACh, a cross-correlation analysis was employed. Results 
revealed that spike-firing between the two signals was well correlated during the control condition, 
but decreased significantly during the ACh+ condition – an effect that was partially reversible during 
wash-out (supplementary material Table S6). This finding indicates that SOM+ cells fired less in 
synchrony with other cortical cells in the presence of ACh. 
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FIGURE 17: ACH-INDUCED CHANGE IN EXCITABILITY OF MARTINOTTI CELLS IN CULTURE. A. Excerpts of 
current clamp recordings during injection of a sinusoidal ramp current in control, ACh+ and wash conditions. 
Note the stronger response of the neuron to current injection during ACh+. For analysis, the number of AP 
induced during current injection was counted. B. Summary data for AP count during current injection (grey, 
individual cells; black, median and 25
th
 and 75
th
 quantiles). 
 
To validate findings from organotypic cultures, ACh was also applied to acute slices of X98 mice. An 
overview of all cell parameters is presented in table 10 (n = 12). Unlike in organotypic cultures, in 
acute slices SOM+ cells were not spontaneously active under the control condition. Overall, 
electrophysiological characteristics were more comparable to values reported by Ma et al. (2006). 
For ACh+ effect analysis, Emrest was analyzed from five cells (the other seven cells could not be held 
for the ACh condition). During the ACh+ condition, Emrest was more depolarized, cells likely received 
more synaptic input, which was quantified by the increased fluctuation of Em (Figure 16Cc), and the 
rate of spontaneous action potentials rose from zero to about 2 Hz (Figure 16Cd). Due to the small 
sample size, no statistical analysis was applied to this data set. Nonetheless, ACh had a clearly 
excitatory (depolarizing) effect on all four cells, which agrees with previous reports (Kawaguchi, 
1997).  
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3.2 The action of GABAAR modulators in the presence and absence of ACh 
3.2.1 Effect of GABAAR modulators on extracellularly recorded network activity under 
different cholinergic conditions   
 
The main objective of this thesis project was to elucidate if ACh alters GABAergic inhibition in 
neocortex. Central to this endeavor was an experimental modulation of the cholinergic status as 
described before in conjunction with a subunit-specific modulation of GABAergic inhibition. 
Extracellular experiments were performed in organotypic cultures of somatosensory neocortex with 
one electrode placed in the supragranular layers, while the second electrode was placed in the 
infragranular layers of the same column. Within each experiment, spontaneous network activity was 
recorded in four different drug conditions. An initial drug-free condition was followed by either the 
ACh+ or the ACh- condition, which served as cholinergic baseline condition. Next, with the cholinergic 
condition maintained, a GABAAR modulator was applied, followed by a wash-out of all drugs (Table 
11). The GABAAR modulators used were zolpidem (in two concentrations), diazepam, diazepam in 
cultures derived from α1 knock-in mice, and L-655,708. Different GABAAR modulators were chosen to 
modulate specific combinations of GABAAR subunits (see Methods section 2.3.4). Briefly, zolpidem 
(0.2 µM) was used to mainly modulate GABAAR containing the α1 (2,3) subunit, zolpidem (1.0 µM) was 
used for α1, 2, 3, diazepam (1.0 µM) for α1, 2, 3, 5, and diazepam (1.0 µM) in the α1-knock-in genotype for 
α2 ,3, 5. L-655,708 (5 µM), the only negative allosteric modulator used, was specific for GABAAR 
containing the α5 subunit. Thus, there were five different means of GABAAR modulation in two 
different cholinergic conditions, resulting in ten unpaired experimental series. In the analyses 
described below, all parameters computed for the combined cholinergic/GABAergic condition were 
normalized to the preceding ACh+ or ACh- condition (Table 11). These normalized parameter values 
were statistically compared between the ACh+ and ACh- series in order to assess the dependence of 
each type of GABAAR modulation on the cholinergic status. As the effects of the ACh
+ and ACh- 
conditions per se have been investigated in detail in previous experiments, it was not of interest to 
evaluate them again in these experimental series. 
 
Condition Drug application design 
 
I 
ACh+ 
 
Control 
(drug-free) 
 
ACh+ 
 
ACh+ &  
GABAAR modulator 
 
Wash-out 
(drug-free) 
 
II 
ACh- 
 
Control 
(drug-free) 
 
ACh- 
 
ACh- & 
GABAAR modulator 
 
Wash-out 
(drug-free) 
TABLE 11: DRUG-APPLICATION DESIGN. Conditions in bold were statistically compared. Bold conditions were 
normalized to respective previous conditions.  
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Three analysis approaches were pursued: 1) classical action potential and burst analysis as with 
previously analyzed extracellular data sets (chapter 3.2.1.1), 2) spectral analysis (chapter 3.2.1.2), 
and 3) cross-correlation analysis between LFP signals filtered at specific frequency bands from the 
supra- and infragranular layers and cross-correlation analysis between the instantaneous firing rate 
(ifr) based on action potentials and LFPs filtered at specific frequency bands, respectively (3.2.1.3).  
3.2.1.1 Cholinergic status differentially changed effects of GABAAR modulators on action 
potential- and burst parameters  
The first approach to analyze the data was to quantify the effects of the different substance 
combinations on action potential and burst parameters. All results are listed in table S7 of the 
supplementary material. Differences between the ACh+ and ACh- condition in combination with 
GABAAR modulators surfaced in very specific parameters and layers. Affected parameters were burst 
rate, burst length and time spent in burst. No differences between the ACh+ and ACh- condition in 
combination with GABAAR modulators were found on the action potential rate, the fraction of active 
bins or the burst amplitude.  
In figure 18A, a raw data example is given for ACh+ and diazepam (Figure 18Aa) and ACh- and 
diazepam (Figure 18Ab). As can been seen in this example, the application of ACh+ had notable 
effects on the bursting pattern (Figure 18Aa second trace), while the addition of diazepam did not 
further modify the effect (Figure 18Aa third trace). On the other hand, diazepam substantially 
shortened burst phases and increased the burst rate when it was applied under the ACh- condition 
(Figure 18Ab third trace). The results for diazepam with regard to burst rate, burst length, and 
relative time in burst were summarized for the infragranular layers as box plots in figure 18B. As 
depicted in the raw data sample, diazepam had different effects in ACh+ than in ACh-. Overall, 
diazepam evoked a change in the burst pattern within the ACh- condition (shorter bursts and higher 
burst rate), but had no impact on the absolute amount of network activity since the total time spent 
in burst remained stable.  
In Figure 18C, auroc values for all parameters, both layers and all GABAAR modulators were 
summarized. For diazepam (α1, 2, 3, 5), the effects on burst rate, burst length and relative time in burst 
were similar for both layers. Zolpidem (0.2 µM and 1.0 µM), on the other hand, evoked small to 
medium effects between ACh+ and ACh- in the supragranular layers, while large differences in the 
infragranular layer were found (Figure 18C). The most affected parameter was the relative time in 
burst. For zolpidem (1 µM) (α1, 2, 3) this effect was the result of a combination of decreases in burst 
rate and burst length under the ACh+ condition, but the single effects were not large enough to bring 
about a significant difference on their own. For zolpidem (0.2 µM) (α1 (2, 3)), additionally to the relative 
time in burst, the burst rate was dramatically lower in the ACh+ than ACh- condition (Figure 18C).  
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FIGURE 18: ANALYSIS OF AP AND LFP PARAMETERS FROM EXTRACELLULARLY RECORDED DATA. A.  Raw data 
example of extracellular activity in control (drug-free), ACh
+ 
(a) or ACh
-
 (b), [ACh
+ 
(a) or ACh
-
 (b) & Diazepam], 
and wash-out. B. Exemplary summary data for three of the six parameters describing alteration of neuronal 
activity by GABAAR modulators in contrasting cholinergic conditions. Here, the effect of diazepam in 
supragranular layers is depicted. Data for [ACh
+
 & GABAAR modulator] and [ACh
-
 & GABAAR modulator] 
conditions were normalized to the preceding ACh
+
 or ACh
-
 conditions, respectively. Pairs of data sets thus 
normalized were compared statistically (the results are depicted in C). C. Summary of comparisons between 
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ACh
+
 and ACh
-
 conditions for all tested GABAAR modulators and both layers. Rows list the six analysis 
parameters, columns list the primary α-subunit(s) of the GABAAR modulated by the chosen drugs: α1 – 
zolpidem 0.2 μM; α1, 2, 3 – zolpidem 1 μM; α2, 3, 5 – diazepam in α1-knock-in; α1, 2, 3, 5 – diazepam in WT; -α5 – L-
655,708. The colored circles represent the auroc effect size of the comparison ACh
+
 versus ACh
-
. Areas of the 
circles are proportional to the effect size (=distance of the auroc value from the null value of 0.5). The 
superiority of the ACh
+
 condition was always tested over the ACh
-
 condition. Thus, blue circles signify that 
values in ACh
+
 fall mostly below those of ACh
- 
(auroc < 0.5), dark blue indicates significance (α) at the 0.05 level. 
Orange circles signify that values in ACh
+
 are mostly above those of ACh
-
(auroc > 0.5), dark orange indicates 
significance at 0.05 level.  
 
L-655,708, a negative allosteric modulator of α5-containing GABAAR (-α5), was clearly more effective 
in the supra- than in the infragranular layer. Under the ACh+ condition, the substance caused higher 
network activity (more time spent in burst) and higher burst amplitudes in comparison to the ACh- 
condition in the supragranular layer only.     
3.2.1.2 Spectral power differed between cholinergic conditions with modulation of α1, 2, 3 
and –α5 subunit-containing GABAARs   
Beyond studying the combined effects of ACh and GABAAR modulators on firing activity and bursting 
pattern, changes of spectral power were investigated. ACh is known to reduce the power in low 
frequency bands (1-10 Hz) (Chen et al., 2015; Metherate et al., 1992). Since EEG studies have 
revealed effects of diazepam and zolpidem on spectral power (Arbon et al., 2015; Brunner et al., 
1991; Scheffzük et al., 2013), it was of interest to investigate if cholinergic modulation would interact 
with GABAAR modulator-induced changes of spectral power. Moreover, action potential and LFP 
parameter analyses described previously were limited to recordings with clearly identifiable bursts 
and silent periods. Cultures with oscillating or highly 'desynchronized' activity could not be properly 
analyzed. To include such data in the analysis, spectral power in the delta [2 5] Hz, theta [6 12] Hz, 
beta [15 30] Hz, gamma low [30 50] Hz and gamma high [50 80] Hz frequency bands were analyzed. 
For each frequency band, the median spectral power across experiments was calculated, normalized 
to the preceding ACh condition and compared for all GABAAR modulators in both ACh conditions. An 
example is provided for zolpidem (1 μM) and L-655,708 (Figure 19). In figure 19A (right panel) it can 
be seen that zolpidem decreased the delta power strongly following both ACh conditions. However, 
the effect was stronger in the presence of ACh+ (median [25th & 75th quantile]): ACh+ = 0.16 [0.09 
0.30]; ACh- = 0.33 [0.23 0.46]; auroc 0.34 [0.21 0.47], p = 0.02. As previously reported for zolpidem, 
when action potential and burst parameters were analyzed (section 3.2.1.1), differences between 
cholinergic conditions were restricted to infragranular layers (Figure 19A). 
L-655,708 differed between both cholinergic conditions in the theta frequency band in the 
supragranular layers, where the normalized power was higher under the ACh+ than the ACh- 
condition (median [25th & 75th quantile]): ACh+ = 1.31 [0.81 2.34]; ACh- = 1.05 [0.63 1.48]; auroc 0.64 
[0.53 0.75], p = 0.02†; Figure 19B). 
Results 
 
66 
 
 
FIGURE 19: POWER SPECTRAL ANALYSIS OF LFP SIGNALS IN CORTICAL CULTURES WITH CHOLINERGIC AND 
GABAERGIC MODULATION. A. Left, exemplary power spectral density (PSD) plots of data recorded from the 
infragranular layer. Black trace shows the PSD in the ACh
+
 condition; orange trace after additional application 
of zolpidem (1 μM). Grey windows depict five different frequency bands in which the PSD was integrated and 
compared between drug conditions: δ [2 – 5] Hz, θ [6 – 12] Hz, β [15 – 30] Hz, γ [30 – 50] Hz, and high γ [50 – 
80] Hz. Center, identical depiction of a data example with the ACh
-
 condition (black) preceding ACh
-
 &  zolpidem 
(1 μM). Right, summary from all experiments of the effects of zolpidem (1 μM) on δ PSD in infragranular layers 
in the ACh
+
 condition (left data set) and in the ACh
-
 condition (right data set). Data were normalized to the 
preceding ACh condition. B. PSD plots of LFP data recorded in the presence of L-655,708 (left and center) and 
summary data (right). Data were recorded from supragranular layers. Same conventions as in A apply.   
 
It also evoked differences in the gamma and high gamma range in the infragranular layers, where the 
power was smaller under the ACh+ than the ACh- condition (gamma: median [25th & 75th quantile]): 
ACh+ = 0.92 [0.80 1.09]; ACh- = 1.04 [0.94 1.16]; auroc 0.37 [0.25 0.49], p = 0.04; high gamma: median 
[25th & 75th quantile]): ACh+ = 0.94 [0.77 1.05]; ACh- = 1.05 [0.93 1.15]; auroc 0.35 [0.24 0.46], p = 
0.01). 
Thus, with regard to spectral changes of spontaneous network activity, effects of GABAARs 
modulation containing the α1, 2, 3 subunit in combination with ACh application were delta-frequency 
specific, while the antagonism of GABAARs with the α5 subunit evoked differences between the ACh
+ 
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and ACh- condition over a broader frequency spectrum. The other GABAAR modulators did not 
influence spectral power in a way that depended on the cholinergic status. 
3.2.1.3 Interlaminar LFP- and intralaminar LFP-ifr correlations especially differed 
between cholinergic conditions during modulation of α1, 2, 3 and -α5 subunit-
containing GABAARs   
One described characteristic of ACh is its decorrelating effect (Goard and Dan, 2009). Thus, the 
question arose whether the correlation of LFP signals between supra- and infragranular layers were 
differentially affected by the cholinergic status in combination with different GABAAR modulators. In 
figure 20A, a raw data sample is given for ACh+ and zolpidem (1.0 μM). At first sight, the raw signal 
from the supragranular layer seemed to change in a similar manner as the signal from the 
infragranular layers across substance conditions in terms of burst amplitude and burst length. 
However, how individual frequency bands were affected at the two different recording sites by the 
drug conditions was not clear. Thus, raw data traces from both recording sites were split up via 
digital filtering into signal components in the five frequency bands stated above (see example of 
theta signals in Figure 20Ab). Signals thus filtered from infra- and supragranular layers in the ACh+ or 
ACh- condition and the subsequent GABAAR modulator condition were cross-correlated with each 
other (Figure 20Ac). The cross-correlation peak amplitude values of the GABAAR conditions were 
normalized to the ACh conditions (as for previous experiments, Figure 20B) and compared to each 
other with a Wilcoxon ranksum test and auroc (supplementary material Table S8, Figure 20C).  
For zolpidem (1.0 μM), the theta (Figure 20B, C) and the high gamma frequency bands (Figure 20C) 
were each stronger decorrelated between layers in the ACh+ than in the ACh- condition. Zolpidem 
(0.2 µM) showed stronger decorrelating effects under ACh+ in the delta and theta frequency bands 
(supplementary material Table S8). For diazepam in the α1 knock-in mutant, the high gamma 
frequency range was more strongly affected by ACh+ than by ACh-.  
Cross-correlations for L-655,708 between the cholinergic conditions also differed. However, results 
indicated that this substance caused higher correlations in the delta, theta and beta frequency range 
under the ACh+ than the ACh- condition. Thus, the analysis demonstrated that especially zolpidem 
induced differences between the cholinergic conditions by decreasing synchrony in interlaminar 
communication more in combination with ACh+ than with ACh- while L-655,708 increased synchrony 
in the ACh+ condition compared to ACh-. 
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FIGURE 20: CROSS-CORRELATION OF LFP SIGNALS BETWEEN CORTICAL LAYERS AND ITS MODULATION BY 
THE ALPHA1 SUBUNIT-PREFERRING GABAAR MODULATOR ZOLPIDEM. Aa. Example of an extracellular 
recording from infra- and supragranular layers in control (drug-free), ACh
+
, [ACh
+
 & zolpidem (1 μM)], and 
wash-out. Ab. Excerpts of the data traces shown in a, bandpass filtered in the theta frequency band (6-12 Hz). 
Ac. Cross-correlation between infra- and supragranular layers of theta bandpass-filtered data traces. Note 
reduced peak correlation in [ACh
+
 & zolpidem (1 μM)] condition. B. Summary data from all experiments of the 
effects of zolpidem (1 μM) on the cross-correlation between theta signals from supra-and infragranular layers. 
The peak cross-correlation values from the [ACh & GABAAR] conditions were normalized to those of the 
preceding ACh conditions. Then, for each GABAAR modulator, the difference between the ACh
+
 and ACh
-
 
condition was analyzed. The example shows that layers did not correlate as well in the [ACh
+
 & zopidem] 
condition compared to the [ACh
-
 & zolpidem] condition. C. Summary of cross correlation analysis for all GABAAR 
modulators (columns) and frequency bands (rows). See Figure 17 for detailed explanation of circle size and 
color. Light blue: auroc < 0.5; dark blue: auroc < 0.5 and significant at 0.05 level. Light orange: auroc > 0.5; dark 
orange: auroc > 0.5 and significant at 0.05 level. 
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Next, intra-electrode coupling of APs to LFP signals in the different frequency bands was studied. To 
illustrate this analysis, examples from the L-655,708 experimental series were chosen (Figure 21). A 
raw data example is given in Figure 21Aa and Ba showing the effects of L-655,708 in combination 
with ACh+ or ACh-, respectively. In Figure 21Ab and Bb, the raw signals were filtered according to the 
five frequency bands stated above and additionally with a lowpass filter with a cutoff of 200 Hz 
('wide band'), which was chosen to represent the entire LFP frequency spectrum. Additionally, action 
potentials as detected by the threshold algorithm described before were converted into a continuous 
signal termed 'instantaneous firing rate', abbreviated ifr (see Methods, Figure 21Ab & Bb third trace 
from top). Finally, the ifr was correlated with LFP signals in the delta, theta, beta, gamma, high 
gamma and wide band range, and the envelope of the correlation was computed in order to obtain a 
measure of the strength of spike-LFP coupling independent of phase. The normalized peak amplitude 
of the cross correlation envelope was compared for different GABAAR modulators between the ACh
+ 
and ACh- condition (Figure 21Ac and 21Bc).  
Again, the strongest decorrelating effect was found with zolpidem (1.0 µM) and ACh+ especially in 
the infragranular layers across all frequency bands (Figure 22B). In the supragranular layers, the 
correlation was especially decreased between the ifr and signals in the beta and high gamma range 
(Figure 22A). Equivalent to the attenuation of interlaminar signal correlations in the delta range, 
zolpidem (0.2 µM) in combination with ACh+ had a decorrelating effect between ifr and the signal in 
the delta and wide band frequency ranges in both layers (Figure 22A & B). Additionally, diazepam in 
the α1 knock-in in combination with ACh
+ had a decorrelating effect in the infragranular layer (delta 
frequency range). Evoking a similar effect with zolpidem (0.2 µM) and diazepam in the α1 knock-in is 
rather counterintuitive. While results found with zolpidem (0.2 µM) were likely to be α1-dependent 
(since zolpidem is supposed to highly prefer GABAAR containing the α1 subunit when applied in low 
concentrations), they must be independent of GABAAR containing the α1 subunit for diazepam in the 
α1 knock-in as this subunit could not be modulated in the mutant. It is speculated that the same 
decorrelating effect was reached via different mechanistic routes, which will be elaborated on 
further in the discussion. Diazepam applied in wild-type had a tendency to decrease the correlation 
in the presence of ACh+ especially in the infragranular layers in the wide band frequency range. As for 
interlaminar correlation analysis, L-655,708 acted contrarily to the other GABAAR modulators and 
improved the correlation of ifr in the theta and beta frequency band in the presence of ACh+ in 
comparison to ACh- (Figure 22B, supplementary material Table S9).  
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FIGURE 21: INTRA-ELECTRODE CROSS-CORRELATION OF INSTANTANEOUS FIRING RATE (IFR) WITH LFP AND 
ITS ALTERATION BY AN ALPHA5 SUBUNIT-SPECIFIC GABAAR MODULATOR. Aa and Ba. Raw data examples of 
extracellular activity in the presence of ACh (A) or cholinergic antagonists (B) and L-655,708. Ab. Excerpts of 
data shown in Aa from one channel, filtered in different frequency bands as indicated (top two traces), and ifr 
(blue trace), derived from AP activity on the same channel (bottom trace). Note that in the presence of L-
655,708, especially signals in the θ and β frequency range become more prominent again in comparison to 
ACh
+
. Ac. Cross-correlation between ifr and θ signals (left) and ifr and β signals (right) for ACh
+
 alone (black 
traces) and [ACh
+
 & L-655,708] (red traces). Thin dotted curves show the cross correlations; continuous lines 
are the envelopes of the correlations from which the peak values were extracted for comparison between 
conditions. Bb. Excerpts of exemplary raw data shown in Ba. Bc. Cross-correlations in the presence of 
cholinergic antagonists and L-655,708. Same conventions as in Ac apply. 
 
 
 
FIGURE 22. SUMMARY OF INTRA-ELECTRODE CROSS-CORRELATION ANALYSES (IFR WITH LFP IN DIFFERENT 
FREQUENCY BANDS). The plots show all comparisons between ACh
+
 and ACh
-
 conditions for all tested GABAAR 
modulators. Results for supra- and infragranular layers are shown left and right, respectively. Refer to figure 17 
for detailed description of GABAAR subunits and auroc effect sizes. 
 
In summary, cross-correlation analyses between both layers and ifr and LFP revealed the largest 
difference by far between the ACh+ and ACh- conditions when zolpidem (1.0 µM) was applied. 
Zolpidem caused a strong decorrelation in combination with ACh+ supposedly by enhancing currents 
through GABAAR containing the α1, 2, 3 subunits. Contrastingly, but consistent with its action as a 
negative allosteric modulator, L-655,708 increased correlation in the presence of ACh+ more than in 
the presence of ACh-. Thus, the effects of positive and negative GABAergic modulators on spike-LFP 
coupling again demonstrated the strong recruitment of GABAergic inhibition during cholinergic 
stimulation.
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3.2.2 Effects of GABAAR modulators on IPSCs under different cholinergic conditions 
  
The analysis of the extracellular data set provided evidence that the cholinergic status indeed 
affected the action of GABAAR modulators with specific subunit affinities differentially. While the 
effect of diazepam seemed to be less impacted by the cholinergic status, the effect of zolpidem 
especially in the higher concentration changed in the presence of ACh. This finding supported the 
hypothesis that ACh modulates specific elements of the GABAergic system, by possibly exciting 
certain groups of INs but not others. To specifically investigate the effect of cholinergic modulation in 
combination with GABAAR modulators on the inhibitory power of the network, inhibitory 
postsynaptic currents (IPSCs) were recorded. Glutamatergic transmission was blocked with AP5 and 
CNQX. Recordings of IPSCs were performed from cortical layer V cells visually identified as pyramidal 
cells. For these experiments, first IPSCs were recorded under the ACh+ condition alone as control. 
Then, the GABAAR modulators zolpidem (1 µM or 0.2 µM) or diazepam (1.0 µM) were applied during 
the ACh+ condition, followed by the ACh- condition plus modulator (Table 12). Thus, by design, the 
ACh+ and ACh- conditions were present within one experiment. Due to a large variability of IPSC 
parameters between cells, a within-subjects (repeated measures) design of the experiments with 
higher statistical power (in comparison to a between-subjects design) was chosen to detect 
differences between the cholinergic conditions. In order to control for experimental time and for 
effects of the cholinergic condition per se (see section 3.1.3), a sham experimental series was 
conducted independent of the effects of GABAAR modulators (Table 12).  
 
Condition Drug application order 
 
I 
Sham 
 
ACh+ 
(control) 
 
ACh+  
 
ACh-  
 
 
ACh+ 
(Wash-out) 
 
II 
ACh+ & ACh- 
 
ACh+ 
(control) 
 
ACh+ &  
GABAAR modulator 
 
ACh- &  
GABAAR modulator 
 
ACh+ 
Wash-out 
TABLE 12: DRUG-APPLICATION DESIGN FOR IPSC EXPERIMENTS.   
 
Raw data examples are shown in figure 23A. Identical to extracellular experiments, zolpidem was 
applied in two different concentrations where the low concentration was suited to predominantly 
enhance currents through GABAAR containing the α1 receptor subunit while the high concentration 
additionally targeted receptors with α2 and α3 subunits (Munakata et al., 1998). 
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FIGURE 23: ALTERATION OF INHIBITORY POSTSYNAPTIC CURRENTS BY GABAERGIC MODULATORS UNDER 
THE ACH+ AND ACH- CONDITIONS. A. Exemplary current traces from cortical cells in culture obtained in 
voltage clamp, shown for the four different drug application series including sham. In all cases, ACh+ was the 
baseline condition (top trace), followed by [ACh+ & GABAAR modulator| sham] (middle trace, and [ACh- & 
GABAAR modulator| sham]  (bottom trace). 
 
As for previous IPSC recordings, four parameters were analyzed: decay time τ, frequency of IPSCs, 
peak IPSC amplitude and the total phasic current. All data and their respective medians and 25th and 
75th quantiles are shown in figure 24 (see also supplementary material Table S10). When the control 
data (ACh+ condition: first condition in each experimental series) was compared across the GABAAR 
modulator and sham conditions, the variability between cultures was noticeable. For example, the 
zolpidem (1 µM) data set had a median IPSC frequency of around 20 Hz under the ACh+ condition, 
whereas the zolpidem (0.2 µM) data set started from a median IPSC frequency of around 50 Hz. Since 
the baseline IPSC activity was not comparable across experimental sets, all data sets were normalized 
to their respective ACh+ control condition.  
 
Results 
 
74 
 
 
FIGURE 24: SUMMARY PLOTS OF IPSC PARAMETERS FOR ALL EXPERIMENTS FOR THE THREE GABAAR 
MODULATORS STUDIED AND SHAM APPLICATION. Grey lines are individual experiments, black lines are 
medians and 25
th
 and 75
th
 quantile. Bonferroni correction: p < 0.02; CI 0.983. 
 
To show the effect of GABAAR modulators alone independent of the cholinergic status, data for each 
GABAAR modulator was pooled across the ACh
+ and ACh- conditions. For the sham condition, ACh+ 
and ACh- data were also pooled. Since these pooled data sets were independent from one another, a 
Kruskal-Wallis test was applied to compare them. Then, three post-hoc comparisons were made 
between zolpidem (1 µM), zolpidem (0.2 µM) and diazepam each with sham (Figure 25). All three 
GABAAR modulators caused significantly longer IPSC decay times in comparison to sham. Since the 
main characteristic of positive allosteric GABAAR modulators consists of the prolongation of channel 
open times and thus, an increase of IPSC decay times (Rudolph and Antkowiak, 2004), this finding 
was expected and confirmed the efficacy of GABAAR modulators in the chosen model system. 
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FIGURE 25: EFFECTS OF GABAAR MODULATORS COMPARED TO SHAM CONDITION ON (FROM TOP TO 
BOTTOM) IPSC PARAMETERS DECAY TIME, FREQUENCY, AND AMPLITUDE, AND THE TOTAL PHASIC CURRENT. 
In this figure data were averaged across the ACh+ and ACh- conditions to illustrate the effects of the GABAAR 
modulators independent of the cholinergic status. Left column, box plots of the IPSC parameters normalized to 
control (ACh+ condition). Sham condition is in rosé. Right, Auroc effect sizes and CIs are shown to evaluate the 
difference between sham and GABAAR modulators. 
 
In terms of IPSC frequency, only zolpidem (0.2 µM) differed substantially from the sham condition 
(auroc = 0.76). The IPSC peak amplitude was not affected by GABAAR modulators; there was no 
indication of a difference between all four conditions (Χ2= 5.82, p = 0.12). The phasic current differed 
most between zolpidem (1 µM) and sham (auroc = 0.85), although application of diazepam also 
resulted in a slightly larger phasic current compared to sham (auroc = 0.72). In summary, all three 
GABAAR modulators differed substantially from the sham condition in decay time. When considering 
the overall inhibitory current, zolpidem (1 µM) and diazepam differed from sham, whereas the 
extraordinarily strong depression of IPSC frequency in zolpidem (0.2 µM) resulted in a net inhibition 
which was even lower than that in the sham condition. 
Next, the effect of each GABAAR modulator was compared between the ACh
+ and ACh- conditions. In 
figure 26, left column, normalized medians for all GABAAR conditions during the ACh
+ and ACh- drug 
condition and sham were plotted per parameter. In order to answer the question if the ACh 
condition impacted the effect of GABAAR modulators, data from [GABAAR modulator & ACh
+] and 
[GABAAR modulator & ACh
-] (second and third recorded condition of each experimental series, 
respectively) were compared statistically (auroc). Results for each parameter are displayed in the 
right column of figure 26.  
In the sham condition, the change of IPSC parameters from the ACh+ to the ACh- condition was 
quantified in the absence of GABAAR modulators. Although the decay time was significantly shorter 
in the ACh+ condition, the overall phasic current was larger in the ACh+ than in the ACh- condition 
accompanied by a significantly higher IPSC frequency and larger IPSC peak amplitudes (Figure 26, 
supplementary material Table S11). In summary, the inhibitory current was larger in the ACh+ than in 
the ACh- condition, confirming previous results (section 3.1.3).  
The main part of the analysis consisted of the comparison of different GABAAR modulators under 
both ACh conditions. For zolpidem (1 µM), the decay time was shorter under the ACh+ than the ACh- 
condition (auroc = 0.3), and IPSC frequency, amplitude and total phasic current were larger under the 
ACh+ than the ACh- condition (Figure 26). Similarly, diazepam had a shorter decay time under the 
ACh+ than the ACh- condition (auroc = 0.21), and IPSC frequency, amplitude and total phasic current 
were larger under the ACh+ than the ACh- condition. When comparing results for these GABAAR  
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FIGURE 26: COMPARISON OF THE EFFECTS OF GABAAR MODULATORS UNDER THE TWO DIFFERENT ACH 
CONDITIONS. On the left, normalized data (to ACh+ condition) is shown for all GABAAR modulators under ACh+ 
and ACh- conditions. Line styles encode different GABAAR modulators (see legend). On the right, auroc values 
with CIs are displayed for the differences between the ACh+ and ACh- condition for each GABAAR modulator. 
 
modulators to the sham condition, it became apparent that all parameters changed qualitatively in 
the same way with an effect of similar size.  
Zolpidem (0.2 µM) differed from zolpidem (1 µM) and diazepam as it remained mostly unaffected by 
the presence or absence of ACh since the effect was close to 0.5 for all four parameters 
(supplementary material Table S11). As mentioned before, an effect of 0.5 or crossing of confidence 
intervals of the 0.5 line indicates no effect (no difference between distributions; see Methods section 
on auroc). Only for IPSC frequency, about 70% of the data points (auroc = 0.69 [0.56 0.88]) under the 
[zolpidem (0.2 µM) & ACh+] condition had higher frequencies than in the [zolpidem (0.2 µM) & ACh-] 
condition, meaning that the IPSC frequency for zolpidem (0.2 µM) was significantly higher in the ACh+ 
than in the ACh- condition. Otherwise, the effect of zolpidem (0.2 µM) was independent of the ACh 
condition.  
In conclusion, IPSC analysis showed that all GABAAR modulators alone prolonged the decay time 
independently of the ACh status. When effects of zolpidem (0.2 µM) were compared under the ACh+ 
and ACh- condition, IPSC parameters were unaffected by the ACh status. Zolpidem (1 µM) and 
diazepam had a shorter decay time in the presence of ACh+, but higher IPSC frequencies, larger IPSC 
peak amplitudes and a larger phasic current qualitatively similar to the sham condition.  
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4 Discussion 
 
The neuromodulator ACh is an essential component of sensory stimulus processing in the cortex. As 
ACh reduces intracortical communication and, at the same time, strengthens afferent thalamic input 
into cortex, newly perceived stimuli can pass through to cortex (Bloem et al., 2014; Eggermann et al., 
2014; Kruglikov and Rudy, 2008; Wester and Contreras, 2013). How is this gating of information 
processing accomplished? Increasingly it appears that the neocortical GABAergic system takes on a 
central role in combination with ACh: numerous, diverse classes of GABAergic INs with differential 
sensitivities to ACh control cortical activity and sensory processing, including neuronal oscillations, 
synchrony and receptive field properties (Chen et al., 2015). Based on in vitro electrophysiology, the 
present thesis project was designed to illuminate how ACh alters qualitative and quantitative aspects 
of neocortical GABAergic inhibition. Specifically, the modulation of different GABAAR subtypes was 
contrasted between the ACh+ condition, in which external ACh was applied, and the ACh- condition, 
in which the cholinergic receptor system was antagonized. Two major results can be reported: 1) ACh 
increased inhibition by exciting parts of the interneuronal system. 2) ACh differentially affected 
GABAAR subunit modulation. In the following, these main results will be elaborated on, followed by a 
more detailed discussion of the various experimental approaches pursued in this thesis. 
Since experiments with GABAAR modulators were based on an alteration of the cholinergic status via 
externally supplied ACh, first, the action of ACh in organotypic cultures was investigated alone. 
Current clamp recordings from neocortical cells revealed two sides of the ACh effect: on the one 
hand, ACh induced increases in average firing rate and burst rate, which seems to point to an 
excitation of the networks. On the other hand, the length of bursts, burst afterhyperpolarizations and 
in-burst peak depolarizations decreased – observations compatible with increased inhibition. 
Although on the behavioral level this neuromodulator is associated with wakefulness and attention 
which may imply general excitation of the network (Hasselmo and Sarter, 2011), findings from the 
current project support the notion that ACh at least partly increases inhibition. Since the focus of the 
thesis was on the interaction between ACh and the GABAergic system, further investigation of the 
inhibitory component of ACh was carried out by recording IPSCs from cortical PYs in the presence 
and absence of cholinergic activity. Results from this experimental series showed a dramatic increase 
in IPSC frequency as well as amplitude. Thus, it was concluded that at least parts of the GABAergic IN 
system were directly activated by ACh. Especially SOM+ INs were suspected to be a major component 
of the GABAergic inhibition evoked through ACh since they had been shown before to depolarize in 
the presence of the neuromodulator (Kawaguchi, 1997). Paired recordings from Martinotti cells, a 
subgroup of SOM+ INs, intracellulary and cortex extracellulary were conducted. Although the overall 
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firing rate of Martinotti cells did not increase during ACh application as might have been expected, 
their firing pattern became more tonic and independent of network activity. It is likely that the role 
of this IN class within the cortical network was altered by the change in firing pattern, which may be 
one key component of the ACh effect. 
The main part of the project was concerned with the question whether or not the action of ACh on 
GABAergic inhibition depended on specific GABAAR subunits. It was hypothesized that inhibition 
mediated via receptors containing the α5 subunit postsynaptic to SOM
+ INs would depend on the 
cholinergic status, since SOM+ cells were shown to be ACh-sensitive. On the other hand, inhibition 
mediated via receptors containing the α1 subunit postsynaptic to PV
+ INs, which are most likely not 
directly affected by ACh, should not be affected by the cholinergic status. To investigate this 
hypothesis, the action of different GABAAR modulators on extracellulary recorded network activity 
was compared between the presence and absence of ACh. This approach yielded a wealth of 
information which confirmed the general hypothesis of an ACh-dependent change in the recruitment 
of GABAAR subtypes, albeit in unexpected ways. 
First, conventional burst and action potential parameters were compared to characterize the effect 
on the activity pattern. This analysis revealed that the burst rate was the most consistently affected 
parameter across all drug conditions. Especially in the infragranular layer, positive modulation of 
receptors containing the α1 (2, 3) (zolpidem 0.2 µM), α2, 3, 5 (diazepam in α1 mutant) and α1, 2, 3, 5 
(diazepam in WT) subunits caused significantly lower burst rates in the presence of ACh than in its 
absence. Differences between cholinergic conditions for GABAergic modulation involving the α1, 2, 3 
subunits (zolpidem 1.0 µM) were similar but smaller. Intriguingly, the presence of α5 among the 
positively modulated subunits determined the effect of GABAAR modulators on the amount of 
network activity: whereas modulation of GABAARs containing the α1 (2, 3)/ α1, 2, 3 subunits in reduced 
network activity in the presence of ACh in comparison to its absence, modulation of GABAARs 
containing the α2, 3, 5/ α1, 2, 3, 5 subunits did not cholinergic-dependently change the amount of network 
activity despite the reduction in burst rate. The decrease in burst rate was compensated for by an 
increase in burst length in the presence of ACh. Thus, the overall amount of network activity stayed 
constant. Overall, modulation of α1 (2, 3)/ α1, 2, 3 -containing receptors reduced the network activity in 
the presence of ACh while modulation of α2, 3, 5/ α1, 2, 3, 5  -containing receptors changed the pattern of 
network activity without decreasing it in the presence of ACh. Fittingly, antagonism of the GABAARs 
with the α5 subunit (L-655,708) increased network activity in the presence of ACh comparatively to its 
absence, which underscores the essential role of this subunit for the ACh effect.     
Second, power spectral analysis revealed that receptor modulation with the α1, 2, 3 subunits decreased 
the delta frequency band in the presence and absence of ACh; however, the effect was stronger in its 
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presence and only found in the infragranular layer. Antagonism of the GABAARs containing the α5 
subunit evoked ACh-dependent changes across a wider frequency spectrum.  
Third, cross-correlations of LFP signals from the infragranular and supragranular layers were 
calculated. While receptor modulation containing the α1 (2, 3)/ α1, 2, 3 subunits had stronger 
decorrelating effects in the presence of ACh than in its absence in some frequency bands, 
modulation of the α2, 3, 5/ α1, 2, 3, 5 subunit-containing receptors depended clearly less on the 
cholinergic status. Antagonism of the α5 subunit-containing receptors enhanced the correlation in the 
presence of ACh. Lastly, cross-correlations between the instantaneous firing rate and LFP signals 
showed the strongest difference between the presence and absence of ACh for modulation of 
receptors with the α1, 2, 3 subunits in the infragranular layers. 
Overall, the project showed that ACh increased inhibition, which was at least in parts mediated via 
Martinotti cells, and that the cholinergic status differently impacts GABAergic inhibition depending 
on specific α-subunit modulation. Differences between the presence and absence of ACh were most 
reliable and explicit across different analyses when the α1, 2, 3 or the α5 subunits were modulated or 
antagonized, respectively. Moreover, the modulation of α1, 2, 3, 5 subunits led to the least differences 
between cholinergic conditions. It is speculated that specifically α1 and α5 may act as opposing forced 
to balance inhibition. Further on, results will be discussed in more detail. 
4.1 Methodological considerations 
 
For the main part of the current thesis project, organotypic cortical cultures were used. In some 
respects, the organotypic culture model system bridges the gap between the in vitro acute slice 
system and in vivo experiments on animals. Cultures are maintained in vitro for at least two weeks 
before experiments are conducted so that recovery of neuronal pathways and further development 
after the slicing process is possible. It has been shown that axonal connections that have been cut 
during the preparation reform to create a cortical network that resembles in vivo conditions (De 
Simoni et al., 2003; Drexler et al., 2010; Gähwiler et al., 1997). This network architecture enables a 
high degree of spontaneous network activity. For experiments relying on this kind of activity cultures 
thus provide a clear advantage over cortical acute slices, in which rates of spontaneous network 
bursts are roughly an order of magnitude less. Although organotypic cultures were used as the 
primary model system in the current project for the reasons named above, they have their own 
limitations. Despite being morphologically and structurally in vivo-like, firing patterns of organotypic 
cultures do not resemble in vivo waking. While organotypic cultures produce distinct states of high 
and low network activity causing a slow-frequency rhythm as described in the introduction (section 
1.4), the awake state in vivo is characterized by tonic, higher frequency activity (Steriade et al., 2001). 
However, slow-frequency activity can also be found in vivo, where it corresponds to slow-wave sleep 
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or anesthesia (Sanchez-Vives and McCormick, 2000; Steriade et al., 1993). Thus, results discussed 
further on should not be compared to in vivo waking. It should be kept in mind that organotypic 
cultures, although in vivo-like in terms of synaptic connectivity and other respects, are merely a 
model system which provided ideal conditions to develop a general idea about the interaction of the 
cholinergic and GABAergic transmitter systems in cortex.      
The second consideration concerns the zolpidem concentrations chosen for the project. Zolpidem 
was used at 0.2 µM and 1.0 µM to create two relatively distinct GABAAR subunit modulating 
conditions. While zolpidem has the highest affinity for α1 subunit-containing receptors, it also binds 
to receptors with the α2 and α3 subunit, but has negligible effects on receptors with the α5 subunit 
(Engelhardt et al., 2007; Munakata et al., 1998; Puia et al., 1991; Sanna et al., 2002). The idea behind 
using the lower concentration of zolpidem was to potentiate the effect transmitted via the α1 
subunit-containing receptors and at the same time attenuate α2- and α3-mediated effects. It can be 
argued that for both concentrations, the α1 subunit is dominating over the other two subunits since 
these concentrations fall relatively close together. However, a concentration-response curve 
measured as the increase of the GABA current in oocytes suggested that zolpidem evoked stronger 
current potentiation via the α1 than the α3 subunit at lower concentrations (< 1 µM) (Wafford et al., 
1993). At 1 µM zolpidem, potentiation via the α1 subunit seemed to reach a plateau, whereas 
potentiation via the α3 subunit still increased with increasing concentration (Wafford et al., 1993). 
These results are in accordance with Puia et al. (1991), by tendency showing higher potentiation via 
the α3 than the α1 subunit for 10 µM zolpidem. Thus, for the current study, 1 µM was considered less 
selective for the α1 subunit than 0.2 µM zolpidem. It also needs to be considered that zolpidem (1.0 
µM) in the presence of ACh in some cultures had such a strong decreasing effect on network activity 
that no signals were detectable during this condition. Further increase of the zolpidem concentration 
(to increase the effect on α2/ α3) most likely would have led to more experiments with unquantifiable 
responses.        
4.2 ACh increased inhibition in organotypic cortical cultures 
4.2.1 Alterations of spontaneous firing patterns by ACh 
 
Acetylcholine is a widely investigated neuromodulator whose impact on different cell types in the 
cortex has been studied in detail (Hasselmo and Sarter, 2011; Picciotto et al., 2012). Many 
conclusions are based on work with acute slices and relatively high ACh or carbachol (cholinergic 
receptor agonist) concentrations (Buhl et al., 1998; Kondo and Kawaguchi, 2001; Kuczewski et al., 
2005). Less is known about the action of ACh on spontaneously active networks as they exist in 
organotypic slice cultures. Since neocortex contains cholinergic INs (Engelhardt et al., 2007) it was 
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plausible to ask whether or not notable amounts of ACh were released by these neurons and 
affected network activity. In acute slices, Engelhardt et al. (2007) found that these neurons did not 
exert direct postsynaptic effects on PYs but only modestly increased the number of spontaneous 
excitatory postsynaptic currents (EPSCs) by acting on nicotinic receptors on presynaptic 
glutamatergic terminals. It was concluded that intrinsic cholinergic INs were unable to modulate the 
cortical network in a notable manner. However, it was unclear whether the same would hold in 
spontaneously active slice cultures, the model system used here. Hence, extracellular experiments 
were carried out contrasting the effect of cholinergic receptor blockade (atropine and 
mecamylamine) subsequent to either no external ACh application (control) or application of 1 µM or 
10 µM ACh in combination with the ACh-esterase inhibitor neostigmine, which was added to ensure 
a stable tonic ACh concentration. The logic behind this comparison was that network activity should 
not differ between aCSF alone and cholinergic receptor antagonism if no or little internal ACh was 
present. Only if amounts of ACh sufficient to shape network activity were released by cholinergic INs, 
receptor blockage was expected to show an effect. By contrast, effects of receptor antagonists were 
definitely anticipated subsequent to ACh application. Overall, cholinergic receptor blockage had little 
effect following the control condition. Only when blockers were applied subsequent to the 
application of either ACh concentration, two distinguishable activity patterns were evoked: while the 
ACh condition was characterized by higher burst rates with short bursts and less action potential 
firing during the initial phase of the burst, cholinergic receptor blockade decreased the burst rate, 
and increased burst length, amplitude and action potential firing during burst beginning.  
Thus, two major conclusions could be drawn. First, the clear difference of cholinergic blocker effects 
in the control and ACh conditions revealed that the impact of intrinsic cholinergic neurons on the 
network, if present, did not match the impact of tonically present ACh at either of the chosen 
concentrations. Second, the lower of the tested concentrations of ACh (1 µM) had sufficiently clear 
effects on spontaneous activity. Therefore, this concentration in conjunction with 1 µM neostigmine 
was defined as the standard cholinergically activated (ACh+) condition for all subsequent 
experiments, including those with GABAAR modulators. The findings reported above may be 
interpreted to mean that intrinsic cholinergic release in the cultures was null, so that the ACh+ 
condition could have been contrasted with the control (drug-free condition). Although this may be 
the case on average, and in some series was done due to experimental considerations/limitations, it 
could not be excluded that putative intrinsic cholinergic release influenced activity in a small subset 
of cultures, or characteristics of activity that were not tested in this experimental series. Therefore, in 
order to exclude any influence of intrinsic cholinergic neurons a priori, in the majority of the 
subsequent experimental series, the ACh+ condition was contrasted with the ACh- condition (defined 
by the presence of cholinergic blockers as described above). 
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Although extracellular experiments discussed previously already provided some insight in the effect 
of ACh on network activity, firing pattern changes in the presence of 1 µM ACh in combination with 
neostigmine were investigated in more detail in current clamp experiments of somatosensory 
cortical cells in cultures. Spontaneous activity during the control condition consisted of synchronized, 
clearly separable network bursts and silent periods. Action potential firing occurred mainly during 
burst phases. The presence of ACh changed the firing pattern substantially. Bursts were shorter but 
more frequent, as in the extracellular recordings described above. Overall, more action potentials 
were triggered as the application of ACh led to a continuous, tonic action potential spiking which 
depended less on global network activity. At the same time, bursts and silent periods became less 
distinguishable from each other, which is an indicator of a more desynchronized activity pattern. 
Desynchronization is defined as a decrease in low-frequency spectral power and has been associated 
with the release of ACh before. For example, Tateno et al. (2005), who studied the effect of 10-50 
µM carbachol on dissociated cortical cultures from rats, reported that carbachol transformed 
synchronous burst firing into a more asynchronous single-spike firing pattern just as has been shown 
in the current work. Another study by Metherate et al. (1992) found that ACh shifted originally large-
amplitude, slow oscillation network bursts to low-amplitude, fast oscillations in the beta to low 
gamma frequency range. Thus, previously reported effects of ACh could be replicated in organotypic 
cultures and confirmed the usability of the chosen experimental conditions and model system.      
In addition to the analysis of network bursts and action potential rates, the membrane potential 
before and during burst onset and after burst offset was analyzed. During the control condition, most 
of the cells were overexcited as the membrane potential went into a depolarization block after burst 
onset, during which no action potentials could be initialized. In the presence of ACh+, the membrane 
potential was less depolarized and more full-scale action potentials occurred in this phase. The ACh-
induced prevention of overexcitation could be explained by an increase in inhibitory currents. ACh 
has been shown to activate GABAergic INs (Alitto and Dan, 2013; Alkondon et al., 2000; Kawaguchi, 
1997; Porter et al., 1999; Xiang et al., 1998) and increase inhibitory postsynaptic currents in 
pyramidal cells (Aracri et al., 2010; Xiao et al., 2009). In the current project, voltage clamp 
experiments were performed to further investigate the role of ACh on GABAergic inhibition, which 
will be discussed later on. Besides increasing GABAergic inhibition, ACh has been associated with a 
decrease in EPSP amplitude in cortical pyramidal neurons which may be due to the activation of 
presynaptically-located M4 receptors (Gigout et al., 2012; Levy et al., 2006). The combination of 
increased inhibition and reduced excitation would lead to less excitatory input during burst beginning 
and thus to less depolarization.    
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Secondly, there was no considerable difference of the membrane potential prior and immediately 
following bursts unlike during the control condition, where notable afterhyperpolarizations (AHPs) 
existed. The reduction of AHP has been reported before for carbachol applied to neostriatal neurons 
(Pineda et al., 1995). Pineda et al. attributed the affected to M1 muscarinic receptors, which are 
coupled to the phospholipase C cascade activating protein kinase C. Protein kinase C might lead to a 
reduction in Ca2+ influx which would cause a decrease in Ca2+-activated K+ currents contributing to 
AHPs. Additionally, the reduction in burst length might lead to a decrease in Na+ and Ca2+ influx and 
thus a decrease in Na+ and Ca2+-activated K+ currents (Sanchez-Vives et al., 2010).   
Combining the results obtained from the analysis of firing patterns and changes in membrane 
potentials, the hypothesis that ACh emphasizes inhibition within the cortical network can be 
supported. First, the dampening of overexcitation during burst phases due to a less depolarized 
membrane potential of the cell hint at more inhibitory input received by the cell. Second, the 
shortening of burst phases also promotes the idea of more inhibition. Shorter, less fatiguing burst 
phases and reduced AHPs may be responsible for the cells increased capacity to quickly enter into 
the next burst phase as could be seen by an increase in burst and action potential rate. Thus, the 
increase of inhibition fundamentally changed the network firing pattern and ultimately led to an 
increase in cell activity.      
4.2.2 Evidence of direct cholinergic excitation of INs in IPSC measurements 
 
The hypothesis of an increase in inhibition by ACh was confirmed by voltage-clamp experiments 
which were performed to quantify inhibitory postsynaptic currents. In the presence of ACh in 
comparison to the control condition and cholinergic blockage, the overall inhibitory current 
increased almost five times and was action potential-dependent. Measurable changes in IPSC 
parameters were most likely resulting from somatic input, while dendritic IPSCs were probably 
underrepresented due to insufficient voltage clamp of the dendrites, a limitation inherent to the 
somatic voltage clamp method (Williams and Mitchell, 2008). Thus, two major IN classes which both 
project to the soma of PY cells in cortex may contribute to the increase in inhibition: PV+ fast-spiking 
basket cells and CCK+ irregular-spiking cells. Xiao et al. (2009) demonstrated the increase of 
spontaneous IPSC frequency and amplitude in cortical pyramidal cells of layer II/III due to the 
activation of the muscarinic M3 receptor subtype. In addition, Rio et al. (2010) ascribed an increase in 
action potential firing frequency of CCK+ INs in hippocampus, but not of PV+ INs, to the activation of 
the M3 receptor. PCR analyses revealed the presence of the M1 as well as the M3 receptor subtype on 
CCK+ INs, whereas only the M1 subunit was detected on PV
+ INs. CCK+ INs in knock-out mice lacking 
the M3 receptor failed to show an increase in firing frequency subsequent to ACh release. Taken 
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together, the direct activation of CCK+ INs via M3 receptors by ACh seems to be a plausible 
explanation for the IPSC increase in pyramidal cells observed in this work.    
While early reports have already negated the direct cholinergic activation of PV+ INs (Kawaguchi, 
1997), some recent studies supported this view. For example, Alitto and Dan (2013) reported that 
PV+ INs were exited in the presence of ACh, but could show that their increase in activity was only a 
secondary effect of ACh and stemmed from activation by PYs, which were directly excited by ACh and 
connected to PV+ INs by a negative feedback loop. Moreover, this IN class has been shown to release 
less GABA in the presence of ACh due to inhibitory presynaptic M2/4 receptors (Kruglikov and Rudy, 
2008). Yet, there are studies providing evidence for a cholinergic excitability of these INs. For 
example, Rio et al. (2010) reported the activation of PV+ INs via the M1 receptor. In contrast to M3 
receptor-containing CCK+ INs, a higher ACh concentration was needed for a notable increase in firing 
frequency. The authors speculated that M1 receptors might be located in a less accessible location 
and thus, may only be activated during sustained ACh release. For cortex, Pafundo et al. (2013) found 
that ACh depolarized PV+ INs but by far less than PYs and Yi et al. (2014) described a stronger 
depolarizing effects for hippocampal than for cortical PV+ INs. In conclusion, ACh seems to directly 
recruit CCK+ INs, while significant activation of PV+ INs by ACh seems to be more dependent on 
corresponding PY activity. Therefore, in a network lacking excitatory transmission as was used for 
voltage clamp experiments, CCK+ cells are proposed to be more likely to contribute large somatic 
IPSCs measured from pyramidal cells in the presence of ACh.  
Combined results from extracellular, current clamp, and voltage clamp experiments suggest that ACh 
increased inhibitory signaling in cortex. One of the possible mechanisms explaining the effect of ACh 
may be an increase in direct inhibitory input to PY cells most likely by activating somatically-
projecting CCK-positive INs, amongst other mechanisms (the role of dendritic-projecting SOM-
positive INs will be discussed later on). Presumably as a consequence of this enhanced inhibition, the 
in-burst membrane potential was not driven into a depolarization block, which resulted in more 
regular action potential firing during the initial phase of the bursts. It is proposed that less excessive 
depolarization and shorter burst durations may be the reason for the absence of the strong AHPs as 
seen under control conditions, which allows for quicker development of a new burst phase. In its 
extreme form, when positive GABAAR modulators come into play (see section 4.3), this modulatory 
mechanism may by a major cause of a shift from phasic activity, which displays as separable burst 
phases and silent periods, to more tonic continuous activity.    
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4.2.3 Basal forebrain-neocortical co-cultures were not affected by cholinergic receptor 
antagonism  
 
The extracellular experimental series with cholinergic receptor antagonists supported the hypothesis 
that intrinsic cholinergic INs did not hold a dominant role in shaping spontaneous network activity. 
Thus, ACh had to be supplied to the network from an external source. In morphological studies it has 
been shown that neocortex receives prominent cholinergic projection afferents from basal forebrain 
(Woolf, 1991). Therefore, a co-culture system between basal forebrain and neocortex was created in 
an attempt to release ACh in a more physiological way instead of bath-applying it via the perfusion 
system. These co-cultures have been described before, but they were exclusively used for 
morphological studies (Baratta et al., 1996; Distler and Robertson, 1992; Gähwiler and Hefti, 1984). 
For this thesis project, electrophysiological recordings from these co-cultures were obtained for the 
first time. Basal forebrain slices were acquired from genetically modified mice with GFP-labelled 
cholinergic cells. Thus, it was possible to record intracellularly from a basal forebrain cholinergic cell, 
while the network activity of the cortex was monitored with an extracellular electrode. 
Electrophysiological characteristics of cholinergic cells in basal forebrain have been reported for 
acute slices (Arrigoni et al., 2006; Griffith and Matthews, 1986; Unal et al., 2012). The comparison 
between these three studies with the results from co-cultures prepared for the current project 
revealed a large divergence in cell resistances. Whereas the cells recorded here had a cell resistance 
of ~ 107 MΩ, Griffith and Matthews (1986), who recorded from cholinergic basal forebrain cells in 
guinea pig brain slices, reported a slightly lower membrane resistance, while Arrigoni et al. (2006) 
and Unal et al. (2012), who worked with the same mutant mouse strain as used in the current 
project, measured a three and six times greater membrane resistance and time constant than was 
reported here, respectively. One possible explanation for the marked difference may have been the 
culture system used here in comparison to acute slices employed by Arrigoni et al. and Unal et al. 
Cells in organotypic cultures are known to be highly interconnected with each other (Debanne et al., 
1995; Drexler et al., 2010). Thus, neurons receive a multiple of the excitatory input neurons in acute 
slices experience. The depolarization block reported above (see cortical current clamp experiments in 
section 4.2.1) is one indicator of high levels of excitatory synaptic input. In order to compensate for 
this intense input, neurons grown in culture may reduce their membrane resistance significantly in 
comparison to cells in acute slices, a phenomenon known as 'homeostatic plasticity' (Desai et al., 
1999).  
As in cortical mono-cultures, the presence of cholinergic effects on network activity was tested by 
the application of cholinergic receptor blockers (which should reverse any ACh effects) and the 
choline-esterase inhibitor neostigmine (which should enhance ACh effects). If ACh had been released 
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in substantial amounts, clear differences in network activity between these two conditions should 
have surfaced. However, neither drug treatment had a consistent modulatory effect, which can be 
attributed to a number of factors. First of all, the connectivity between neocortex and basal forebrain 
was not systematically studied. Although it could be shown that cholinergic neurons fired well 
attuned to cortical bursts, implying connectivity from cortex to basal forebrain, the connectivity from 
basal forebrain to cortex has only been visually verified. In all preparations, axons could be traced 
from basal forebrain to neocortex spanning the gap between tissues. However, their distribution 
within cortex remains unclear. Taking earlier studies into account, it can be assumed that the 
connectivity between basal forebrain and cortex should develop easily in culture. For example, 
Gähwiler and Hefti (1984) showed that cholinergic neurons readily grew into target tissue 
independently of the original anatomical predetermined connectivity. Distler and Robertson (1992, 
1993) reported rapid ingrowth of cholinergic fibers into cortex after the first week in vitro. Therefore, 
connectivity between the tissues is the less likely problem.  
The other, more serious issue may be the attunement of cholinergic neurons to the cortical burst 
firing rhythm. For ACh to have a dominant effect on cortical network activity, it appears essential that 
cholinergic neurons fire independently and specifically prior to cortical burst beginnings. However, 
membrane potential comparison and cross-correlational analysis revealed that cortical bursts were 
the initiator of basal forebrain activity in most of the recorded cultures. Thus, cholinergic neurons 
were merely following the cortical rhythm. Another point to consider may be the amounts of ACh 
released. Cholinergic fibers have been shown to form classical synapses (Turrini et al., 2001). 
However, another body of evidence exists supporting the volume transmission hypothesis of ACh, 
which states that ACh is released into the extracellular space (Sarter et al., 2014). In agreement with 
the volume-transmission hypothesis, the previously discussed muscarinic M1 receptor is not directly 
contacted by cholinergic varicosities (Yamasaki et al., 2010) but proposed to be activated by ambient 
ACh. In order to exert an effect on network activity under these circumstances, ACh would have to be 
released over a longer period of time in order to accumulate to a receptor-activating concentration. 
It is possible that cortical burst frequency was not sufficiently high and silent periods between bursts 
were too long to drive cholinergic afferents sufficiently to release enough ACh in cortex for a notable 
effect on network activity.    
In order to study the effects of ACh released by basal forebrain afferents independently of 
spontaneous activity, stimulation of cholinergic cells would be necessary, which would best be 
achieved with the optogenetic approach. The cholinergic cell population could then be stimulated 
independent of cortical activity and amounts of ACh released would be better controllable.  
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4.2.4 Cholinergic excitation of Martinotti cells 
 
While IPSC recordings from cortical PYs indirectly disclosed the effect of ACh on somatic and 
perisomatic INs, the effect of ACh on dendritically projecting Martinotti cells could not be evaluated 
by this experimental series. By using a genetically modified mouse strain, in which Martinotti cells 
expressed GFP and could thus be visually identified, current clamp recordings were made from these 
cells to evaluate their response to ACh application. As previously discussed for basal forebrain 
cholinergic cells, Martinotti INs showed an about six times smaller membrane resistance in culture as 
compared to acute slices. This finding supports the notion that differences in membrane resistance 
between culture and acute slices are not cell type- or mouse strain-specific but rather a general 
difference between cultures and acute slices. It supports the idea that spontaneous activity in 
cultures and high network interconnectivity causes an increased amount of synaptic input received 
by cells, which is compensated for by a lower membrane resistance as prevention from 
overexcitation. 
The action of ACh on Martinotti cells has only been sparsely studied thus far. Distinctions between 
studied INs were often made based on firing properties (Yamamoto et al., 2010) or molecular 
markers (Chen et al., 2015; Porter et al., 1999: PV+ vs. SOM+). However, SOM+ INs can be further 
subdivided by their morphology as Ma et al. (2006) showed. In this study, three different genetically 
modified mouse lines were investigated, in which SOM+ neurons were labeled with GFP. SOM+ INs in 
the X98 mouse line used in the current project perfectly resemble the structural properties of 
‘classical’ Martinotti INs as their axons project to layer 1, where they branch extensively and span 
multiple columns. SOM+ INs in the X94 strain were mainly detected in layer 4 and projected within 
the same layer. SOM+ INs from the third examined mouse line called Gin does share properties of 
Martinotti cells as they project to layer 1; however their somas were located in layer 2/3. Based on 
distinct electrophysiological and chemical characteristics additionally to different morphology, Ma et 
al. (2006) concluded that in these three mouse lines, three non-overlapping SOM+ groups were 
labelled. Nonetheless, the terms “SOM+” and “Martinotti cell” are used almost interchangeably in the 
literature. For example, Fanselow et al. (2008) used the Gin line and claimed to study the effects of 
carbachol and muscarine on Martinotti cells. To the knowledge of the author, this is the closest study 
to investigate the action of ACh on Martinotti cells. Therefore, the investigation of cholinergic effects 
on layer 5 Martinotti cells in the X98 mouse line was necessary.  
In the current work, the presence of ACh caused a strong depolarization and heightened excitability 
in Martinotti cells, which is in agreement with results reported by Fanselow et al. (2008), where 
carbachol caused a persistent action potential discharge in layer 2/3 SOM+ INs. Especially interesting 
was the change in firing pattern observed here: driven by spontaneous network activity in cultures, 
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Martinotti cells fired during network burst phases under control condition. With the application of 
ACh, some cells switched into a tonic firing mode independent of burst phases. Recent work on IN 
connectivity has shown that Martinotti cells are connected to the entire IN types- spectrum and to 
PYs, with slightly stronger connection probability to the former (Jiang et al., 2015; Pfeffer et al., 
2013). The only connection they do not form is onto themselves (Jiang et al., 2015; Pfeffer et al., 
2013). Thus, their impact especially on the inhibitory network activity is supposedly powerful. Their 
change in activity pattern as achieved by ACh may influence the activity pattern of the entire 
network. In fact, Chen et al. (2015) could demonstrate that the activation of SOM+ INs alone by ACh 
was sufficient to evoke desynchronization and decorrelation, while VIP INs were not involved in 
these processes. The authors argued that SOM+ IN activity might not be the only source of 
desynchronization and decorrelation, but they play a most central role.        
4.3 ACh changed the mode of action of GABAAR modulators  
 
After the effects of ACh had been extensively investigated, the groundwork was laid to tackle the 
main question of the thesis project: Do GABAAR modulators differ in their effect in the presence of 
ACh? Research has suggested that IN classes are differentially modulated by ACh (Alitto and Dan, 
2013; Chen et al., 2015; Kawaguchi, 1997; Porter et al., 1999). Thus, it was hypothesized that GABAAR 
modulators depend in their effect on network activity on the cholinergic status. Additionally, IN 
classes form synapses with specific GABAAR subunits (Ali and Thomson, 2008; Freund, 2003; 
Klausberger et al., 2002; Nyíri et al., 2001; Thomson et al., 2000). Combining both findings, the 
hypothesis can be formulated that the action of GABAAR modulators with different GABAAR subunit 
affinities will be differentially altered by the presence of ACh. Five GABAAR subunit combinations 
were investigated in the ACh+ and ACh- condition: Zolpidem (0.2 µM) with preference for GABAARs 
with the α1 (2, 3) subunit; Zolpidem (1.0 µM) with preference for α1, 2, 3; Diazepam (1.0 µM) with 
preference for α1, 2, 3, 5, Diazepam (1.0 µM) in the α1-knock-in mutant with preference for α2, 3, 5, and L-
655,708 with preference for the α5 subunit.          
4.3.1 Differences in burst parameters  
4.3.1.1 During the presence of ACh, network activity decreased when α1 subunit-containing 
GABAARs were modulated, and increased when α5 subunit-containing GABAARs 
were blocked  
First, results from action potential and bust parameter analyses were consulted to describe the mode 
of activity of GABAAR modulators in the presence and absence of ACh. For zolpidem in both 
concentrations, differences between ACh conditions were largest for the time spent in bursts. 
Especially in infragranular layers, cultures spent less time in bursts when zolpidem was applied 
together with ACh instead of cholinergic receptor antagonists. The fact that both zolpidem (1.0 μM) 
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and zolpidem (0.2 μM) achieved the same effect on the network activity suggests that the α1 subunit 
played an essential role, since it is the dominant subunit target for both concentrations tested.  
For once, this result is surprising since the effect is more pronounced in the infragranular than in the 
supragranular layer. GABAARs containing the α1 subunit have been shown to be postsynaptic to PV
+ 
INs. Both, the α1 subunit and PV
+ INs were localized in layers one to six (Fritschy and Mohler, 1995; 
Kawaguchi and Kondo, 2002). Since PV+ INs are located near PY somata to exert local inhibition, their 
presence would be expected in layers two/three and five corresponding to PY somata distribution; 
thus equal results would have been expected for both layers. Taking a closer look at the results 
reveals almost equally large effect size values for supra- and infragranular layers, although 
supragranular effects were not significant. It is likely that random variation caused the discrepancy 
between layers. Here, more experiments might have helped to clarify whether or not results would 
also be significant for the supragranular layers. Another explanation may be developmental changes. 
Experiments with organotypic cultures used for this project were performed between 14 and 36 days 
in vitro. A study by Lecea et al. (1995) showed that PV+ INs were almost exclusively present in layer 
five during early development (up to postnatal day 12). At postnatal day 14, they started to be also 
present in layers two and three, however, there were still twice as many cells detected in layer five. 
Only later in development, layers two to six encompass about equal amounts of PV+ INs. Thus, it is 
possible that younger cultures used for the experiments might not show an effect in supragranular 
layers, while older cultures would show the effect.  
The second surprising factor for this experimental set was that the action of zolpidem on 
spontaneous network activity was affected by the presence of ACh. As has already been stated in the 
introduction, PV+ INs are likely not directly activated by ACh. Their GABA release may even be 
reduced in the presence of ACh by presynaptic inhibitory muscarinic M2 receptors and inhibition by 
ACh-activated SOM+ INs (Chen et al., 2015; Kruglikov and Rudy, 2008; Salgado et al., 2007). Reduced 
PV+ activity might become apparent by shortened burst periods, as has been shown for UP states in 
vivo (Kuki et al., 2015). However, in the current project, there were no differences between ACh 
conditions in burst length and thus, no evidence of reduced PV+ IN activity. An explanation for the 
differential effect of zolpidem during different cholinergic conditions could be found through the 
tight reciprocal coupling between PV+ INs and PYs and the activation of PYs by ACh. When ACh was 
applied, PY neurons were excited, which then activated nearby PV+ cells regulating the output of PY 
cells and preventing overexcitation. It is assumed that the addition of zolpidem increased the 
inhibitory power at the α1 subunit postsynaptic to PV
+ INs. This increase of somatic PY inhibition led 
to stronger hyperpolarization of PYs, which ultimately led to less network activity. By antagonizing 
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ACh receptors, PV+ INs were not activated by heightened PY activity and thus, the effect of zolpidem 
under this condition differed. 
Interestingly, only zolpidem (0.2 μM) but not zolpidem (1.0 μM) caused a distinctly lower burst rate 
in the presence of ACh than in its absence for the infragranular layer. It is plausible that with the 
higher concentration and the enhanced modulation of GABAARs with the α2, 3 subunits, PV
+ neuron 
activity was itself inhibited and thus, less inhibition was present. Overall, these results underline the 
complexity of the cortical network and its many distinct set screws. Although this project was based 
on the hypotheses of direct effects of ACh on the GABAergic IN system, zolpidem results provide 
evidence that secondary actions of ACh also shape network activity fundamentally.  
In order to gain more insight in the role of the α5 subunit during different cholinergic conditions, L-
655,708, a functional antagonist at α5 subunit-containing receptors, was used. In this case, GABAARs 
containing the α1, 2, 3 subunits were still functional, but not positively modulated as with zolpidem or 
diazepam. Thus, it is difficult to make predictions about the effects of L-655,708 based on results 
with these substances.  
First of all, differences between the two ACh conditions and L-655,708 could only be observed for the 
supragranular layers. This finding is plausible since the α5 subunit is located on PY dendrites reaching 
the upper layers, but not on their soma as the α1 subunit or axon initial segment as the α2, 3 subunits, 
respectively (Freund and Katona, 2007; Serwanski et al., 2006). Secondly, blocking α5 resulted in 
more time spent in bursts during the presence of ACh than during its absence. Hence, network 
activity was increased more in the presence of ACh than in its absence. It can be assumed that the 
application of ACh evoked an increase of SOM+ IN-mediated inhibition transmitted via GABAARs with 
the α5 subunit. When these receptors were antagonized, SOM
+ inhibition was disrupted resulting in 
an overall increase of network activity. The inhibitory impact of the remaining active receptors with 
the α1 and α2, 3 subunits may not have been strong enough to maintain the inhibitory component of 
the ACh effect. This finding points to the powerful role of α5 subunit-containing GABAARs for the ACh 
effect. Additionally, the blockage of the α5 subunit-containing receptor led to a higher burst 
amplitude in the presence of ACh than during its absence. The burst amplitude is an indirect measure 
of the firing synchrony of neurons (provided other relevant factors are constant). Large burst 
amplitudes indicate that more cells fired simultaneously at burst onset while small burst amplitudes 
indicate a more tonic firing pattern and less neurons firing, respectively. Higher burst amplitudes 
during the combined application of ACh and L-655,708 indicate that synchrony was larger when the 
α5 subunit-containing receptors were blocked. This result supports findings by Chen et al. (2015), who 
concluded that SOM+ activity alone was the source of ACh-induced desynchronization. Overall, 
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results from the current project underline the role of GABAARs with the α5 subunit and consequently 
of presynaptic SOM+ INs for the ACh effect on network activity.                
4.3.1.2 Change of activity pattern via GABAARs containing the α2, 3, 5 subunit in the absence 
of ACh 
Diazepam applied in WT and in the α1-knock-in mutant both showed differences across ACh 
conditions for burst rate and burst length. The application of diazepam in the presence of ACh caused 
fewer but longer bursts relative to the absence of ACh. These changes were found in both examined 
cortical layers. In contrast to zolpidem, which decreased the overall time spent in bursts, diazepam 
had no effect on the total time spent in bursts since the increase in burst length nullified the 
decrease of burst rate. Thus, diazepam changed the bursting pattern; however the overall amount of 
bursting activity stayed the same. PV+ cells have been reported recently to maintain UP states (Kuki 
et al., 2015) and could be a possible reason to explain longer bursts seen here. However, since the 
effects were so similar between WT and knock-in, it is assumed that the α1 subunit postsynaptic to 
PV+ INs was not involved but that changes were evoked via α2, 3, 5-containing GABAA receptors. It was 
originally hypothesized that ACh would enhance diazepam effects strongly since INs presynaptic to 
α2, 3 and α5 subunits are excited by ACh. Thus, a combination of increased GABA release and 
prolonged channel open times at the same synapse should lead to more inhibition than in the 
absence of ACh when INs where not especially activated. First of all, a difference was found between 
the two ACh conditions for diazepam. However, when considering the raw data it becomes clear that 
the difference can mainly be reduced to effects of diazepam when ACh was absent. In the presence 
of ACh, diazepam had no major impact. This finding suggests that ACh sufficiently modulated the 
inhibitory network to such a degree that the addition of diazepam could not further enhance the ACh 
effect. CCK+ INs presynaptic to α2, 3 subunits and SOM
+ INs presynaptic to the α5 subunit are both 
directly activated by ACh. ACh may increase GABA release significantly that prolongation of the 
postsynaptic channel open times via diazepam had no further effects on the network activity. Only 
when these IN classes were not previously activated by ACh was diazepam able to evoke notable 
changes. Another possible explanation may be that ACh modulates the network in such a way that 
diazepam effects at different GABAARs cancel each other out.  
In summary, burst parameter analysis revealed that GABAAR modulators acted differently in the 
presence and absence of ACh. Furthermore, ACh in combination with an α1 modulator and an α5 
antagonist had an effect on the total amount of network activity, while the pattern of activity was 
affected by α2, 3, 5 modulation only in the absence of ACh. 
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4.3.2 ACh-evoked LFP desynchronization in low frequency ranges mediated via the α1, 2, 3 
subunit and in low and high frequency ranges via the α5 subunit   
 
Beyond affecting burst parameters, ACh and GABAergic INs have been proposed to influence 
neuronal activity in specific frequency bands. ACh for example is known to reduce power in the low 
frequency range (< 10 Hz) but to enhance power in higher frequency ranges (Chen et al., 2015; 
Kalmbach and Waters, 2014; Metherate et al., 1992; Roopun et al., 2010). For GABAergic INs, the 
activation and synchronization of PV+ firing has been associated with the origin of gamma rhythms 
(Cardin et al., 2009; Kuki et al., 2015; Sohal et al., 2009; Suffczynski et al., 2014; Whittington et al., 
1995). For SOM+ INs, little is known about their effect on frequency bands. Kuki et al. (2015) 
demonstrated an increase in delta frequencies in the absence of SOM+ activity. Thus, it was of 
interest to analyze the power spectrum of the GABAAR modulators under both ACh conditions. A 
second motivation for spectral analysis was the fact that ACh sometimes changed the activity pattern 
in such a way that clearly separable bursts and silent periods gave way to continuous ongoing activity 
or oscillations. Traditional burst analysis was not suited to analyze these patterns. Therefore, spectral 
power analysis of LFP signals with an emphasis on five different frequency bands (delta, theta, beta, 
low gamma and high gamma) was employed. Of all GABAAR modulators tested, only zolpidem (1.0 
µM) and L-655,708 modulated the power of frequency bands in a manner that depended on the ACh 
status. In both ACh conditions, zolpidem caused a strong decrease in the delta frequency band. This 
finding is supported by clinical studies measuring brain activity with EEG (Arbon et al., 2015; Brunner 
et al., 1991). However, it is novel that additional ACh application can even strengthen this effect as 
data from the current project suggest. Since ACh alone decreased power in the lower frequency 
ranges as stated above and zolpidem had the same effect, effects of both modulators seem to have 
added together. Equivalent to results from burst parameter analysis (section 4.3.1), it was surprising 
to find a difference between cholinergic conditions and zolpidem since α1 subunits – the main target 
of zolpidem – are postsynaptic to PV+ INs not directly activated by ACh. Since this effect was not 
observed for zolpidem at the lower concentration (0.2 µM), it needs to be assumed that it is not α1-
specific, but also depends on the α2, 3 subunits. It is possible that ACh-activated CCK
+ INs presynaptic 
to these subunits were responsible for the particularly strong decrease in the delta frequency band. 
To the knowledge of the author, the role of CCK+ INs in shaping the frequency spectrum of cortical 
LFP activity have not been investigated thus far. Future research should focus on attributing spectral 
changes to specific IN activity. 
Antagonizing GABAARs with the α5 subunit with L-655,708 increased power in the theta frequency 
band, but decreased power in low and high gamma frequency bands in the presence of ACh 
compared to its absence. These results are in accordance with Chen et al. (2015). That study 
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demonstrated that the activation of SOM+ INs (which are presumably presynaptic to α5) caused the 
ACh-typical desynchronization by reducing low frequency power (< 10 Hz) and increasing high 
frequency power (10-100 Hz). When the receptors with the α5 subunit were blocked in the current 
experiments, this SOM+ IN-mediated effect could not be evoked, hence low frequencies increased 
while higher frequencies decreased. In the absence of ACh, SOM+ INs were not especially activated 
and thus the blockade of the α5 subunit did not lead to a change in spectral power.  
For diazepam in WT or the α1 knock-in mutant, no difference between cholinergic conditions was 
observed although GABAARs containing the α2, 3 were also facilitated. It is possible that the additional 
facilitation of α5 subunit-containing receptors under the diazepam treatment counteracted the α2, 3 –
effect, e.g. via some as yet unknown disinhibitory mechanism.  
Again, these results accentuate the central role of SOM+ INs and the α5 subunit for the ACh effect. 
Moreover, CCK+ INs and the α2, 3 subunit may distinctly affect the lower frequency ranges during the 
presence of ACh.   
4.3.3 Differences in LFP cross-correlations were strongest with ACh and α1, 2, 3 -
containing GABAAR  modulation 
 
The action of ACh on network activity is not only characterized by a power shift from low to high 
frequencies, but also by decorrelation of neuronal firing (Chen et al., 2015; Goard and Dan, 2009). As 
local field potentials mostly reflect synaptic input into the local pool of neurons in the vicinity of the 
recording electrode, and there were no extracortical sources of synaptic input in the investigated 
slice cultures, a decorrelation of neuronal firing should be visible in a decorrelation of the field 
potential. Specifically, the burst parameter and spectral analysis hinted at the possibility of 
differences between the supra- and infragranular layers in terms of the interaction of ACh and GABAA 
receptor modulation. Hence, cross-correlations between signals filtered at the five different 
frequency bands mentioned above between the supra- and infragranular layers were analyzed. 
Cross-correlation can be understood as a measure of the similarity between two signals. For 
example, a decrease in correlation can be interpreted as more autonomic action of layers. 
Differences between both ACh conditions were detected for zolpidem at both concentrations, 
diazepam in the α1 knock-in mutant, and L-655,708. ACh induced a decorrelation between layers 
together with zolpidem (0.2 µM) in the delta and theta frequency range and with zolpidem (1.0 µM) 
in the theta frequency range. For zolpidem, previous analyses revealed stronger differences between 
cholinergic conditions in the infragranular layers. Especially the decorrelation in the theta frequency 
band for zolpidem (1.0 µM) may be ascribed to the reduction of theta spectral power in the 
infragranular layer but not in the supragranular layer discussed above. As already pointed previously 
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and supported by these findings, effects of zolpidem (1.0 µM) are layer-dependent. Zolpidem (0.2 
µM) decorrelations in the presence of ACh cannot be explained as intuitively. The delta and theta 
frequency band are the signature frequencies of LFP bursts while activity in higher frequency ranges 
may also be found outside of bursts. It is plausible that the larger reduction in burst rate by zolpidem 
(0.2 µM) in the infragranular layer (see burst parameter analysis) is responsible for the decorrelation 
seen between layers in the lower frequency bands.      
By contrast, L-655,708 caused an ACh-dependent increase in correlations in the delta, theta and beta 
frequency bands suggesting that at least some of ACh’s decorrelation action is mediated via GABAARs 
containing the α5 subunit. This finding is in agreement with Chen et al. (2015) who demonstrated 
that the cholinergic activation of SOM+ INs – presynaptic to this receptor subunit – seems to be the 
major contributor to decorrelations. Interestingly, diazepam in WT did not alter correlations 
depending on the cholinergic status. This result suggests that the additional modulation of receptors 
with the α1, 2, 3 subunits counteracts the modulation of the α5 subunit-containing receptors. 
Overall, these findings illustrate that decorrelating effects of ACh rely on subtype-specific GABAAR 
modulation. Moreover, decorrelation results provide evidence of layer-specific actions of ACh. Due to 
the specific activation of certain IN classes and postsynaptic receptor subunits with differential 
expression across layers, ACh affects different layers. 
Additionally to analyzing the cross-correlation between LFP signals of the two layers, the 
'instantaneous firing rate' (ifr) synthesized from action potential activity was correlated with LFP 
signals filtered in the five frequency bands as above for each layer separately. Especially in 
infragranular layers, differences were detected between the two ACh conditions. Zolpidem (1.0 µM) 
evoked strong decorrelations between the ifr and all frequency bands in the presence of ACh. 
Zolpidem (0.2 µM), on the other hand, only showed differences in the correlation between the ifr 
and the delta frequency. Hence, the modulation of the α1 subunit-containing receptors together with 
the α2, 3 subunit-containing receptors led to the most extended differences between cholinergic 
conditions. Presumably, the combined activation of PV+ INs via PY neurons and CCK+ INs may lead to 
more independent firing of these IN classes but also of PY neurons. This finding highlights the 
involvement of INs and according subunits other than SOM+ cells with the corresponding α5 subunit 
for decorrelation. The modulation of the α1, 2, 3, 5 subunit-containing receptors (diazepam in WT) was 
not significantly affected by the presence or absence of ACh, similar to the results from the cross-
correlational analysis between layers. However for the infragranular layer, effects were similar to α1, 
2, 3 subunit-containing receptor modulations, only toned down. Again, the possibility that α5 
counteracts α1, 2, 3 activation to some degree in the presence of ACh seems supported. Firstly, Jiang et 
al. (2015) showed that Martinotti cells form connections to all other IN classes and PYs. Hence, 
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inhibition of PV+ and CCK+ activity may be the reason for smaller effects with diazepam than 
zolpidem. Secondly, the inhibition of PY cells by SOM+ INs may down-regulate the PY-PV+ feedback 
loop, which would decrease the effects of α1 modulation. Similar to results from the LFP cross-
correlation analysis, L-655,708 increased correlations in combination with ACh in comparison to the 
absence of ACh in the theta and beta frequency band. Again, evidence for the involvement of α5 
subunit for ACh-evoked decorrelation is provided. 
To sum up, correlational differences for the two cholinergic conditions where especially pronounced 
with the modulation of the α1, 2, 3 subunit-containing receptors but weakened when GABAARs with the 
α5 subunit were additionally facilitated. This suggests that in the presence of ACh, α5 subunit-
containing GABAAR at least partially counteract the action of α1, 2, 3-containing GABAAR. Moreover, a 
blockade of α5-mediated inhibition also caused differences between cholinergic conditions. However, 
in this case, the correlation was improved with ACh, indicating that α5 is a main mediator of ACh-
induced decorrelation of network activity as suggested by Chen et al. (2015).     
4.3.4 ACh enhanced inhibitory efficacy of α1,2,3- and α1,2,3,5 GABAAR modulator, but not of 
α1 GABAAR modulator  
 
To understand the extracellular results on a cellular level, IPSCs were recorded from cortical 
pyramidal cells. The modulation of three different GABAAR subunit combinations was tested in the 
presence and absence of ACh:  α1 (2, 3) (zolpidem 0.2 µm), α1, 2, 3 (zolpidem 1.0 µm), and α1, 2, 3, 5 
(diazepam 1.0 µm).   
Across all four parameters analyzed (decay time, IPSC frequency, amplitude and total phasic current), 
α1, 2, 3 and α1, 2, 3, 5 modulation was affected by the cholinergic status. While the decay time was 
shorter in the presence of ACh than in its absence when these subunits were modulated, frequency, 
amplitude and phasic current were larger in comparison to the absence of ACh. This finding points to 
an overall increase in inhibition when ACh is present. Since ACh alone already increased the 
inhibitory current as has been shown in the current project, it is not surprising that the additional 
modulation of GABAAR subunits enhanced this effect. In contrast to results from extracellular burst 
parameter and cross-correlation analyses, effects of α1, 2, 3, 5 and α1, 2, 3 subunit-containing receptor 
modulation on IPSCs were equally influenced by ACh. Thus, the IPSC data do not support the notion 
that α5 counteracts α1, 2, 3 in the presence of ACh. This discrepancy may result from the experimentally 
required pharmacological blockade of the excitatory subnetwork during voltage clamp experiments. 
It is possible that excitatory input, which was present during extracellular recordings, is necessary to 
evoke the counterplay between α1, 2, 3 and α5. Especially the PY input to PV
+ INs may be the key factor 
missing in this experimental condition. Without increased PY activity by ACh during voltage clamp 
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experiments, PV+ INs may not be active and hence, modulation of the α1 subunit might have no 
impact. To confirm this hypothesis, experiments are needed specifically investigating the 
interrelationship between α1 and α5 modulation.  
 A further indication of the importance of full network activity for unravelling the interaction 
between ACh and the GABAergic system is the fact that α1 (2, 3) modulation was only affected by the 
ACh status in terms of IPSC frequency. Modulating α1 (2, 3) in the presence of ACh increased IPSC 
frequency in comparison to the absence of ACh. In contrast to extracellular recordings where effects 
of α1 (2, 3) modulation were enhanced on a number of parameters, IPSC results rather suggest an 
insensitivity of this subunit modulation to the cholinergic status. As stated above, network effects are 
very likely causal for differences between voltage clamp and extracellular results. As PV+ INs 
presynaptic to α1 –containing receptors are likely not directly activated by ACh, a difference between 
the two ACh conditions is not expected. Differences detected in the extracellular data set most likely 
resulted from the activation of PY neurons by ACh, which in turn increase the activity of nearby PV+ 
neurons. Hence, α1 modulation in an intact network seems to indeed dependent on the cholinergic 
status. IPSC results underline the limitations of studying complex interactions like ACh and GABAAR 
subunit modulation on isolated subnetworks.  
4.4 Summary 
 
The current project was designed to investigate the effects of the cholinergic status on GABAAR 
modulation. Due to differential modulation of IN classes by ACh and specific IN-GABAAR coupling, it 
was hypothesized that GABAAR modulators should have different effects in the presence or absence 
of ACh. First, ACh alone was investigated on a range of experiments. Direct evidence for an increase 
in inhibition by ACh was provided in voltage clamp results by an increase in IPSC frequency and 
amplitude. Increased firing and burst rates in current clamp experiments indicated the more complex 
effects ACh had on a spontaneously active network. 
Secondly, the effects of GABAAR modulators on the extracellular network were investigated in the 
presence and absence of ACh. Experiments involving L-655,708 and ACh supported the role of the α5 
subunit and consequently of SOM+ INs in ACh´s desynchronizing and decorrelating effect as already 
reported by Chen et al. (2015). Additionally, data from zolpidem (1.0 µM) experiments suggest the 
involvement of CCK+ INs as well. Here, further research is needed to confirm their role for the ACh 
effects. The lack of effects across different parameters investigated when diazepam was applied in 
the presence and absence of ACh implies that the α1 and the α5 subunit may counteract each other’s 
effects when modulated together. 
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6 Supplementary material 
 Treatment Test comparisons 
 I 
ACh- 
(norm. to Ctrl) 
n = 13 
II 
ACh- 
(norm. to ACh+1µm) 
n = 21 
III 
ACh- 
(norm. to ACh+10µm) 
n = 14 
I & II & III I & II I & II I & III I & III 
Parameter Layer md [25th & 75th 
quantile] 
md [25th & 
75thquantile] 
md [25th & 75th 
quantile] 
Kruskal-Wallis 
Χ2, p 
Wilcoxon 
ranksum p 
auroc [CIs] Wilcoxon 
ranksum p 
auroc [CIs] 
Action 
potential 
rate 
Supra 0.81 [0.56 1.06] 0.75 [0.36 1.07] 0.68 [0.54 1.01] 0.31, 0.85 -- -- -- -- 
Infra 0.51 [0.25 0.94] 0.59 [0.44 0.84] 0.88 [0.56 1.30] 4.32, 0.12 -- -- -- -- 
Fraction of 
active bins  
Supra 0.75 [0.58 1.07] 0.63 [0.39 0.94] 0.51 [0.38 0.81] 2.03, 0.36 -- -- -- -- 
Infra 0.51 [0.34 0.70] 0.53 [0.35 0.82] 0.64 [0.44 0.95] 1.64, 0.44 -- -- -- -- 
Burst rate Supra 1.09 [0.90 1.57] 0.66 [0.28 0.89]  0.62 [0.32 0.79] 9.47, 0.009 0.01 0.77 
[0.56 0.94] 
0.005 0.82 
[0.60 0.97] 
Infra 1.10 [0.93 1.61] 0.59 [0.28 0.81] 0.72 [0.31 0.83] 16.2, 0.0003 0.0002 0.88 
[0.72 0.99] 
0.0009 0.88 
[0.70 1.00] 
Relative 
time in 
burst 
Supra 0.71 [0.55 1.03] 0.81 [0.58 0.93] 0.64 [0.54 0.77] 2.18, 0.34 -- -- -- -- 
Infra 0.81 [0.65 0.96] 0.68 [0.56 0.89] 0.68 [0.58 0.87] 2.19, 0.33 -- -- -- -- 
Burst 
length 
Supra 0.90 [0.55 1.01] 1.44 [1.04 1.99] 1.03 [0.79 1.26] 9.79, 0.008 0.0014 0.17 
[0.04 0.35] 
0.17 0.34 
[0.12 0.59] 
Infra 0.73 [0.41 0.92] 1.20 [0.98 1.65] 1.00 [0.83 1.92] 11.99, 0.003 0.0007 0.14 
[0.02 0.31] 
0.02 0.24 
[0.06 0.47] 
Burst 
amplitude 
Supra 0.96 [0.64 1.22] 1.66 [1.30 1.80] 1.46 [1.18 2.16] 14.22, 0.0008 0.0005 0.14 
[0.03 0.3] 
0.0024 0.15 
[0.02 0.35] 
Infra 0.78 [0.69 0.95] 1.57 [1.06 2.44] 1.32 [1.18 2.04] 17.55, 0.0002 0.0003 0.12 
[0.01 0.27] 
0.0003 0.08 
[0.0 0.23] 
Table S1: Extracellular data comparing the effect of ACh- subsequent to different control conditions. ACh-
 
normalized to aCSF (I), ACh 1 µM (II), and ACh 10 µM (III). Medians 
(md) [25
th
 and 75
th
 quantiles] are presented. All three groups were compared with a Kruskal-Wallis test for independent data. Post-hoc analysis was done with the Wilcoxon 
ranksum test. Effect size as auroc [95% confidence intervals]. Bonferroni correction: p < 0.025; CI 0.975. 
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 Treatment Test comparisons 
 I 
Control 
II 
ACh+ 
III 
Wash-out 
I & II & III I & II I & II II & III II & III 
Parameter md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
Friedman’s 
Χ2, p 
Wilcoxon 
signrank p 
auroc [CIs] Wilcoxon 
signrank p 
auroc [CIs] 
Action 
potential rate 
(Hz) 
3.06 [0.81 3.89] 4.33 [1.34 7.60] 2.66 [0.79 5.57] 8.67, 0.01 0.01 0.35  
[0.22 0.44] 
0.02 0.62  
[0.49 0.77] 
Fraction of 
active bins 
0.09 [0.04 0.15] 0.17 [0.08 0.27] 0.07 [0.05 0.15] 6.17, 0.05 0.009 0.32  
[0.15 0.48] 
0.01 0.66  
[0.49 0.83] 
Burst rate (Hz) 0.08 [0.04 0.11] 0.14 [0.09 0.20] 0.05 [0.02 0.11] 15.27, 
0.0005 
0.003 0.30  
[0.13 0.41] 
0.001 0.75 
 [0.69 0.90] 
Relative time in 
burst 
0.24 [0.14 0.26] 0.23 [0.17 0.48]  0.17 [0.11 0.26] 7.09, 0.03 0.01 0.37  
[0.25 0.49] 
0.04 0.66  
[0.55 0.80] 
Burst length 
(ms) 
1897  
[1140 8101] 
1559  
[555 4631] 
7001  
[972 14710] 
7.17, 0.03 0.12 0.60  
[0.47 0.76] 
0.02 0.33  
[0.19 0.44] 
Table S2: Analysis of current clamp ACh+ data. Medians (md) with 25
th
 and 75
th
 quantile were calculated. Friedman’s test for dependent data was applied to compare control, 
ACh+, and wash-out conditions, and Wilcoxon signed rank test and auroc with 95% confidence intervals (CIs) were used for post-hoc analyses.
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 Treatment Test comparisons 
 I 
Control 
II 
ACh+ 
III 
ACh- 
I & II & III I & II I & II II & III II & III 
Parameter md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
Friedman’s 
Χ2, p 
Wilcoxon 
signrank p 
auroc [CIs] Wilcoxon 
signrank p 
auroc [CIs] 
Time constant τ (ms) 7.78  
[6.52 10.37] 
7.75  
[7.08 11.12] 
9.24  
[8.09 12.40] 
4.00, 0.14 -- -- -- -- 
IPSC frequency (Hz) 6.51  
[4.47 9.97] 
21.88  
[19.01 23.11] 
5.15  
[3.78 10.52] 
12.25, 0.002 0.008 0.08  
[0.0 0.19] 
0.008 0.94  
[0.81 1.00] 
IPSC amplitude (pA) 43.57 
[40.22 69.20] 
55.30  
[49.60 75.41] 
40.59  
[38.08 63.52] 
13.00, 0.002 0.008 0.25 
[0.03 0.55] 
0.008 0.80  
[0.53 1.00] 
Phasic current (pA) 2.92 
[1.71. 5.17] 
12.65 
[10.33 19.47] 
3.63 
[2.49 6.57] 
12.25, 0.002 0.008 0.02  
[0.00 0.09] 
0.008 0.94 
[0.78 1.00] 
Table S3: IPSC parameters for comparison between control, ACh
+
 and ACh
-
. Friedman’s test was calculated for the omnibus effect, Wilcoxon signed rank test was used as post 
hoc test for specific group comparisons. md = median; CI = confidence interval 
 
 
 
 Treatment Test comparisons 
 I 
ACh+ (norm. to aCSF) 
II 
TTX & ACh (norm. to TTX) 
I & II I & II 
Parameter md [25th & 75th quantile] md [25th & 75th quantile] Wilcoxon ranksum p auroc [CIs] 
Time constant τ 1.02 [0.93 1.08] 1.23 [1.09 1.28] 0.02 0.14 [0.00 0.39] 
IPSC frequency 3.56 [2.24 4.67] 0.72 [0.50 1.04] 0.0003 1.00 [1.00 1.00] 
IPSC amplitude 1.20 [1.10 1.34] 1.01 [0.93 1.04] 0.002 0.95 [0.80 1.00] 
Phasic current 4.04 [3.78 4.92]  0.86 [0.63 0.95] 0.01 0.88 [0.63 1.00] 
Table S4: Comparison between effects of ACh
+ 
and [TTX and ACh
+
]. Data were normalized to preceding control condition. The two independent data sets were compared with a 
Wilcoxon ranksum test and effect sizes were determined with auroc. 
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 Treatment  Test comparisons 
 I 
Ctrl 
II 
ACh+ 
III 
ACh- 
IV 
Wash-out 
I & II & III I & II I & II I & III I & III 
Parameter Rec 
Type 
md  
[25th & 75th 
quantile] 
md  
[25th & 75th 
quantile] 
md  
[25th & 75th 
quantile] 
md  
[25th & 75th 
quantile] 
Friedman’s 
Χ2, p 
Wilcoxon 
signed rank 
p 
auroc [CIs] Wilcoxon 
signed 
rank p 
auroc [CIs] 
Action 
potential rate 
(Hz) 
Extra 9.15  
[5.29 12.10] 
7.26 
[4.79 10.07] 
5.36 
[1.98 13.55] 
5.90 
[2.57 12.14] 
8.24, 0.04 0.08 0.63  
[0.47 0.81] 
0.74 0.56 
[0.36 0.77] 
Intra 0.74  
[0.28 1.20] 
0.60 
[0.08 1.13] 
0.32 
[0.05 0.77] 
0.36 
[0.04 0.82] 
1.18, 0.76 -- -- -- -- 
Fraction of 
active bins 
Extra 0.19 
[0.09 0.21] 
0.14 
[0.08 0.18] 
0.10 
[0.05 0.19] 
0.13 
[0.08 0.15] 
8.25, 0.04 0.15 0.63 
[0.50 0.81] 
0.55 0.57 
[0.36 0.80] 
Intra 0.06 
[0.03 0.09] 
0.04 
[0.01 0.10] 
0.03 
[0.01 0.07] 
0.03 
[0.00 0.05] 
2.61, 0.46 -- -- -- -- 
Burst rate (Hz) Extra 0.31 
[0.21 0.41] 
0.25 
[0.17 0.41] 
0.17 
[0.12 0.35] 
0.14 
[0.13 0.20] 
12.15, 
0.007 
0.74 0.53 
[0.30 0.80] 
0.38 0.59 
[0.42 0.77] 
Relative time in 
burst 
Extra 0.14 
[0.11 0.18] 
0.12 
[0.10 0.15] 
0.13 
[0.08 0.15] 
0.13 
[0.09 0.14] 
8.55, 0.04 0.02 0.64  
[0.53 0.80] 
0.64 0.52 
[0.34 0.69] 
Burst length 
(ms) 
Extra 419 
[342 624] 
336 
[265 622] 
513 
[381 587] 
577 
[398 970] 
1.95, 0.58 -- -- -- -- 
Burst 
amplitude (mV) 
Extra 0.07 
[0.05 0.11] 
0.08 
[0.05 0.11] 
0.08 
[0.05 0.10] 
0.10 
[0.05 0.12] 
0.15, 1.00 -- -- -- -- 
Table S5: Comparison of Control (Ctrl), ACh
+
, ACh
-
, and wash condition for extra- and intracellular current clamp recordings in cortex-basal forebrain MIK co-cultures.  
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 Treatment Test comparisons 
 I 
Control 
II 
ACh+ 
III 
Wash-out 
I & II & III I & II I & II II & III II & III 
Parameter md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
md [25th & 75th 
quantile] 
Friedman’s 
Χ2, p 
Wilcoxon 
signrank p 
auroc [CIs] Wilcoxon 
signrank p 
auroc [CIs] 
Resistance (MΩ) 52.92 
[43.40 58.62] 
58.43 
[49.85 74.60] 
53.70 
[48.15 59.10] 
1.4, 0.50 -- -- -- -- 
Emrest (mV) -76.49 
[-80.28 -72.72] 
-69.63 
[-76.22 -64.51] 
-74.30 
[-82.89 -68.07] 
12.2, 0.002† 0.01† 0.28 
[0.11 0.42] 
-- -- 
Emrest fluct (mV) 0.80  
[0.57 1.38] 
1.70 
[1.14 5.89] 
0.83 
[0.53 1.20] 
7.8, 0.02 0.01 0.21  
[0.05 0.38] 
0.01 0.82  
[0.66 0.97] 
Emburst (mV)  
(10-100 ms) 
-66.22 
[-69.70 -59.01] 
-61.93 
[-68.36 -59.84] 
-63.92 
[-66.90 -58.86] 
4.2, 0.12 -- -- -- -- 
Action potential 
rate (Hz) 
2.57 [0.79 6.51] 2.88 [1.24 3.52] 1.34 [0.52 2.77] 2.21, 0.33 -- -- -- -- 
Excitability (# SPX) 4.00 [3.19 5.09] 7.50 [6.08 8.58] 6.00 [4.67 7.17] 12.67, 0.002 0.004 0.10 
[0.00 0.22] 
0.02 0.70 
[0.57 0.89] 
Cross-correlation 
of SPX 
0.66 [0.44 0.68] 0.41 [0.16 0.57] 0.54 [0.44 0.72] 6.75, 0.03 0.02 0.72  
[0.53 0.91] 
0.04 0.30  
[0.09 0.47] 
Table S6: Analysis of intracellular current clamp parameters of X98 data set of organotypic cultures. Data sets, where p-values were marked with † do not fulfill the 
requirement of equal variances.   
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 Treatment 
  Zolpidem 1 µM Zolpidem 0.2 µM 
Parameter Layer ACh+ 
md [25th & 75th 
quantile]  
(n = 37) 
ACh- 
md [25th & 75th 
quantile]  
(n = 35) 
Wilcoxon 
ranksum p 
auroc [CIs] ACh+ 
md [25th & 75th 
quantile] 
(n = 49) 
ACh- 
md [25th & 75th 
quantile] 
(n = 33) 
Wilcoxon 
ranksum 
p 
auroc [CIs] 
Action 
potential rate 
Supra 0.21 [0.04 1.01] 0.57 [0.27 0.78] 0.17 0.40  
[0.26 0.55] 
0.34 [0.16 0.86] 0.49 [0.29 0.71] 0.41 0.45  
[0.32 0.57] 
Infra 0.49 [0.17 0.74] 0.51 [0.34 0.65] 1.00 0.50  
[0.36 0.64] 
0.75 [0.52 1.02] 0.73 [0.42 0.82] 0.38 0.56 
[0.43 0.69] 
Fraction of 
active bins 
Supra 0.42 [0.06 1.14] 0.72 [0.49 1.09] 0.09 0.38 
[0.24 0.52] 
0.55 [0.29 1.06] 0.84 [0.60 1.11] 0.11† 0.40 
[0.28 0.52] 
Infra 0.76 [0.41 1.13] 0.83 [0.48 1.06] 0.94† 0.49 
 [0.35 0.64] 
1.01 [0.87 1.15] 0.92 [0.71 1.11] 0.26 0.58 
[0.44 0.70] 
Burst rate Supra 0.80 [0.52 1.29] 1.05 [0.67 1.36] 0.27 0.42  
[0.29 0.56] 
0.50 [0.32 0.74] 0.78 [0.46 1.10] 0.07 0.37 
[0.23 0.51] 
Infra 0.99 [0.73 1.39] 1.18 [0.67 1.42] 0.56 0.46 
[0.32 0.60] 
0.52 [0.31 0.91] 0.84 [0.62 1.01] 0.01 0.32 
[0.19 0.46] 
Relative time 
in burst 
Supra 0.63 [0.17 1.04] 0.79 [0.53 1.12] 0.07 0.37 
[0.24 0.51] 
0.36 [0.17 0.80] 0.70 [0.29 0.84] 0.13 0.39 
[0.25 0.53] 
Infra 0.62 [0.30 1.18] 0.92 [0.65 1.23] 0.04 0.36 
[0.23 0.50] 
0.49 [0.12 0.86] 0.82 [0.60 0.97] 0.02 0.33 
[0.20 0.47] 
Burst length Supra 0.72 [0.28 1.07] 0.80 [0.39 1.40] 0.26 0.42  
[0.29 0.56] 
0.73 [0.19 1.08] 0.86 [0.51 1.08] 0.27 0.42 
[0.29 0.56] 
Infra 0.60 [0.28 1.04] 0.84 [0.50 0.98] 0.18 0.41 
[0.27 0.54] 
1.01 [0.64 1.48] 0.97 [0.68 1.06] 0.33 0.57 
[0.43 0.71] 
Burst 
amplitude 
Supra 0.51 [0.33 0.81] 0.55 [0.45 0.73] 0.72 0.47 
[0.34 0.62] 
0.63 [0.45 0.93] 0.71 [0.50 0.87] 0.64 0.47 
[0.33 0.60] 
Infra 0.56 [0.41 0.79] 0.57 [0.44 0.72] 1.00 0.50 
[0.36 0.64] 
0.81 [0.53 0.99] 0.69 [0.62 0.87] 0.76 0.52 
[0.38 0.67] 
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 Treatment 
  Diazepam Diazepam in alpha 1 
Parameter Layer ACh+ 
md [25th & 75th 
quantile]  
(n = 26) 
ACh- 
md [25th & 75th 
quantile]  
(n = 22) 
Wilcoxon 
ranksum p 
auroc [CIs] ACh+ 
md [25th & 75th 
quantile] 
(n = 38) 
ACh- 
md [25th & 75th 
quantile] 
(n = 36) 
Wilcoxon 
ranksum 
p 
auroc [CIs] 
Action 
potential rate 
Supra 0.42 [0.26 0.68] 0.40 [0.19 0.77] 0.72 0.53  
[0.36 0.70] 
0.72 [0.37 1.01] 0.79 [0.59 1.05] 0.36 0.44 
[0.30 0.58] 
Infra 0.54 [0.32 1.08] 0.60 [0.44 0.95] 0.99 0.50  
[0.32 0.67] 
0.84 [0.51 1.13] 0.75 [0.59 1.04] 0.98 0.50  
[0.36 0.65] 
Fraction of 
active bins 
Supra 0.86 [0.61 1.06] 0.77 [0.54 1.20] 0.89 0.49 
[0.32 0.66] 
0.90 [0.69 1.06] 1.08 [0.80 1.30] 0.06 0.37 
[0.24 0.51] 
Infra 1.09 [0.49 1.40] 1.09 [0.92 1.63] 0.56 0.45 
[0.28 0.62] 
0.97 [0.75 1.18] 0.96 [0.86 1.24] 0.59 0.46 
[0.32 0.61] 
Burst rate Supra 0.88 [0.42 0.98] 1.41 [0.74 1.76] 0.01 0.29 
[0.12 0.45] 
0.84 [0.67 1.20] 1.15 [0.79 1.55] 0.01† 0.32 
[0.20 0.45] 
Infra 0.82 [0.41 1.04] 1.32 [0.64 1.66] 0.03 0.31 
[0.16 0.48] 
0.87 [0.62 1.17] 1.21 [0.89 1.55] 0.005 0.29  
[0.17 0.43] 
Relative time 
in burst 
Supra 0.82 [0.58 1.15] 0.86 [0.59 1.14] 0.87 0.52 
[0.34 0.68] 
0.87 [0.71 1.10] 0.91 [0.64 1.16] 0.83 0.52 
[0.38 0.65] 
Infra 0.85 [0.53 1.06] 0.86 [0.50 1.17] 1.00 0.50 
[0.33 0.66] 
0.83 [0.61 0.97] 0.85 [0.54 1.21] 0.31† 0.42 
[0.28 0.57] 
Burst length Supra 0.92 [0.81 1.05] 0.65 [0.25 0.84] 0.001 0.78 
[0.63 0.91] 
0.98 [0.81 1.18] 0.80 [0.51 0.92] 0.001 0.72 
[0.60 0.84] 
Infra 0.97 [0.64 1.12] 0.75 [0.29 0.91] 0.07 0.66 
[0.49 0.81] 
0.95 [0.75 1.13] 0.79 [0.34 0.94] 0.04 0.65  
[0.51 0.79] 
Burst 
amplitude 
Supra 0.54 [0.44 0.75] 0.57 [0.47 0.74] 0.86 0.48 
[0.32 0.65] 
0.76 [0.63 0.87] 0.75 [0.58 0.83] 0.31 0.57 
[0.43 0.70] 
Infra 0.57 [0.51 0.92] 0.57 [0.48 0.76] 0.42 0.57 
[0.40 0.73] 
0.77 [0.63 0.86] 0.63 [0.55 0.76] 0.01 0.69 
[0.55 0.82] 
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  Treatment 
  L-655,708 
Parameter Layer ACh+ 
md [25th & 75th quantile]  
(n = 54) 
ACh- 
md [25th & 75th quantile]  
(n = 36) 
Wilcoxon ranksum p auroc [CIs] 
Action 
potential rate 
Supra 1.14 [0.64 1.40] 1.02 [0.83 1.35] 0.86 0.51  
[0.39 0.63] 
Infra 0.98 [0.72 1.17] 1.08 [0.75 1.37] 0.36 0.44  
[0.32 0.57] 
Fraction of 
active bins 
Supra 1.00 [0.70 1.24] 0.93 [0.75 1.06] 0.39 0.56 
[0.43 0.68] 
Infra 0.95 [0.66 1.08] 0.89 [0.73 1.12] 0.91 0.49 
[0.37 0.61] 
Burst rate Supra 1.25 [0.83 1.80] 1.12 [0.93 1.37] 0.67† 0.53 
[0.40 0.65] 
Infra 1.29 [0.76 1.91] 1.20 [0.91 1.58] 0.71† 0.53 
[0.40 0.65] 
Relative time 
in burst 
Supra 1.23 [1.04 1.56] 1.02 [0.84 1.27] 0.01 0.67 
[0.55 0.78] 
Infra 1.07 [0.87 1.37] 1.00 [0.86 1.21] 0.49 0.55 
[0.41 0.68] 
Burst length Supra 0.96 [0.75 1.20] 0.96 [0.71 1.10] 0.47 0.55 
[0.42 0.67] 
Infra 0.90 [0.65 1.27] 0.93 [0.70 1.10] 0.65 0.53 
[0.40 0.66] 
Burst 
amplitude 
Supra 1.10 [0.92 1.45] 0.96 [0.87 1.11] 0.04† 0.64 
[0.52 0.76] 
Infra 0.97 [0.79 1.42] 1.01 [0.82 1.10] 0.35† 0.56 
[0.43 0.68] 
Table S7: Extracellular parameter analysis for all GABAAR modulators. Data sets were normalized to ACh
+
 or ACh
- 
and then compared per GABAAR modulator for each layer 
separately.  
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 Treatment Test comparisons 
 I  
ACh+ 
II  
ACh- 
I & II I & II 
Frequency band 
Drug condition 
md [25th & 75th quantile] md [25th & 75th quantile] Wilcoxon ranksum p auroc [CIs] 
Delta [2 5] Hz 
Zolpidem 1.0 µM 
Zolpidem 0.2 µM 
Diazepam 
Diazepam alpha 1 
L-655.708 
 
0.88 [0.52 0.98] 
0.77 [0.52 0.89] 
0.87 [0.67 0.96] 
0.98 [0.90 0.99] 
1.02 [0.97 1.07] 
 
0.93 [0.81 0.98] 
0.95 [0.82 1.04] 
0.94 [0.90 0.99] 
0.99 [0.91 1.02] 
0.99 [0.95 1.02] 
 
0.09 
0.0008 
0.16 
0.47 
0.04 
 
0.38 [0.25 0.52] 
0.28 [0.17 0.40] 
0.38 [0.22 0.55] 
0.45 [0.31 0.59] 
0.63 [0.51 0.75] 
Theta [6 12] Hz 
Zolpidem 1.0 µM 
Zolpidem 0.2 µM 
Diazepam 
Diazepam alpha 1 
L-655,708 
 
0.63 [0.41 0.81] 
0.73 [0.43 0.86] 
0.75 [0.57 0.92] 
0.89 [0.71 0.97] 
1.05 [0.93 1.28] 
 
0.89 [0.78 0.99] 
0.85 [0.68 0.99] 
0.87 [0.76 0.95] 
0.96 [0.82 1.00] 
0.99 [0.90 1.04] 
 
0.0001 
0.03 
0.13† 
0.29 
0.04† 
 
0.23 [0.13 0.35] 
0.36 [0.24 0.48] 
0.37 [0.21 0.54] 
0.43 [0.29 0.57] 
0.63 [0.51 0.74] 
Beta [15 30] Hz 
Zolpidem 1.0 µM 
Zolpidem 0.2 µM 
Diazepam 
Diazepam alpha 1 
L-655,708 
 
0.66 [0.42 0.88] 
0.82 [0.69 1.00] 
0.75 [0.53 0.93] 
0.90 [0.57 1.08] 
1.10 [0.93 1.47] 
 
0.78 [0.58 0.91] 
0.80 [0.62 1.11] 
0.83 [0.70 1.03] 
0.90 [0.76 1.05] 
0.95 [0.74 1.07] 
 
0.16 
0.83 
0.14 
0.54† 
0.003 
 
0.40 [0.27 0.54] 
0.49 [0.35 0.62] 
0.37 [0.22 0.54] 
0.46 [0.32 0.60] 
0.68 [0.57 0.79] 
Gamma [30 50] Hz 
Zolpidem 1.0 µM 
Zolpidem 0.2 µM 
Diazepam 
Diazepam alpha 1 
L-655,708 
 
0.91 [0.64 1.07] 
1.05 [0.91 1.15] 
0.92 [0.62 1.27] 
0.97 [0.70 1.30] 
1.05 [0.90 1.34] 
 
1.02 [0.71 1.46] 
1.06 [0.79 1.36] 
0.87 [0.81 1.03] 
0.99 [0.78 1.16] 
1.08 [0.83 1.30] 
 
0.20 
0.98† 
0.86 
0.90 
0.90 
 
0.41 [0.28 0.55] 
0.50 [0.36 0.65] 
0.48 [0.32 0.65] 
0.51 [0.37 0.65] 
0.49 [0.37 0.61] 
High gamma [50 80] Hz 
Zolpidem 1.0 µM 
Zolpidem 0.2 µM 
 
0.90 [0.78 1.00] 
1.00 [0.94 1.21] 
 
 
 
 
1.04 [0.73 1.27] 
1.06 [0.89 1.21] 
 
0.04† 
0.87 
 
0.36 [0.23 0.50] 
0.49 [0.36 0.62] 
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Diazepam 
Diazepam alpha 1 
L-655,708 
0.99 [0.89 1.25] 
0.90 [0.72 1.04] 
0.96 [0.81 1.11] 
 0.95 [0.82 1.08] 
1.02 [0.87 1.32] 
0.98 [0.85 1.10] 
0.33 
0.009 
0.75 
0.58 [0.42 0.74] 
0.32 [0.20 0.45] 
0.48 [0.36 0.60] 
Table S8: Cross correlation between signals from supra- and infragranular layers for given frequency band and substance.  
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 Treatment Test comparisons 
 I 
ACh+ 
II 
ACh- 
I & II I & II 
Frequency band 
Drug condition/ Layer 
md [25th & 75th quantile] md [25th & 75th quantile] Wilcoxon ranksum p auroc [CIs] 
Delta [2 5] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
Diazepam alpha 1/ L2 
L-655,708/ L2 
 
0.70 [0.24 1.01] 
0.69 [0.48 0.79] 
0.77 [0.57 0.90] 
0.89 [0.76 1.04] 
1.03 [0.94 1.29] 
 
0.77 [0.60 1.02] 
0.81 [0.71 0.90] 
0.81 [0.64 0.93] 
0.96 [0.88 1.03] 
1.01 [0.97 1.06] 
 
0.19 
0.004 
0.67 
0.16 
0.47 
 
0.41 [0.27 0.55] 
0.31 [0.20 0.43] 
0.46 [0.30 0.63] 
0.40 [0.27 0.54] 
0.55 [0.43 0.67] 
Theta [6 12] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
Diazepam alpha 1/ L2 
L-655,708/ L2 
 
0.74 [0.35 1.12] 
0.72 [0.45 1.04] 
0.79 [0.54 1.14] 
0.93 [0.67 1.02] 
1.02 [0.96 1.45] 
 
0.96 [0.75 1.12] 
0.83 [0.70 0.99] 
0.89 [0.77 1.05] 
1.01 [0.90 1.07] 
1.01 [0.92 1.08] 
 
0.09 
0.11 
0.19 
0.06 
0.10† 
 
0.38 [0.25 0.52] 
0.39 [0.28 0.52] 
0.39 [0.23 0.55] 
0.37 [0.24 0.50] 
0.60 [0.48 0.72] 
Beta [15 30] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
Diazepam alpha 1/ L2 
L-655,708/ L2 
 
0.78 [0.33 1.25] 
0.89 [0.59 1.25] 
0.97 [0.52 1.43] 
0.97 [0.80 1.32] 
1.12 [0.89 1.46] 
 
 
 
1.02 [0.78 1.37] 
0.77 [0.64 1.13] 
0.99 [0.77 1.56] 
1.00 [0.86 1.17] 
0.93 [0.77 1.22] 
 
0.04 
0.57 
0.41 
0.86 
0.03 
 
0.35 [0.22 0.49] 
0.54 [0.41 0.67] 
0.43 [0.27 0.60] 
0.49 [0.35 0.63] 
0.64 [0.52 0.76] 
Low gamma [30 50] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
Diazepam alpha 1/ L2 
L-655,708/ L2 
 
0.90 [0.49 1.26] 
0.79 [0.59 1.01] 
0.83 [0.72 0.98] 
0.89 [0.71 1.01] 
1.06 [0.94 1.20] 
 
 
 
 
 
0.95 [0.76 1.06] 
0.93 [0.78 1.01] 
0.90 [0.79 1.00] 
0.97 [0.84 1.06] 
0.98 [0.89 1.07] 
 
0.67† 
0.11† 
0.40 
0.07 
0.06† 
 
0.47 [0.32 0.62] 
0.40 [0.28 0.52] 
0.43 [0.26 0.59] 
0.37 [0.24 0.51] 
0.62 [0.50 0.73] 
High gamma [50 80] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
 
0.69 [0.48 0.94] 
0.78 [0.49 0.98] 
0.88 [0.77 1.08] 
 
 
 
1.01 [0.79 1.18] 
0.90 [0.82 0.98] 
0.94 [0.75 1.04] 
 
0.01 
0.06† 
0.94 
 
0.32 [0.19 0.45] 
0.38 [0.26 0.50] 
0.49 [0.32 0.66] 
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Diazepam alpha 1/ L2 
L-655,708/ L2 
0.97 [0.70 1.13]  
1.03 [0.94 1.16] 
0.95 [0.88 1.04] 
1.00 [0.95 1.09] 
0.74† 
0.53† 
0.48 [0.34 0.62] 
0.54 [0.42 0.66] 
Wideband [0 200] Hz 
Zolpidem 1.0 µM/ L2 
Zolpidem 0.2 µM/ L2 
Diazepam/ L2 
Diazepam alpha 1/ L2 
L-655,708/ L2 
 
0.64 [0.22 1.00] 
0.67 [0.47 0.76] 
0.74 [0.56 1.04] 
0.90 [0.75 1.01] 
1.05 [0.97 1.28] 
 
 
 
0.79 [0.57 0.98] 
0.81 [0.79 0.90] 
0.80 [0.71 0.88] 
0.93 [0.87 1.00] 
1.01 [0.91 1.06] 
 
0.08 
0.002 
0.83 
0.20† 
0.09 
 
0.38 [0.25 0.52] 
0.30 [0.19 0.42] 
0.48 [0.31 0.65] 
0.41 [0.27 0.55] 
0.61 [0.49 0.72] 
 
 Treatment Test comparisons 
 I 
ACh+ 
II 
ACh- 
I & II I & II 
Frequency band 
Drug condition/ Layer 
md [25th & 75th quantile] md [25th & 75th quantile] Wilcoxon ranksum p auroc [CIs] 
Delta [2 5] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5 
Diazepam alpha 1/ L5 
L-655,708 
 
0.59 [0.48 0.79] 
0.59 [0.51 0.84] 
0.69 [0.55 0.99] 
0.82 [0.70 0.10] 
1.04 [0.99 1.34] 
 
0.89 [0.71 1.03] 
0.81 [0.68 0.96] 
0.92 [0.74 1.00] 
0.95 [0.86 1.02] 
0.98 [0.91 1.10] 
 
0.0008 
0.005 
0.12 
0.03 
0.06 
 
0.26 [0.15 0.39] 
0.31 [0.20 0.44] 
0.37 [0.21 0.53] 
0.35 [0.22 0.48] 
0.62 [0.49 0.74] 
Theta [6 12] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5  
Diazepam alpha 1/ L5 
L-655,708/ L5 
 
0.73 [0.49 0.97] 
0.83 [0.63 1.11] 
0.85 [0.57 1.27] 
0.87 [0.74 1.07] 
1.07 [0.96 1.42] 
 
0.98 [0.81 1.38] 
0.87 [0.63 1.03] 
1.05 [0.92 1.13] 
0.98  [0.84 1.10] 
0.96 [0.85 1.09] 
 
0.005 
0.94 
0.15† 
0.35 
0.007† 
 
0.30 [0.18 0.43] 
0.49 [0.37 0.62] 
0.38 [0.21 0.55] 
0.43 [0.30 0.58] 
0.67 [0.55 0.78] 
Beta [15 30] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5 
Diazepam alpha 1/ L5  
L-655,708/ L5 
 
0.84 [0.64 1.09] 
0.98 [0.76 1.24] 
1.05 [0.72 1.31] 
0.90 [0.76 1.15] 
1.16 [0.92 1.48] 
 
 
 
1.18 [0.96 1.49] 
1.01 [0.76 1.25] 
1.19 [1.01 1.68] 
1.05 [0.87 1.22] 
0.92 [0.82 1.18] 
 
0.02 
0.86 
0.13 
0.27 
0.02 
 
0.33 [0.20 0.47] 
0.51 [0.38 0.64] 
0.37 [0.21 0.53] 
0.42 [0.29 0.56] 
0.65 [0.53 0.76] 
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Low gamma [30 50] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5 
Diazepam alpha 1/ L5 
L-655,708/ L5 
 
0.71 [0.57 1.02] 
0.88 [0.64 1.06] 
0.83 [0.69 1.04] 
0.96 [0.85 1.08] 
0.99 [0.88 1.10] 
 
 
 
0.97 [0.73 1.11] 
0.91 [0.78 1.08] 
0.99 [0.87 1.10] 
0.96 [0.83 1.05] 
0.95 [0.85 1.03] 
 
0.04 
0.48 
0.08 
0.72 
0.19 
 
0.35 [0.22 0.49] 
0.45 [0.33 0.58] 
0.34 [0.19 0.51] 
0.53 [0.38 0.67] 
0.58 [0.46 0.70] 
High gamma [50 80] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5 
Diazepam alpha 1/ L5 
L-655,708/ L5 
 
0.71 [0.47 0.90] 
0.83 [0.70 0.99] 
0.86 [0.62 1.07] 
0.97 [0.82 1.14] 
1.01 [0.91 1.07] 
 
 
 
0.95 [0.67 1.14] 
0.92 [0.79 1.01] 
0.93 [0.83 1.21] 
0.93 [0.85 1.05] 
0.97 [0.89 1.04] 
 
0.02 
0.21 
0.12 
0.56 
0.24 
 
0.33 [0.20 0.46] 
0.42 [0.29 0.54] 
0.36 [0.21 0.53] 
0.54 [0.40 0.68] 
0.57 [0.45 0.70] 
Wideband [0 200] Hz 
Zolpidem 1.0 µM/ L5 
Zolpidem 0.2 µM/ L5 
Diazepam/ L5 
Diazepam alpha 1/ L5 
L-655,708/ L5 
 
0.62 [0.48 0.84] 
0.58 [0.47 0.83] 
0.68 [0.53 0.77] 
0.82 [0.72 1.00] 
1.09 [0.96 1.25] 
 
 
 
0.87 [0.76 1.10] 
0.83 [0.73 0.91] 
0.82 [0.62 0.94] 
0.92 [0.81 0.99] 
1.00 [0.90 1.12] 
 
0.001 
0.01 
0.05 
0.44 
0.11 
 
0.28 [0.16 0.40] 
0.33 [0.21 0.45] 
0.33 [0.17 0.49] 
0.44 [0.30 0.59] 
0.60 [0.48 0.71] 
Table S9: Cross correlation of ifr with different frequency bands (gamma and high gamma envelop). Zolpidem (1.0 µM), zolpidem (0.2 µM), diazepam, diazepam in alpha 1 
knock-in, and L655, 708 were analyzed for supragranular (L2) and infragranular (L5) layers for all frequency bands listed in the table. Data sets, where p-values were marked in 
red with † do not fulfill the requirement of equal variances.   
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 Treatment 
 I 
Zolpidem  (1 µM)  
II 
Zolpidem  (0.2 µM) 
III 
Diazepam 
IV 
Sham 
Parameter md [25th & 75th quantile] md [25th & 75th quantile] md [25th & 75th quantile] md [25th & 75th quantile] 
Time constant τ  1.65 [1.48 1.95] 1.91 [1.71 2.16] 2.03 [1.87 2.26] 1.25 [1.13 1.47] 
IPSC frequency 0.82 [0.38 1.03] 0.25 [0.15 0.38] 0.56 [0.33 0.67] 0.40 [0.15 0.65] 
IPSC amplitude 0.96 [0.80 1.06] 0.95 [0.74 1.11] 0.80 [0.66 0.93] 0.85 [0.75 1.01] 
Phasic current 0.88 [0.53 1.94] 0.43 [0.19 0.89] 0.73 [0.41 1.10] 0.49 [0.18 0.63] 
 
 Treatment 
 I, II, III & IV I & IV 
 
II & IV 
 
III & IV 
 
Parameter Kruskal-Wallis Χ2, p Wilcoxon 
ranksum p 
auroc [CIs] Wilcoxon 
ranksum p 
auroc [CIs] Wilcoxon 
ranksum p 
auroc [CIs] 
Time constant τ  35.46, 0.0000001 0.0003 0.85 [0.68 0.97] 0.00001 0.94 [0.83 1.00] 0.0000005 0.99 [0.94 1.00] 
IPSC frequency 18.76, 0.0003† 0.006 0.76 [0.55 0.92] 0.34 0.40 [0.16 0.66] 0.12 0.65 [0.41 0.86] 
IPSC amplitude 8.03, 0.045 0.11 0.65 [0.42 0.86] 0.20 0.63 [0.39 0.85] 0.34 0.41 [0.19 0.63] 
Phasic current 14.67, 0.002 0.002 0.80 [0.60 0.93] 0.50 0.50 [0.25 0.73] 0.03 0.71 [0.49 0.89] 
Table S10: Comparison of zolpidem (1 µM), zolpidem (0.2 µM), and diazepam against sham for analysis of GABAAR modulator effect independent of ACh condition. For all four 
groups, ACh
+
 and ACh
-
 data were pooled. Data were normalized to control condition. For post-hoc pairwise comparisons with Wilcoxon ranksum test, p-value was adjusted with 
Bonferroni correction: p < 0.02; CIs 0.983. 
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 Treatment 
 Zolpidem 1 µM (n = 11) Zolpidem 0.2 µM (n = 9) 
Parameter ACh+ 
md [25th & 75th 
quantile] 
ACh- 
md [25th & 75th 
quantile] 
Wilcoxon 
signrank p 
auroc [CIs] ACh+ 
md [25th & 75th 
quantile] 
ACh- 
md [25th & 75th 
quantile] 
Wilcoxon 
signrank p 
auroc [CIs] 
Time constant τ 
(ms) 
1.50 
[1.38 1.80] 
1.85 
[1.51 2.10] 
0.02 0.30 
[0.15 0.45] 
1.82 
[1.63 2.04] 
1.93 
[1.74 2.23] 
0.36 0.41 
[0.22 0.61] 
IPSC frequency 
(Hz)  
0.99 
[0.85 1.06] 
0.52 
[0.30 0.79] 
0.03 0.74 
[0.55 0.93] 
0.32  
[0.18 0.42] 
0.15 
[0.13 0.38] 
0.01 0.69 
[0.56 0.88] 
IPSC amplitude 
(pA) 
1.05 
[0.93 1.10] 
0.89 
[0.80 0.97] 
0.05 0.74 
[0.52 0.93] 
0.90 
[0.85 1.08] 
1.03 
[0.73 1.28] 
0.50 0.52 
[0.33 0.73] 
Phasic current 
(pA) 
1.46 
[1.02 1.96] 
0.54 
[0.41 0.80] 
0.001 0.83 
[0.71 0.98] 
0.41 
[0.26 0.61] 
0.52 
[0.15 0.97] 
1.00 0.48 
[0.26 0.74] 
 
 
 Treatment 
 Diazepam (n = 11) Sham (n = 8) 
Parameter ACh+ 
md [25th & 75th 
quantile] 
ACh- 
md [25th & 75th 
quantile] 
Wilcoxon 
signrank p 
auroc [CIs] ACh+ 
md [25th & 75th 
quantile] 
ACh- 
md [25th & 75th 
quantile] 
Wilcoxon 
signrank p 
auroc [CIs] 
Time constant τ 
(ms) 
1.94 
[1.77 2.03] 
2.12 
[2.03 2.46] 
0.02 0.21 
[0.05 0.41] 
1.15 
[1.12 1.27] 
1.47 
[1.22 1.54] 
0.02 0.19 
[0.00 0.39] 
IPSC frequency 
(Hz) 
0.67 
[0.59 0.78] 
0.33 
[0.27 0.47] 
0.002 0.93 
[0.75 1.00] 
0.63 
[0.40 0.71] 
0.15 
[0.04 0.36] 
0.02 0.88 
[0.67 1.00] 
IPSC amplitude 
(pA) 
0.86 
[0.70 1.08] 
0.77 
[0.59 0.81] 
0.02 0.73 
[0.55 0.93] 
1.00 
[0.79 1.02] 
0.84 
[0.55 0.86] 
0.01 0.73 
[0.70 0.89] 
Phasic current 
(pA) 
0.90 
[0.74 1.25] 
0.41 
[0.22 0.70] 
0.01 0.87 
[0.68 1.00] 
0.64 
[0.55 0.79] 
0.18 
[0.15 0.35] 
0.02 0.94 
[0.75 1.00] 
Table S11: IPSC analysis for zolpidem (1 µM), zolpidem (0.2 µM), diazepam and sham in the ACh
+
 and ACh
-
 condition.    
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